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Abstract 
In recent years, photoredox catalysis emerged as a privileged tool for small molecules 
activation via single-electron transfer mechanisms. Despite their ubiquity as reagents in 
organic synthesis, the use of boronic acid derivatives to generate carbon-centred radicals 
remains elusive. This dissertation explores the utilisation of photoredox catalysis to 
generate carbon radicals from boronic acid derivatives and subsequently engage them in 
C–C cross-coupling reactions. 
In the first chapter, an introduction to photoredox catalysis and organoboron reagents is 
provided, as well as a discussion on the key mechanistic aspects of photoredox 
catalysed C–C cross-coupling reactions. 
The second chapter presents our initial coupling strategy and how it evolved in 
understanding that pinacol boronic ester species can be used as a source of carbon 
radicals via single-electron oxidation from a photoredox catalyst. Coordination of the 
boronic esters with Lewis basic species was identified as a fundamental activating 
interaction. The synthetic utility of this discovery was highlighted by performing a wide 
range of photoredox catalysed arylations of pinacol boronic esters. 
The third chapter builds on our mechanistic understanding to identify a set of Lewis 
base catalysts that conveniently activates boronic esters and acids towards single-
electron oxidation. The usefulness of this improved set of conditions was demonstrated 
by alkylating a wide range of boronic acid derivatives. 
The fourth chapter describes the application of this methodology in synthesising four 
active pharmaceutical ingredients from the GABA family. An emphasis was made on 
developing an efficient flow process and “transition metal free” conditions to survey the 
attractiveness of the method for the pharmaceutical industry. 
Finally, the fifth chapter describes the experimental procedures relevant to the results 
described in chapters 2 to 4. 
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1 Introduction 
1.1 Visible light photoredox catalysis 
Achieving the conversion of abundant solar energy into useful chemical energy has been 
a long-standing objective of scientists from all disciplines over the past 100 years.[1] It is 
commonly accepted that harnessing even a fraction of the power delivered by the sun to 
earth would enable the humanity to live sustainably without relying on fossil fuels.[2] At 
the beginning of the 20th century, Ciamician realised the immense power of solar light to 
drive chemical processes.[3] By reporting the first documented photochemical organic 
reactions, he paved the way to UV light photochemistry which ultimately led to the 
discovery of a wealth of new chemical reactivity.[4] The concept was revolutionary at the 
time, but if one wants to harness the full power of the sun, the entire spectrum of emission 
has to be captured. 
 
Graph 1 – Solar emission spectrum received on earth.[5] 
From Graph 1, it can be seen that the low UV-content of sunlight (only 3%) does not 
make it an efficient light source to photoactivate UV-absorbing organic molecules. On the 
other hand, with 44% of the overall irradiation from the sun received on earth, visible 
light constitutes a much more attractive frequency window to be used to perform 
photochemistry.[6] Therefore, the use of photocatalysts which absorb visible light to 
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mediate photochemical reactions is highly attractive as a more efficient solar energy 
harnessing process. 
1.1.1 Photocatalysis in chemical synthesis 
In general, visible light photoredox catalysis describes the use of low energy visible light 
(380 nm – 750 nm) to drive otherwise energetically disfavoured chemical redox reactions. 
The development of modern transition metal-based catalysts (such as [Ru(bpy)3]2+) with 
efficient absorption properties and long-lived excited states has enabled the development 
of efficient visible light induced photoreactions. The opportunity to use natural sunlight 
for chemical transformations introduces new possibilities to transfer and store energy in a 
sustainable manner, such as the production of hydrogen by water-splitting or solar fuels 
from carbon dioxide, which encourages significant scientific understanding and progress 
in this field.[7–10] 
Although pioneering applications of this principle in organic synthesis date back to the 
work of Kellogg et al. in 1978,[11] it took three decades for the organic synthetic 
community to realise the full synthetic potential of these methods. The year 2008 marked 
a clear resurgence of interest in this field with the landmark work of Yoon[12] and 
MacMillan[13] shortly followed by Stephenson[14]. 
 
Figure 1 – Examples of commonly employed homogeneous and heterogeneous photocatalysts. 
This approach has now been used in a wide variety of transformations in organic 
synthesis, including C–C or C–X bond forming reactions, cycloadditions, oxidations, and 
reductions with applications ranging from complex natural product synthesis to late-stage 
functionalisation of pharmaceutical compounds.[15–18] The majority of these protocols 
make use of homogeneous iridium- or ruthenium-based transition metal complexes as 
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photocatalysts (such as [Ru(bpy)3]2+ in Figure 1). Organic dyes, such as eosin Y, represent 
an interesting alternative to transition metal based photocatalysts for industrial 
applications where the purity of the products needs to comply with residual transition 
metal limits (permitted daily exposure (PDE) ∑(Ir, Os, Rh, Ru) ≤ 100 µg/day).[17,19,20] A 
recent demonstration of organic photocatalysis on an industrial scale was made by Sanofi 
to produce the anti-malarial drug artemisinin (35 tonnes/year in 2013).[21–23] 
Apart from organic photocatalysts, inorganic semiconductors, such as TiO2, carbon 
nitride or CdS, can act as heterogeneous photocatalysts.[7,9] While these offer the obvious 
benefits of being non-miscible, their efficiency is limited by the absorption properties of 
the material, light scattering, surface defects, and the diffusion rate of electron/hole pairs 
towards the surface of the material.[24] Because homogeneous transition metal 
photocatalysts are less influenced by these factors, they are often preferred for developing 
new catalytic reactions. Although heterogeneous photocatalysts hold great promise for 
more sustainable solar synthetic chemistry, the work presented in this thesis will focus on 
the development of new catalytic methods for small molecule activation and will 
consequently make use of (so far) more efficient homogeneous photoredox catalysts. 
1.1.2 Mechanisms underlying photoredox catalysis 
Despite the high structural and physical diversity of the photocatalysts described in the 
literature, every photoredox reaction relies on the absorption of light energy by the 
ground state catalyst, leading to long-lived photoexcited states that are both more 
oxidising and reducing than the ground state species.[16]  
 
Figure 2 – Photophysical processes of photoredox catalysts.[17] 
Photons with higher energy than the energy gap (Eg) initially excite the catalyst to its 
singlet excited state (S1, Figure 2) by the excitation of an electron from the highest 
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occupied molecular orbital (HOMO) to the lowest unoccupied molecular orbital 
(LUMO). Because the transition is performed under spin retention of the excited electron, 
the excited catalyst can return in a spin-allowed recombination of the electron/hole pair to 
its ground state (S0) by either radiative (fluorescence) or non-radiative transition (internal 
conversion). Another possible pathway involves the transition to its triplet excited state 
(T1) by intersystem crossing (ISC). Due to its symmetry forbidden relaxation to the 
ground state, T1 is the longest-lived excited state. Although both excited states (S1 and T1) 
can react by single-electron transfer (SET) with other substrates, for example, with single-
electron acceptors (A) or single-electron donors (D), SET events are limited by the 
average lifetime of the excited states. Whereas the singlet excited state lifetime lies in the 
nanoseconds range, the T1 state can last up to several microseconds (depending on the 
catalyst) and therefore is more available for SET between substrates and the 
photocatalyst.[16,17] With their long-lived triplet excited states, transition metal-based 
photocatalysts often offer better reactivity for bimolecular quenching events.[18] 
Considering that the excited states can both act as a reductant or oxidant, two different 
catalytic cycles are possible once the excited species has been formed. These two modes 
of action are summarised in Figure 3. 
 
Figure 3 – Reductive and oxidative quenching cycles of the excited photocatalyst (PC*). 
If the excited PC* (either S1 or T1) species is first quenched by an electron acceptor (A) it 
will be an oxidative quenching cycle (from the point of view of the catalyst). 
Alternatively, in the reductive quenching cycle, the excited species first abstracts an 
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electron from an electron donor (D). In each case, the quenching step of the excited PC* 
species generates a highly oxidised PCox or reduced PCred species that requires a 
subsequent reduction or oxidation respectively (turnover step) to regenerate the ground 
state PC.[16] 
Both an electron donor (D) and an electron acceptor (A) need to be present to allow 
catalytic reactions to take place. The photoredox catalyst is a single-electron mediator that 
will help to transfer an electron from a donor to an acceptor in order to generate highly 
reactive open-shell species.[25,26] 
1.1.3 Practical photoredox catalysis 
1.1.3.1  Photocatalyst selection 
A crucial factor in the development of new photoredox methods is the catalyst selection. 
Appropriate catalysts can be selected based on the redox potentials needed to 
oxidise/reduce the desired species (A and D). Irradiation wavelength (and thus light 
source selection) is then fixed according to the absorption region of the ground state 
species of the chosen catalyst. If no absorption data is available, the colour of the catalyst 
itself can serve as a guide for light source selection. Bright yellow to light orange 
powders will absorb better in the blue light region (e.g. ruthenium and iridium 
complexes), darker orange to red will preferably absorb green light (e.g. eosin Y) and 
blue catalysts absorb red light preferentially (e.g. methylene blue). 
Examples of commonly used photocatalysts are presented in Table 1. Although other 
transition metal complexes can be used as photosensitisers,[27] ruthenium and iridium 
polypyridyl complexes are by far the most employed catalysts in synthetic photoredox 
catalysis. Indeed, these complexes both combine visible light absorption, long excited 
state lifetimes and high ISC yields. However, there are some differences between the two 
most used metal complexes. Using iridium instead of ruthenium allows the production of 
stronger oxidising species. This is because iridium needs to be at the +III oxidation state 
to reach the low-spin d6 configuration to allow octahedral ligand substitution, whereas 
ruthenium must be at the +II oxidation state. Also because of its higher oxidation state, 
iridium is capable of accommodating orthometallated ppy-derived ligands (LX type) to 
compensate its electron-deficiency.[28] 
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Table 1 – Commonly employed visible light absorbing homogeneous photocatalysts. 
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Finally, iridium complexes can be heteroleptic without losing their photoactivity. This 
property allows them to separate, in space, the HOMO and LUMO of the complex more 
efficiently and thus enables the variation of one potential without affecting the other. For 
these reasons, iridium complexes are more tuneable catalysts and will be able to achieve 
more challenging oxidations and reductions than the homoleptic ruthenium-based 
polypyridine complexes. Substituents on ligands also alter redox potentials. As a general 
rule, electron-donating substituents on the ligands render the complex more strongly 
reducing, while electron-withdrawing substituents cause the complex to be more strongly 
oxidising. 
Organic dye photocatalysts are rising competitors to commonly used transition metal 
ones, they also feature a high structural diversity and therefore interesting optimisation 
possibilities.[17] Despite their usually shorter excited state lifetimes, they show an 
impressive range of redox potential windows. There are few strongly reducing dyes, with 
10-phenyl-phenothiazine most likely being the best example of this family.[29] Fluorescein 
to Eosin Y[30–32] and the more recently developed donor-acceptor scaffolds such as 
4CzlPN[33] offer a well-balanced and large redox window comparable to the commonly 
used Ir-3 and Ir-4 catalysts. Another class of donor-acceptor scaffold is the strongly 
oxidising mesityl-acridinium dyes family. The 9-mesity-10-methylacridinium (Mes-Acr-1) 
was originally developed by Fukuzumi[34] and further optimised by Nicewicz (Mes-Acr-2 
to Mes-Acr-4)[35]. The strongest single-electron-oxidant is probably 3-cyano-1-
methylquinolinium[36] that can be used to perform extremely challenging oxidations. 
1.1.3.2  Standard reduction potential notation and uses 
Standard reduction potentials are commonly used to assess the thermodynamic feasibility 
of the single-electron transfer (SET) reactions studied.[17] In the general notation, E1/2
ox/red 
is the electrochemical reduction potential of the half reaction written in the direction of 
the reduction: ox + e-  red. This value is given in volts against the saturated calomel 
electrode (SCE), usually measured in acetonitrile.[37] 
For photocatalysts, the full notation will be employed to avoid confusion between the four 
species that can exist. For example, in a reductive quenching cycle, the potential 
associated with the half reaction: PC* + e-  PCred is written as E1/2*/red (PC) and the 
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potential for the consecutive turnover reaction PC + e-  PCred is written as E1/2gd/red (PC) 
(where “gd” stands for ground state). 
For electron acceptors (A) and donors (D), a simpler notation will be employed. The 
standard reduction potential associated with the reaction A + e-  Ared is written Ered (A) 
to shorten the expression E1/2
A/Ared, this can also be read as “reduction potential of A”. For 
electron donors, the reaction potential associated with the reaction Dox + e
-  D is referred 
to as Eox (D) (= Ered (Dox)) to simplify the E1/2
Dox/D notation, this could also be read as 
“oxidation potential of D”. 
To approximate the thermodynamic feasibility of an electron transfer reaction, the 
simplification of the Gibbs free energy of electron transfer equation can be used.[17] By 
neglecting the electrostatic work, the relation E1/2
ox1/red1 > E1/2
ox2/red2 means a negative 
variation of Gibbs free energy for the reaction ox1 + red2  ox2 + red1 that will be 
thermodynamically favoured in the forward direction. 
Using this rule, one can draw the redox potentials of a photocatalyst on a linear axis to 
visually “predict” the thermodynamic feasibility of electron transfer reactions (Scheme 1). 
The resulting grey area is where both Ered (A) and Eox (D) must lie to successfully quench 
and turnover the photoredox catalyst. This is a convenient approach to think about these 
electron transfer reactions since reduction potentials are measurable (using 
electrochemical measurements) and many research groups publish these values against 
reference electrodes.[37] 
 
Scheme 1 – Reduction potential axis picturing the redox window of the Ir-3 catalyst in its oxidative and 
reductive quenching cycles. 
Notably, we can see that the oxidative quenching cycle generates a highly oxidised PCox 
species that is a better oxidant than PC* (E1/2
ox/gd > E1/2
*/red). The same observation can be 
made for the reducing quenching cycle where the highly reduced PCred is a more potent 
reducer than PC* (E1/2
ox/* > E1/2
gd/red). Also, more difficult oxidations or reductions can be 
performed with these more reactive species and the potentials of these should be 
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considered when planning a photoredox reaction. If the redox potentials of the species 
used do not fit in either of these windows, a triplet-triplet energy transfer pathway can be 
suggested.[16] This process, however, accounts for a minority of the reactivities observed 
using photoredox catalysis and is not easy to prove experimentally. Therefore, this 
process will not be described in further detail in this thesis. 
1.1.3.3 Overall redox balance 
With these considerations in mind, the last thing to rationalise before engaging in the 
development of a photoredox reaction is the overall redox balance of the transformation. 
Photoredox reactions fall into three categories: net oxidative, net reductive, and net redox-
neutral reactions. In fact, the desired reactive species may not fit in either of the reductive 
or oxidative redox windows of the catalyst. In this case, an external oxidant (D) or 
reductant (A) can be used to initially quench PC* and generate the highly oxidised (PCox) 
or reduced (PCred) species. If the only purpose of D or A is to quench (or turnover) the 
photocatalyst (i.e. sacrificial purpose) the transformation will be categorised as 
respectively net oxidative or net reductive. In general, these transformations could be 
achieved without using photoredox catalysis by stoichiometric single-electron transfer 
reagents[38] or electrochemical[39] methods. 
Net redox-neutral reactions, on the other hand, are much more challenging to achieve 
without the tool of photoredox catalysis. As opposed to the other two categories, they do 
not require any sacrificial oxidant or reductant to turn the photocatalytic cycle over. They 
are more attractive in the sense that all electron transfer events are synthetically relevant 
and therefore do not conceptually generate stoichiometric waste products. Even though 
net redox-neutral transformations can present a considerable number of productive radical 
chains,[40] they remain the most synthetically interesting class of photoredox reactions. 
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1.2 Strategies for photoredox C–C cross-couplings 
1.2.1 A parallel with palladium-catalysed cross-couplings 
Throughout this project, we have been interested in assessing the potential of photoredox 
catalysis to achieve predictable and scalable C–C cross-couplings. Therefore, it seemed 
legitimate to compare its mode of action to one of the most widely used C–C bond 
forming process, namely: the Nobel-awarded palladium-catalysed cross-coupling 
paradigm. Even though they both rely on a distinct class of interaction with the substrates 
(coordination chemistry vs. electron-transfer chemistry), it is instructive to compare their 
catalytic cycles side-by-side (Scheme 2). 
 
Scheme 2 – Comparison of palladium and photoredox catalytic cycles. 
On the left side, palladium cross-couplings rely on a thermally activated catalytic cycle 
involving coordination chemistry and organometallic species. Extensive optimisation 
possibilities combined with intensive development over decades resulted in fine-tuned 
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conditions for a virtually infinite number of coupling-partners.[41] However, common 
hurdles to these palladium-catalysed methodologies remain, such as the involvement of 
C(sp3) nucleophiles and electrophiles. Alkyl substrates are usually associated with slow 
transmetallation and oxidative addition steps.[42] Additionally, the presence of β-
hydrogens allows competitive β-hydride elimination and thereby compromising the 
outcome of these coupling reactions. To tackle these issues innovative approaches have 
been implemented, including Fu’s impressive work.[43] For example, he uses nickel 
catalysts able to react via single-electron transfers to cross-couple C(sp3) electrophiles, 
thereby circumventing the slow oxidative addition step. Faster “one-electron” 
transmetallation steps are also observed in nickel couplings with C(sp3) nucleophiles able 
to generate carbon radicals.[44,45] 
On the right side of Scheme 2, we see a chance in photoredox catalysis to aid these alkyl 
partner coupling issues. Just like nickel, photoredox catalysis enables single-electron 
transfer reactions. The conditions are synthetically extremely interesting since it only 
requires a minute amount of a photocatalyst to proceed at room temperature with only 
visible light irradiation. Interestingly, like the palladium cycle, it also consists of 
successive oxidative and reductive steps with the distinction that they are one-electron 
redox steps instead of two. Another similarity is the electronic-demand of the substrates 
that interact in the catalytic cycles. The electron acceptor (A) is an electron-deficient 
species able to accept an electron and could therefore be considered as a “one-electron 
electrophile”. In parallel, the electron donor (D) is an electron-rich species and could be 
referred as a “one-electron nucleophile”. In a redox-neutral setting, this paradigm could 
be used to cross-couple one-electron electrophilic entities to one-electron nucleophilic 
ones. This process could somehow mimic the mode of action of the palladium-catalysed 
cross-couplings in a “one-electron” fashion, provided that selective mechanisms allow 
their combinations. During the course of this writing, reports of visible light-triggered 
excited state palladium and copper catalysis enabled challenging alkyl electrophile 
substrates to be engaged in cross-coupling reactions via electron-transfer.[46–48] These 
recent communications further demonstrate the growing importance of electron-transfer 
processes in cross-couplings.  
Finally, another drive for exploring these reactions is the possibility of using photoredox 
reactions under strictly “transition metal free” conditions. Indeed, the electron transfer 
mechanisms of the catalytic cycles do not require the employment of transition metals 
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and could, therefore, become a cleaner and more sustainable alternative to the classic 
transition metal-based chemistry. 
1.2.2 Carbon radical generation 
With this hypothesis in mind, we need to be more specific about the nature of the electron 
donors and acceptors that will be used in the photoredox catalysis cycle. When thinking 
of performing C–C coupling reactions using single-electron transfer chemistry, the 
reactive intermediates must be open-shell carbon species. This means intermediates 
involved in these reactions would either be carbon radical cations, carbon radical anions 
or neutral carbon radicals. We will refer to them under the more general terms of “carbon-
centred radicals” or “carbon radicals”. 
Using this rationale, the initial step of a photoredox-based C–C cross-coupling is the 
generation of a carbon radical from a spin-paired precursor. The nature of these 
precursors and the mechanisms leading to these reactive intermediates are described in 
this section (1.2.2). In stark contrast with classic radical generation methods, typically 
making use of direct photolysis with non-selective UV-irradiation or radical initiators,[49] 
photoredox catalysis enables a mild and catalytic generation of radicals. This paradigm 
shift enables an unprecedented control over these reactive species. Firstly, the catalytic 
nature of the radical initiator often allows to circumvent commonly observed radical 
chain terminations like dimerisation or disproportionation side-reactions.[50,51] Secondly, 
redox-neutral reactions that cannot sustain a radical chain mechanism are made possible 
using the photoredox catalyst as the electron mediator.[52] 
Strategies to generate carbon radical intermediates using photoredox catalysis can be 
categorised in two main groups, carbon radicals formation via direct SET with organic 
substrates (1.2.2.1) or via hydrogen atom transfer (HAT) pathway (1.2.2.2). 
1.2.2.1 Using single-electron transfer 
Before the generalisation of photoredox catalysis, redox methods to generate carbon-
radicals were making use of stoichiometric single-electron oxidant/reductants, 
electrochemical methods or UV light-based photoinduced electron transfers.[38,49] The 
extensive amount of existing research in electron transfer chemistry allowed an initial fast 
progression of the field of photoredox catalysis.[53] Also, by providing a simple setup and 
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rationale to predict these reactions and carry them out selectively, photoredox catalysis 
enabled a multitude of new applications building on these previous discoveries. This 
section presents the redox methods commonly used to generate carbon radicals using 
photoredox catalysis. 
The generation of carbon radicals by direct SET can be organised in two subgroups: 
organic radicals produced via a single-electron oxidation of electron donors (left part in 
Figure 4) and carbon radicals generated via a single-electron reduction of electron 
acceptors (right part in Figure 4).[54–56] 
 
Figure 4 – Common oxidative and reductive approaches to carbon radicals using photoredox catalysis. 
The first group (on the left) is composed of electron-rich organic molecules that readily 
donate an electron to the photoredox catalyst. Electron-rich tertiary amines (1) are good 
single-electron donors and will readily give an electron (typically Eox (1) = +0.7 – 
+1.0 V)[57] to generate an amino radical cation (2) which can rearrange upon 
deprotonation to form a neutral α-amino radical (3). Extensive chemistry involving these 
radical intermediates has been developed, marking a new era for amine α-
functionalisation.[58] Although being typically challenging (Eox (5 or 7) = +1.5 – 
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+2.5 V)[37], the direct oxidation of electron-rich unsaturated systems (5 and 7) has been 
increasingly used, especially since the rise of strongly oxidative mesityl acridinium dyes. 
This strategy enables interesting transformations such as cycloadditions[12,59] and anti-
Markovnikov hydrofunctionalisations[60] using 6 intermediates and arylations of amines 
using 8 intermediates[61]. A more common strategy to oxidatively generate carbon radicals 
is to single-electron oxidise electron-rich “ate” salts (9), such as organoborates[62], 
carboxylates[63], oxalates,[64] sulfinates[65,66] or silicates[67,68]. The transient neutral radical 
(10) generated undergoes a C–X cleavage to produce a carbon radical (11) that can be 
used to conduct alkylation reactions. This method is often used to produce reactive C(sp3) 
radicals from less “electronically biased” starting materials since they usually do not 
require extra electron-donating substituents.[55] This approach will be described in more 
detail in the following section (cf. 1.2.3). Finally, 1,4-dihydropyridines (12) represent a 
neutral functional group alternative to this practice. Similarly, they can undergo single-
electron oxidation (Eox (12) = +1.05 V) to generate a neutral carbon radical (11) and a 
protonated pyridine (13).[69,70] 
The second group is composed of electron-poor organic substrates that can potentially 
accept an electron from the photocatalyst. Organohalides (14) have been widely used, for 
example, generating a transient radical anion (15) which subsequently eliminates a halide 
anion to produce neutral alkyl or aryl radicals (11).[71–73] The ease of reduction increases 
descending in the halogen series (Cl < Br < I). Electron-deficient unsaturated systems (16 
and 18) can also be single-electron reduced, an interesting example being the reduction of 
electron-deficient cyanoarenes (Ered (18) = -2.4 – -1.61 V)[37] that have been widely 
exploited for arylation chemistries[74–76] and will be discussed in more detail in the 
following section (1.2.3). Electrophilic “onium” salts (20), can also easily accept an 
electron to generate a transient radical (21) prone to eliminate a spin-paired leaving group 
(22) and produce a carbon-centred radical (11). This strategy can be used to generate aryl 
radicals from aryl diazonium salts (Ered = -0.1 V)
[77,78] or diaryliodonium salts[79] and the 
trifluoromethyl radical from Umemoto’s reagent (Ered = -0.4 V)[80,81]. To finish, (N-
acyloxy)phthalimides (23) or N-hydroxyphthalimide esters (NHPI) have been 
longstanding alkyl radical precursors using photoredox systems.[82] Upon one-electron 
reduction of the phthalimide moiety (Ered (23) = -1.2 V), they rapidly undergo a 
decarboxylative collapse leaving behind the desired carbon radical (11). 
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1.2.2.2 Using hydrogen atom transfer 
The formal transfer of a hydrogen atom has also been used as a strategy to form carbon-
centred radicals with photoredox catalysis. Among the other atom transfer processes, 
hydrogen atom transfer is the most synthetically interesting since it enables a formal C-H 
functionalisation. This process relies on the ability of some radical species to abstract 
homolytically a weakly bonded hydrogen atom, the driving force being the resulting 
stronger bond created in the process. 
Some specific photocatalysts such as tetrabutylammonium decatungstate can directly 
abstract hydrogen atoms from their excited states (pathway A in Scheme 3).[83] Another 
approach making use of simple HAT co-catalysts have been developed by the MacMillan 
group (pathway B in Scheme 3). Commonly used HAT co-catalysts are thiols (26)[76,84,85] 
or quinuclidine (30)[86] derived and are compatible with photoredox cycles. 
 
Scheme 3 - Hydrogen Atom Transfer (HAT) mechanisms. 
The mechanism starts with the single-electron oxidation of the HAT co-catalyst (27 and 
30) by the photoredox catalyst to generate either a thiyl radical (28) or an amine radical 
cation (31). These radicals are known to be involved in the homolytic cleavage of weak 
C–H bonds (from 25) via hydrogen atom abstraction, generating the desired carbon-
centred radical (11). The protonated co-catalysts (26 and 29) are then reactivated by the 
simple action of a base. Prediction of the feasibility of hydrogen atom abstractions can be 
carried out using bond dissociation energies (BDE) of C–H bonds.[76] Intramolecular 
variants of this process have recently flourished, allowing the generation of carbon 
radicals at distal positions of nitrogen atoms (pathway C).[87,88] These methods offer 
complementary approaches to the direct SET activation of organic substrates to generate 
carbon-centred radicals. 
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1.2.3 Redox-neutral photoredox C–C cross-couplings 
Now that the nature of the precursors and the mechanisms underlying carbon radicals 
generation have been presented, the subsequent engagement of these species in C–C 
cross-couplings is described. Since net redox-neutral conditions are synthetically the most 
interesting ones and the most specific to photoredox systems, it was decided to limit this 
brief review to this category of transformations. 
1.2.3.1 Carbon radical reactivities 
In a general sense, intermolecular C–C bond forming reactions with radical intermediates 
are challenging tasks.[89] The intermediacy of the species involved coupled to the 
concentration effects, arising from the bimolecular nature of the coupling, makes it more 
laborious than intramolecular reactions.[90] In order to successfully engage carbon radicals 
in cross-couplings, it is important to understand their reactivity. 
Carbon-radicals are generally highly reactive species, but this does not mean that they 
cannot operate selectively. A general rule is that they proceed towards the formation of 
the strongest bonds (thermodynamic control).[91] Also, as neutral species, radicals are not 
affected much by coulombic interactions, making their addition to polarised groups 
unfavourable. In analogy to “soft” nucleophiles and electrophiles, the chemical reactivity 
of radicals is mostly dictated by frontier orbitals interactions.[92] A typical example is the 
different reactivity trends observed for the additions of carbon radicals to olefins. Carbon 
radicals can be stabilised by both adjacent electron-withdrawing and donating groups. 
These groups are directly affecting the energy levels of the singly occupied molecular 
orbitals (SOMOs) of these reactive species, resulting in a different “character” of the 
radicals (Figure 5).[93] 
As observed in this figure, the low-energy SOMO of 33 resulting from an adjacent 
electron-withdrawing group have a better overlap with the HOMO of an electron-rich 
alkene (32), making 33 an “electrophilic” radical. On the other hand, the high-energy 
SOMO of 34 can favourably interact with the LUMO of an electron-deficient alkene (35), 
resulting in a “nucleophilic” character of the radical 34. This principle of radical 
“characters” will further help us to rationalise successful radical coupling reactions based 
on the nature of the radicals employed. 
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Figure 5 – Frontier orbital diagram explaining the reactivity preferences of different carbon radicals.[93] 
An important consequence of these unequal energy levels are the different redox 
potentials of nucleophilic and electrophilic radicals. Because of this, radical intermediates 
can be subject to single-electron transfers in photoredox catalysis cycles. This 
phenomenon is generally referred as a radical-polar crossover event, where radicals are 
transformed into ionic closed-shell species. An electron-rich benzylic radical (34), for 
example, is easily oxidised (Eox (34) = +0.8 V) to its corresponding carbocation and the 
electrophilic α-ester radical is easily reduced (Ered (33) = -0.6 V) to its corresponding 
carbanion.[89] These common reactivities need to be thoroughly considered in order to 
plan successful coupling strategies. 
1.2.3.2 Neutral couplings using oxidative radical precursors 
The following redox-neutral strategies for photoredox C–C coupling reactions are 
organised based on the nature of the radical precursors (pro-oxidative = Rox or pro-
reductive = Rred). This organisation is used since the strategy is usually fixed based on the 
choice of the radical precursor. This classification only clashes if the radical selectively 
couples to another transiently generated radical, which is commonly disregarded as a 
productive approach.[16] However, this does not exclude the possibility for this transient 
(short-lived) radical to couple with a persistent (long-lived) radical as it will be discussed 
in the next section (1.2.3.2). In the latter case, the transient radical precursor will be 
considered as the reference radical precursor. Finally, generation of radicals using HAT 
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catalysts formally falls under the category of “oxidative radical precursors” since the 
HAT catalysts are oxidatively activated (cf. Scheme 3). 
Net redox-neutral photoredox couplings strategies relying on an oxidative carbon radical 
formation are described in Scheme 4. Once the oxidative generation (blue arrow) of the 
carbon radical from 36 (pro-oxidative carbon-radical precursor) is achieved, an effective 
trapping method (grey arrows) needs to be employed to selectively couple the carbon-
radical intermediate. In order to neutrally close the redox cycle, a complementary single-
electron reduction (red arrow) needs to take place. This interdependent step can be used 
to activate the other coupling partner when the transient radical is coupled with a 
persistent radical (b), or to regenerate a closed shell-species after the trapping of the 
radical (a, c, or d). 
 
Scheme 4 – Redox-neutral photoredox C–C coupling using oxidative radical precursors (Rox). 
a) Addition to C–C multiple bonds 
Even though this is not a general rule, oxidatively generated carbon radicals tend to be 
nucleophilic. This is often the case because oxidation sensitive substrates have to be 
electron-rich, also if the substrate keeps its electron rich-character at the radical stage, the 
corresponding radical will be nucleophilic. Therefore, an effective way to trap oxidatively 
generated radicals intermolecularly is to use electrophilic olefins with a low lying LUMO 
(cf. Figure 5). These trapping methods have been one of the most used redox-neutral 
photoredox C–C cross-coupling procedures (Scheme 5). 
Radical couplings with electron-deficient olefins are often referred as “Giese-type” 
additions. They have been exemplified through a wide range of oxidative alkyl radical 
precursors including trifluoroborates and trialkoxyborates,[80,94,95] carboxylates,[96] 
oxalates,[64] silicates,[67] and sulfinates[65] but also electron-rich tertiary amines[97] or α-
silylamines[98]. The catalysts used for these couplings are usually strong oxidants such as 
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Ir-3, Ir-4 or Mes-Acr-1, often proceeding via a reductive quenching cycle. The mechanism 
starts with the single-electron oxidation of the radical precursor (36) to lead to a neutral 
carbon radical (11). 
 
Scheme 5 – Mechanism for photoredox-catalysed alkylation with electron-deficient olefins. 
This nucleophilic radical is subsequently trapped by an electron-deficient olefin (16), 
which is often used in excess. The resulting electrophilic radical (37) can then undergo a 
selective reduction to regenerate the ground state photocatalyst (PC) and a carbanion (38) 
that is quenched by a proton source to deliver the coupling product (39). The reaction 
proceeds with a wide range of alkyl residues from unactivated primary to tertiary alkanes 
or activated, α-heteroatom and benzylic positions. Asymmetric variants of this reaction 
have been successfully developed by Yoon[99] and Meggers[100] using a chiral Lewis acid 
catalyst and by Melchiorre[101] making use of a chiral iminium olefin acceptors. 
Apart from alkylations, radical addition to C–C multiple bonds can also lead to useful 
vinylation and alkynylation reactions. For example, olefins bearing a sulfonyl group (40 
in Scheme 6) can successfully trap nucleophilic radicals generated from carboxylic 
acids[102] or tertiary amines[103].  
The radical initially attacks the carbon bearing the sulfone to generate a stabilised 
benzylic radical (44) from which the sulfonyl group can act as a radical leaving group to 
generate a vinylated product (42).[104] The resulting “open-shell nucleofuge” (45) can then 
be single-electron reduced to close the redox cycle. A similar process making use of gem-
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difluoro styrenes (41) has been recently described leading to interesting mono-
fluoroalkenylated products (43).[105] 
 
Scheme 6 – Vinylation and alkynylation reactions based on leaving group strategy. 
Based on a similar mechanism, alkynes bearing tosyl (Ts, 46)[68], benziodoxolone (BI, 
47)[106] and iodo (48)[107] leaving groups were successfully employed to deliver 
alkynylated products (49) in a redox-neutral fashion. 
b) Coupling with a persistent radical 
Another approach to engaging radicals in selective bimolecular couplings makes use of 
the persistent radical effect (PRE).[108] This kinetic effect demonstrates that if two radicals 
are generated at the same rate, selective heterocoupling occurs (preferentially to 
homocoupling) if one of the radical is significantly longer-lived than the other.[109] 
The concept was introduced in the field of photoredox catalysis by MacMillan and co-
workers in 2011 to perform selective C–H α-arylation of electron-rich tertiary amines 
with cyanoarenes.[74] The proposed mechanism for this arylation (Scheme 7) starts with 
the absorption of a photon by the ground state Ir-1 to generate the active triplet state Ir-1*.  
This triplet state has a low enough reduction potential (E1/2
ox/* (Ir-1) = -1.73 V) to reduce 
the 1,4-dicyanobenzene (Ered (51) = -1.61 V) and form a long-lived radical anion (52). Ir-
1ox (E1/2
ox/gd = +0.77 V) which can then oxidise the electron-rich tertiary amine (53) 
leading to the α-amino radical (55) after deprotonation. Shortly after its generation, 55 can 
selectively engage in bimolecular radical-radical coupling with the stabilised radical 
anion (52). The resulting anion (56) can then eliminate cyanide to deliver the coupling 
product (57). 
This fundamental work led to an extensive development of photoredox arylations by the 
MacMillan group. The challenging β-arylation of ketones and aldehydes (58) was realised 
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by the single-electron oxidation of their corresponding enamines.[110] Boc-protected 
amino acids (59) were also successfully engaged in decarboxylative arylations using the 
same principle.[63] By making use of a HAT co-catalyst, it was possible to engage weak 
C–H bonds from ethers (60)[84] or allylic (61)[76] positions in redox-neutral arylations. 
 
Scheme 7 – Photoredox arylation via a radical-radical coupling with persistent radicals from cyanoarenes. 
Inspired by these effective arylation methods, other persistent radicals were engaged in 
bimolecular radical coupling using similar mechanisms (Scheme 8). 
Shiff bases derived from benzaldehydes (62) are subject to single-electron reduction to 
generate persistent radical anions (64). These were selectively coupled to transiently 
generated radicals from ethers,[85] amines,[111] and silicates[112], leading to elaborated 
benzylamines (63). The concept was amenable to an enantioselective radical-radical 
cross-coupling using a chiral Brønsted acid catalyst supposedly forming a chiral radical 
ion pair with the 64 intermediate.[113] 
Aldehydes and ketones (65) also generate long-lived radical anions (67) upon single-
electron reduction. Using this reactivity, transient radicals generated from enamines[114] 
and tertiary amines[111] were transformed into benzyl alcohols (66). An asymmetric 
variant of this transformation was also described by Meggers, using a chiral Lewis acid 
and an iridium-based photocatalyst.[115] 
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Scheme 8 – Persistent-radical couplings of imines, aldehydes, and ketones. 
c) Homolytic Aromatic Substitution 
Homolytic Aromatic Substitution (HAS) is another synthetically interesting redox-neutral 
cross-coupling strategy. This mechanism is more prevalent in reductive precursors as we 
will see in the next paragraph (1.2.3.3). However, some examples of this mechanism from 
oxidative radical precursors have been described. For example, a complementary method 
for amine C–H α-arylation has been reported by MacMillan using a wider variety of 
electron-deficient chloroarenes (Scheme 9).[116] In this case, a HAS mechanism is 
proposed because of the thermodynamic impossibility of reducing the corresponding 
chloro heteroarenes (68) with the iridium photocatalyst Ir-2 (in contrast to cyanoarenes). 
The reaction is expected to start with the generation of the α-amino radical (54) that can 
add to the electrophilic heteroarene (68) to form a neutral radical (69). This radical could 
be reduced by the photocatalyst to eliminate chloride and deliver the coupling product 
(70). 
 
Scheme 9 – Example of a redox-neutral HAS coupling from an oxidative radical precursor. 
A similar reaction has been disclosed by Weaver and co-workers, however, no postulate 
on the mechanism was made.[117] 
d) Nickel co-catalysis 
While previous coupling strategies were solely relying on the use of a photoredox 
catalyst, emerging cross-coupling methods make use of an additional nickel 
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catalyst.[51,118,119] These methods take advantage of the mild generation of reactive radical 
intermediates via photoredox methods and the ability of nickel to capture nucleophilic 
radical species (11) and perform oxidative addition of two-electron electrophiles (73). 
Using this strategy, Molander[45] and MacMillan[44] simultaneously reported a “single-
electron transmetallation” of C(sp3) radicals on nickel centres in 2014. In these processes, 
they could couple alkyl trifluoroborates (Molander) or carboxylates (MacMillan) with 
aryl halides at room temperature to deliver a wide range of C(sp2)–C(sp3) cross-coupled 
products. 
The general mechanism is depicted in Scheme 10: it starts with the reductive quenching 
of the excited photocatalyst (PC*) to deliver a carbon radical (11) in an oxidative 
fragmentation of 36. This radical (11) is then captured by the Ni0 complex (71) in a so-
called “single-electron transmetallation” step. The alkylated NiI complex (72) can then 
favourably engage in an oxidative addition of the two-electron electrophile (73) to lead to 
a pentavalent NiIII complex (74).[120] Reductive elimination can then occur from this 
highly oxidised NiIII (74) to deliver the coupling product (75) and a NiI complex (76) that 
can accept an electron from the PCred to restore both the active Ni
0 species (71) and the 
ground state photocatalyst (PC). 
 
Scheme 10 – General mechanism of the dual nickel and photoredox catalysis paradigm. 
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Since being reported in 2014, this new paradigm was rapidly applied to a wide variety of 
coupling partners. The range of oxidative carbon radical precursors (Rox, 36) was 
progressively extended, notably to silicates,[68,121,122] sulfinates,[66] 1,4-
dihydropyridines,[123] amines,[124] and ethers[125] allowing the generation of C(sp3) radicals 
from primary[122], secondary[126] and tertiary[127] carbon centres. Alternative two-electron 
electrophiles (73) such as alkenyl,[121,128,129] acyl,[130] and even alkyl halides[131,132] were 
also successfully engaged using this dual catalysed cross-coupling principle. Finally, this 
process could be made enantioselective by using chiral ligands to coordinate the nickel 
centre.[45,133] 
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1.2.3.3 Neutral couplings using reductive radical precursors 
Reductive radical precursors are less common in redox-neutral photoredox C–C 
couplings. This can be due to the fewer number of reductive radical sources compatible 
with photoredox catalysts or the lack of compatibility of these with redox-neutral 
coupling methods. The main strategies employed to couple reductively generated radicals 
in a redox-neutral setting are summarised in Scheme 11. 
 
Scheme 11 – Redox-neutral photoredox C–C coupling from reductive radical precursors. 
a) Addition to C–C multiple bonds 
Reductively generated radicals can also undergo additions to C–C multiple bonds 
(Scheme 12). In parallel to our observation on oxidatively generated radicals (cf. 1.2.3.2 
a), reductively generated radicals will tend to be electrophilic. Consequently, most 
efficient trapping agents often are electron-rich to electron-neutral olefins. 
 
Scheme 12 – Examples of a redox-neutral radical addition processes to electron-rich olefins/enamines. 
The general process starts with the addition of the reductively generated radical (11) into 
the electron-rich olefin (78). The resulting electron rich radical (79) can then be 
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successively oxidised to a cation (80) in a radical-polar cross-over step. From there, the 
cation can either be trapped by a nucleophile to lead to alkylated products (82),[81,134,135] 
or deprotonation can occur to lead to the alkenylated product (81)[136]. 
Inspired by this reactivity, MacMillan and Nicewicz reported the use of an imidazolidone 
chiral organocatalyst (84) able to condense with enolisable aldehydes (83) to generate in 
situ chiral enamines (85). This enamine could efficiently trap electrophilic radicals (11) 
from alkyl halides (14) with facial selectivity.[71,137,138] The α-amino radical intermediate 
(87) resulting from this addition can then be further oxidised to an iminium (88), which 
can liberate an enantioenriched alkylated aldehyde (89). 
b) Addition to electron-deficient aromatic rings: the Minisci reaction 
Also known as the Minisci reaction,[139] the addition of nucleophilic radicals to electron-
deficient protonated heterocycles is a powerful arylation method.[140] Despite the large 
number of reports of net oxidative photoredox Minisci reactions,[141–143] these are not 
easily achieved in a redox-neutral setting (Scheme 13). Indeed, once the carbon radical 
(11) has attacked the protonated ring (90), the intermediate radical cation (91) needs to be 
further oxidised to restore the aromaticity (92). 
 
Scheme 13 – Example of a redox-neutral photoredox Minisci coupling. 
This means that reductive radical precursors (77) must be used to keep an overall redox-
neutral balance. Unfortunately, most of the reductively generated radicals fall into the 
category of electrophilic radicals, making them unsuited for the attack on an electron-
deficient aromatic ring (electronic mismatch). As a result, the only examples of redox-
neutral Minisci reactions reported were making use of aryl diazonium salts[144] or more 
recently alkyl N-hydroxyphthalimide esters[145] that could reductively produce 
nucleophilic radicals. 
c) Addition to electron-rich aromatic rings 
As discussed previously, the mostly “electrophilic” character of reductively generated 
radicals makes them easier to trap with electron-rich aromatic rings. König and co-
workers pioneered using these methods to achieve photoredox arylations of 
Introduction 27 
 
aryldiazonium salts (93)[30,77,146] and aryl iodide (94)[147] (Scheme 14). These were 
followed by reports using diaryliodonium salts (95) as reductive radical precursors.[79,148] 
 
Scheme 14 – Example of a redox-neutral arylation with an electron-rich aromatic ring. 
The mechanism follows a similar path to the Minisci reaction, addition of the radical (96) 
to 97 and oxidation of 98 to deliver the coupling product (99). It can be noted that by 
measuring the quantum yields of these reactions, a significant number of radical chains 
were found to be responsible for the product formation.[149] 
d) Transition metal co-catalysis 
Dual catalysis methods were also applied to reductive radical precursors.[150] In 2011, 
Sanford described a merger of palladium-catalysed C–H activation with photoredox 
catalysis (Scheme 15).[78] In this process, aryl radicals (96) generated by the reductive 
fragmentation of aryl diazonium salts undergo addition to the PdII C–H activation 
complex (100) to generate a PdIII species (101). The consecutive single-electron oxidation 
is believed to help the metal to reach the highly oxidised PdIV species (102) from which 
reductive elimination can easily occur to regenerate the palladium catalyst and the 
arylated product (103). 
 
Scheme 15 – Dual catalysed photoredox and Pd or Cu cross-couplings by Sanford. 
Building on the success of this concept, a year later the Sanford group disclosed a merger 
of photoredox and copper catalysis for the trifluoromethylation of aryl boronic acids 
Introduction 28 
 
(108).[151] The method relies on the reductive formation of the trifluoromethyl radical 
(105) from trifluoroiodomethane (104). This radical is trapped by the active CuII species 
(106) to generate a trifluoromethylated CuIII species (107) on which the aryl boronic acid 
(108) can transmetallate. This step is followed by a reductive elimination delivering the 
trifluoromethylated product (110) and the CuI species (111) that can be reactivated to the 
CuII (106) active catalyst by the complementary single-electron oxidation. 
 
Scheme 16 – Example of dual catalysed Au and photoredox cross-couplings. 
Following these successes with palladium and copper, Glorius and Toste probed the 
possibility to interlock the photoredox catalytic cycle with a gold catalyst (Scheme 16). 
They discovered that the reductively generated aryl radicals (96) could be intercepted by a 
AuI complex (112) to generate a AuII organogold species (113). Upon a successive single-
electron oxidation, a highly electrophilic AuIII organogold complex (114) is generated.[152] 
This reactive organogold species could be intercepted with electron-rich C–C triple bonds 
to deliver alkynylated (115)[153,154] or alkylated (116)[155] cross-coupled products. 
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1.3 Organoboron reagents 
1.3.1 Properties and preparation of  organoboron compounds 
1.3.1.1  General properties and definitions 
Boron is the fifth element in the periodic table and occurs with an abundance of 0.001% 
in the Earth’s crust, prevalently in form of its oxides. Its three valence electrons allow it 
to form three covalent bonds in the neutral form and adopt a trigonal planar geometry 
with a vacant p-orbital.[156] Organic compounds that process at least one C–B bond are 
commonly referred as organoboron compounds (117–121, Figure 6). 
 
Figure 6 – Commonly encountered organoboron compounds arranged by their Lewis acidity. 
Molecules from the first group (117-120) have an sp2 hybridised boron centre, with a 
vacant p-orbital, making these Lewis acidic. The most Lewis acidic members of this 
family are boranes (117), they are highly reactive and air-sensitive reagents making them 
difficult to be isolated and stored. Boronic acid derivatives (118–120) have a boron atom 
bonded to a carbon and two oxygen atoms, decreasing their Lewis acidity by lone-pair 
donation. They are the most commonly used organoboron reagents.[157] Boroxines (118) 
are trimeric boronic acid species, formed by dehydration of boronic acids (119) 
(Scheme 17). These compounds are quite strongly Lewis acidic and a high proportion of 
them can be found when employing boronic acids in non-aqueous media. With similarity 
to boronic acids, the Lewis acidity of boronic esters (120) is weakened by the stronger 
conjugation of the oxygen lone pairs towards the boron centre, which results in higher 
stability of these compounds.[158] Most boronic esters are stable under neutral aqueous 
conditions, their stability is influenced by steric and entropic effects.[157] Cyclic esters like 
the 1,2-ethanediol esters (124, Figure 7) are entropically stabilised, their hydrolysis 
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releases only one molecule of ethandiol whereas two molecules of water are consumed. 
Pinacol (125) and pinanediol esters (126) are stabilised by the extra steric shielding 
provided by the adjacent alkyl groups, protecting them against the attack of water or other 
nucleophiles, they are some of the most stable esters. 
 
Figure 7 – Stability of various boronic esters against hydrolysis.[157]  
Unfortunately, the exceptional stability of pinanediol esters (126) is often linked to a 
reduced reactivity. On the other hand, boronic pinacol esters (125), often have an 
advantageous balance between stability and reactivity. These reagents are preferentially 
chosen, especially if their corresponding boronic acids are known for their chemical 
instability.[158] Additionally, boronic esters are soluble in apolar solvents and can be 
purified either by distillation or silica gel chromatography, making them convenient 
reagents for organic synthesis.[157] 
Borates (121, Figure 6) are tetra-coordinated and negatively charged organoboron 
compounds. Since they are not Lewis acidic, they are stable against aerobic oxidation. 
However, because of their salt nature, borates are often less soluble in apolar solvents, 
which requires the use of undesirable highly polar and water-miscible solvents.[157,158] 
1.3.1.2 Preparation of  organoboron compounds 
Interchanging between boronic acid derivatives is relatively straightforward (Scheme 17). 
Boroxines (118) are obtained by forcing the dehydration of boronic acids (119), for 
example with the azeotropic distillation of water in toluene, using a Dean-Stark 
apparatus.[159] Boronic esters (120) are readily prepared by esterification of boronic acids 
(119) with an excess of the desired alcohol, this can be done at room temperature in the 
presence of a drying agent or using azeotropic distillation.[157] Borates (127 and 128) are 
prepared by successive nucleophilic attacks on the trivalent boron species. Boronic acid 
derivatives treated with an excess of alkoxide or fluoride are transformed to their 
corresponding trialkoxyborate (127) or trifluoroborates (128) respectively. Since these 
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transformations are equilibria, these can be simply and efficiently driven in the desired 
direction. 
 
Scheme 17 – Boronic acid derivative equilibria. 
Due to the widespread use of boronic acid derivatives in organic synthesis, intensive 
research efforts have been made to efficiently introduce boron atoms into organic 
compounds (Scheme 18). The reactions presented do not consist of a comprehensive list 
of borylation methods but represent the main strategies employed to introduce boron 
atoms into organic scaffolds. Most of the time these methods introduce a boronic ester 
group, requiring further manipulation if a different boronic species is to be used.[157] 
The most common approach is the transmetallation of nucleophilic organomagnesium[160] 
or organolithium[161] species with electrophilic boronic species (Scheme 18 a). This 
method allows an easy and cheap access to aryl or alkyl boronic esters, but the use of 
reactive organometallic species intermediate species limit its functional group tolerance 
and often requires cryogenic temperatures. Hydroboration of alkynes or alkenes is 
probably the most effective method to access alkyl boronic esters (Scheme 18 b).[162] 
 
Scheme 18 – Common routes to boronic acid derivatives. 
While hydroboration with dialkyl boranes happens spontaneously at low temperatures, 
the lowered reactivity of oxygenated borane reagents often requires the use of transition 
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metal catalysts or elevated temperatures.[163,164] Regio-selectivity and limited substrate 
scope are common issues with these methods. 
Transition‐metal‐catalysed borylation reactions have emerged as an alternative and 
powerful tool to produce boronic acid derivatives.[165] The mildest and most versatile 
method to access functionalised aryl boronic acid derivatives is the Miyaura borylation 
(Scheme 18 c).[166–168] This method relies on the engagement of aryl or alkenyl halides in 
palladium-catalysed cross-couplings with diboron compounds. Pioneered by Hartwig and 
Smith, more recent transition metal (mainly iridium) catalysed methods allow direct C–H 
borylation of arene or alkyl groups (Scheme 18 d).[169] 
1.3.2 Organoboron compounds as reactants in C–C cross-
couplings 
1.3.2.1 By transmetallation with transition metals 
As mildly nucleophilic and non-toxic organometallic species, organoboron compounds 
have found tremendous applications based on their ability to transmetallate with various 
transition metals.[157] Importantly, this property propelled them as first choice 
nucleophilic partners for palladium-catalysed C–C cross-coupling reactions.[170] For 
developing this transformation, Suzuki shared the 2010 Nobel Prize in Chemistry, further 
outlining the key role of organoboron reagents in modern organic synthesis (Scheme 
19).[42,171] 
 
Scheme 19 – A generalised mechanism of Suzuki-Miyaura cross-coupling reactions.[158]  
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Although a range of different organoboron reagents undergo rapid transmetallation (TM) 
with the active PdII complex (129), the choice of the exact species to employ is influenced 
by their stability under aerobic conditions, accessibility, and price. Boranes are easily 
produced by the hydroboration of olefins but are sensitive to oxidation by oxygen, and 
dehydroboration by water.[157] Best results in transmetallation are given by using boronic 
acids and their corresponding boroxines.[158] A range of different aryl boronic acids are 
commercially available, but many electron-deficient aryl boronic acids and alkyl boronic 
acids are sensitive to oxidation or protodeboronation under reaction conditions.[156,157,172] 
To circumvent this issue, boronic acids can be transformed into their more stable ester or 
trifluoroborate salt analogues.[157,158] Trifluoroborate salts are hydrolysed to the 
corresponding boronic acids under protic conditions, however releasing toxic and 
corrosive hydrofluoric acid. Finally, despite the great utility of Suzuki couplings to form 
biaryl products, challenges to cross-couple alkyl partners still remain (cf. 1.2.1).[42] 
1.3.2.2 By 1,2-migration from ate-complexes 
Another remarkable property of organoboron compounds is their ability to undergo 
stereospecific 1,2-metallate rearrangements (or 1,2-migrations) from tetra-coordinated 
ate-complexes (Scheme 20). This synthetically powerful transformation was first 
discovered by Matteson in 1980.[173,174] He could perform a one-carbon homologation of a 
chiral boronic ester with ZnCl2 and (dichloromethyl)lithium with high diastereoselectivity 
(Scheme 20).[173,175]  
In the first step, the ate-complex 132 is formed by a nucleophilic attack of 
(dichloromethyl)lithium (131) on a chiral boronic ester (130). Although different isomers 
of the intermediate 132 can be formed, the configuration of the isomer depicted is 
favoured due to the lower steric repulsion with the coordinating ZnCl2.
[176] 1,2-migration 
of the alkyl group from the boron centre with the concomitant anti-periplanar elimination 
of a chloride substituent affords the homologated boronic ester (133) in high 
diastereomeric ratios. Coordination of the zinc chloride additive not only aids in the 
elimination of chloride by stabilising the antiperiplanar orientation in the transition state 
132 but also promotes the process by weakening the C–Cl bond. 
The stereospecific nature of these transformations later inspired Aggarwal to conduct a 
series of homologations employing chiral organolithium nucleophiles (134) accessed via 
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enantioselective deprotonation of Hoppe carbamates.[177] Their addition to alkyl boronic 
esters allows a chiral ate-complex (135) to form, which, upon further warming of the 
reaction mixture, undergoes a stereospecific 1,2-migration, leading to the boronic ester 
136 with a high degree of enantiomeric control. Interestingly this process could be 
repeated up to nine times, providing a conceptually powerful method for assembling C–C 
bonds in an iterative fashion with absolute stereocontrol at each homologated carbon.[178] 
Since their initial work, other coupling methods employing chiral boronic esters were 
further developed by his group, also relying on the 1,2-migration principle.[179,180] 
 
Scheme 20 – C–C cross-couplings of organoboron reagents relying on a 1,2-migration mechanism. 
The coupling of diazo compounds with organoboron reagents[181] was initially reported by 
Hooz in 1968 with trialkyl boranes and further popularised by Barluenga in 2009 with 
aryl boronic acids.[182] These transformations also rely on a 1,2-migration mechanism, 
with the nucleophilic species being a zwitterionic diazo compound (138). Its attack is 
favoured on highly Lewis acidic organoboron compounds (137) such as boroxines.[183] 
This attack leads to the formation of a zwitterionic ate-complex (139) that can easily 
undergo 1,2-migration by eliminating nitrogen and leaving behind a highly reactive 
boronic acid derivative (140), that can be oxidised, protodeborylated or further 
homologated.[184,185] 
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1.3.2.3 As carbon radical precursors 
A less recognised reactivity of organoboron compounds is the possibility to use them as 
carbon radical precursors.[49] The low polarity of the C–B bond allows it to be cleaved 
homolytically. Such reactions are usually thermodynamically favoured by the formation 
of strong B–O (~124 kcal/mol) or B–N (~100 kcal/mol) bonds at the expense of the 
weaker B–C bond (~81 kcal/mol).[186] 
Trialkyl boranes (117) were first used as carbon-centred radical (11) precursors in 
1967.[187] Due to their ability to spontaneously react with molecular oxygen (Scheme 21), 
they have been widely used as convenient low-temperature radical initiators.[186] 
 
Scheme 21 – Generation of carbon-centred radicals from trialkyl boranes.[186,188] 
This property was discovered by Brown and Suzuki, reporting the use of trialkyl boranes 
(117) as substrates in radical conjugate additions to electron-deficient olefins.[187] The 
proposed mechanism for this conjugate addition (Scheme 22) starts with the oxygen-
mediated formation of a carbon-centred radical (11) which adds an olefin (142) to form a 
radical enolate (143). Due to the strong B–O bond energy, the intermediate 143 
propagates the radical chain mechanism with a second equivalent of borane (117) to form 
a boron enolate (144), which releases the addition product (145) after aqueous 
workup.[188,189] 
 
Scheme 22 – Brown’s radical chain mechanism of trialkyl borane conjugate addition.[189]  
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To circumvent the lack of selectivity in the cleavage of unsymmetrical trialkyl boranes, in 
1999 the Renaud group reported the use of catechol boronic esters (123) as radical 
precursors.[190] In analogy to their trialkyl borane homologs, these highly Lewis acidic 
boronic esters are sensitive to radical displacement with oxygen-centred radicals. 
However, less efficient chain propagation requires the use of a radical chain carrier, such 
as the Barton carbonate (PTOC-OMe, 146), to enable efficient radical addition to a wide 
range of Michael acceptors (Scheme 23).[191] In the absence of oxygen, the Barton 
carbonate (146) served as a radical initiator, generating the oxygen-centred radical (147) 
upon UV light irradiation. This radical is efficiently engaged in a homolytic substitution 
with a catechol boronic ester (123) to liberate a carbon-centred radical (11) that efficiently 
adds to an electron-deficient olefin (16). The intermediate radical 37 can then be trapped 
by the Barton carbonate (146) to provide the coupled product (149) and regenerate the 
oxygen-centred radical (147).  
 
Scheme 23 – Mechanism of Renaud’s modification of the Brown reaction. 
However, in these processes, oxygen sensitive organoboron starting materials (123) 
required an in situ generation method with a hydroboration step, thereby limiting the full 
synthetic potential of these reactions.[190,192] 
A major paradigm shift in the use of bench-stable organoboron compounds as radical 
precursors was the discovery that electron-rich organoborates are readily single-electron 
oxidised.[193,194] It was only between 2010 and 2011 that this property was identified as a 
useful synthetic approach by Fensterbank and Molander.[195,196] Both groups reported the 
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use stoichiometric metallic oxidants (CuII and MnIII) to single-electron oxidise 
trifluoroborate salts (128, Scheme 24). In a separate report, strong stoichiometric oxidants 
were employed to generate aryl radicals (96) from aryl boronic acids (108), although the 
mechanism underlying this fragmentation was not fully described.[196–202] The radicals 
thus generated (96) could be further engaged in net-oxidative transformations such as 
oxidative additions to olefins (78) or aromatic systems (90). 
 
Scheme 24 – Single-electron oxidation of organoborates and aryl boronic acids and their coupling reactions. 
In 2012, Akita demonstrated the compatibility of the single-electron oxidation of 
organoborates with photoredox catalysis.[62] Using the Ir-3 photocatalyst, he could 
generate alkyl and aryl radicals from a variety of trifluoroborate (128) and 
trialkoxylborate (127) salts without using stoichiometric metallic oxidants. These radicals 
could be trapped with TEMPO or engaged in redox-neutral couplings with electron-
deficient olefins (16, cf. 1.2.3.2 a). In 2014, the Molander group reported a 
nickel/photoredox dual catalysed C(sp2)–C(sp3) cross-coupling of benzylic trifluoroborate 
salts with aryl halides (151, cf. 1.2.3.2 d), further highlighting the synthetic potential of 
these methods.[45] 
These seminal reports revived the interest in using organoboron reagents as easily 
accessible radical precursors.[203,204] However, the synthetic utility of this concept can still 
be improved. Due to the low oxidation potentials of common photoredox catalysts, only 
organoborates can be activated using photoinduced single-electron oxidation. Extending 
this approach to a wider range of commercially available organoboron reagents would be 
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attractive – especially as the low solubility of organoborate salts in common organic 
solvents limits the scale-up capabilities of the current methods for industrial processes. 
1.4 Summary and project overview 
Organoboron reagents have shown their synthetic utility as “two-electron nucleophiles” 
with the immense success of the Suzuki-Miyaura cross-coupling that is often considered 
as the most used C–C coupling method (cf. 1.3.2.1).[170] While this method is particularly 
powerful for C(sp2)–C(sp2) couplings, its extension to C(sp3) nucleophiles is still a 
challenge (cf. 1.2.1).[42] For these reasons, alkyl couplings are often performed with alkyl 
zinc or Grignard reagents lacking a broad functional group tolerance.[43] As a result, 
finding selective and general methods to couple bench-stable C(sp3) organoboron 
reagents is still of high interest. 
As thoroughly discussed in 1.2.3, photoredox catalysis has become a method of choice to 
perform C–C cross-coupling reactions of pro-oxidative or pro-reductive carbon radical 
precursors in a redox-efficient manner. In this context, finding alternative widely 
commercially available starting materials able to act as a “radical reservoir” (cf. 1.2.2) is 
of high importance for these methodologies to be applied by a wider synthetic audience. 
Organoboron reagents are becoming more commonly used as oxidative carbon radical 
precursors (cf. 1.3.2.3). While this discovery was initially made with unstable 
organoboranes, bench stable trifluoroborate salts are now increasingly used as radical 
precursors under photoredox-catalysed conditions.[203] 
 
Scheme 25 – A single-electron transfer activation of boronic acid derivatives for C–C couplings. 
In this thesis, we present our work towards using more commonly available boronic acid 
derivatives as reagents in photoredox-catalysed C–C cross-couplings (Scheme 25).  
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Chapter 2 presents our original discovery that pinacol boronic esters can be activated 
under photoredox-catalysed conditions and used in C(sp2)–C(sp3) cross-couplings. Based 
on our mechanistic understanding, Chapter 3 focuses on the use of a Lewis base catalyst 
to promote the photoinduced single-electron oxidation of boronic esters and acids and 
their efficient alkylations. Finally, Chapter 4 describes the application of these methods 
for the efficient synthesis of active pharmaceutical ingredients and our work in finding 
suitable organic dye catalyst to perform these reactions without using a transition metal-
based catalyst. 
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2 Photoredox arylations: from trifluoroborates to 
boronic esters 
2.1 A redox-neutral coupling: proof-of-concept 
We decided to start investigating net-neutral photoredox coupling procedures with 
organoboron reagents that were already known for their reactivity towards photoinduced 
single-electron transfer. The success of Akita’s and Molander’s procedures, relying on the 
formation of alkyl radicals using single-electron oxidation of alkyl 
trifluoroborates,[45,62,126,205,206] encouraged us to use these as model organoboron reagents 
(Scheme 26, A). 
 
Scheme 26 – Starting idea: oxidise a trifluoroborate and reduce a cyanoarene. 
To arylate these radicals in a redox-neutral fashion, we were naturally attracted to the 
recent work of MacMillan describing the coupling of various carbon-centred radicals to 
electron-poor aromatic nitriles used as electron acceptors via a radical-radical 
coupling.[74,76,84,114,207] With two complementary substrates, one that can provide an 
electron (benzyl trifluoroborate, “1e- nucleophile”) and another that can accept an 
electron (cyanoarene, “1e- electrophile”), it is conceptually possible to perform a net 
neutral photoredox coupling of these two entities (cf. 1.2.3.2 b). We started to investigate 
this concept using trifluoroborate 153 and cyanoarene 154 as model coupling partners 
with known complementary reactivity in photoredox-catalysed reactions. 
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2.1.1 Optimisation 
Photocatalyst selection was the initial step of this optimisation. The important redox 
potential difference between the two reagents (2.7 V) encouraged us to investigate 
photocatalysts associated with a wide redox window (Table 2, entries 1–4). This initial 
screening allowed us to identify the strong excited state oxidant Ir-3 (E1/2
*/red = +1.21 V) 
as the most promising catalyst, leading to 58% yield in coupling product as the initial 
result (entry 1). This is not surprising given the high oxidation potential of the benzyl 
trifluoroborate (Eox (153) = +1.10 V)
[45], requiring a strongly oxidising photocatalyst. 
Surprisingly, the potent oxidants Mes-Acr-1 (E1/2
*/red = +2.08 V, entry 2) and Ru-4 (E1/2
*/red 
= +1.45 V, entry 3) did not provide a good conversion of 154.  
Table 2 – Optimisation of photoredox coupling of benzyl trifluoroborate (153) with 4-cyanopyridine (154). 
 
Entry PC Light source temp. equiv.a Yieldb 
1 Ir-3 LED470 30°C 0.625 58% 
2 Mes-Acr-1 LED470 30°C 0.625 13% 
3 Ru-4 LED470 30°C 0.625 0% 
4 Ir-1 LED470 30°C 0.625 3% 
5 Ir-3 LEDwhite 35°C 0.625 23% 
6 Ir-3 Intense bulb 90°C 0.625 6% 
7 Ir-3 CFL bulb 40°C 0.625 42% 
8c Ir-3 LED470 30°C 0.625 5% 
9 Ir-3 no light 25°C 0.625 0% 
10 Ir-3 LED470 30°C 1.2 72% 
11d Ir-3 LED470 30°C 1.2 85% (81%) 
Reactions carried out by adapting GP(II) to the conditions described. aEquivalents of 153 used. bYield in 155 
determined by 1H–NMR analysis of crude reaction mixture using CH2Br2 as an internal standard. Isolated 
yield in parentheses. cWith 2.0 equiv. of TEMPO. dIrradiated 48 h instead of 16 h. Isolated yield in 
parentheses. 
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This is probably because of their lower reducing abilities (E1/2
gd/red (Mes-Acr-1) = -0.57 V 
and E1/2
gd/red (Ru-4) = -0.80 V) preventing them to reduce 154 (Ered  = -1.78 V). Finally, 
the strong excited state reducer Ir-1 (E1/2
ox/* = -1.73 V) was not effective in this reaction 
(entry 4). With a suitable catalyst in hand, the influence of light source on the reaction 
was investigated (entries 5–7 vs. entry 1). Notably, the nature of the light source 
influenced the temperature of the reaction. While the LEDs and the CFL light bulb 
provided irradiation at just above ambient temperature (30°C to 40°C), using a more 
powerful bulb, heated the reactor up to 90°C and led to the degradation of the catalyst 
(entry 6). Blue LEDs (Thorlabs, λmax = 470 nm, 2 x 253 mW) provided the most efficient 
irradiation by only emitting within the absorption spectrum of the catalyst (λmax (Ir-3) = 
380 nm). In contrast, white LEDs emit a smaller proportion of light that can be absorbed 
by the catalyst, making them less efficient. Interestingly, a simple household CFL light 
bulb could be used as a cheap irradiation device, only giving a slightly lower yield than 
the blue LEDs (42% vs. 58%). Control experiments were then carried out. Addition of the 
persistent radical TEMPO (entry 8) suppresses the reaction as expected, due to the 
trapping of the postulated radical intermediate (TEMPO adduct detected by MS). No 
reaction was observed when stirring the mixture in the absence of light (entry 9). The 
influence of the stoichiometry of the reaction was then examined (entry 1 vs. entry 10). 
The limiting reagent was changed from 153 to 154 with a significant enhancement of the 
yield in the coupling product (58% to 72%). Since 154 was not fully converted, irradiating 
the mixture for 48 h instead of 16 h allowed the reaction to reach full conversion of 154, 
resulting in 85% of the coupling product (entry 11).  
2.1.2 Scope of  the transformation 
With optimised conditions in hand, the scope of potassium trifluoroborates was 
investigated using 4-cyanopyridine (154) as model coupling partner (Table 3). As 
observed during the optimisation, electron-neutral benzyl trifluoroborate (153) required 
48 h of irradiation to afford 81% isolated yield. However, the more activated 
4-methoxybenzyl trifluoroborate (155) delivered a high yield of coupling product 162 
after only 16 h of irradiation, probably because of an easier single-electron-oxidation step. 
The more electron-rich secondary benzyl trifluoroborate (156) was fully converted within 
3 h and was transformed in high yield to the hetero-arylated product (163). The 
regioselectivity of this coupling product is interesting since rearrangement of the 
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postulated benzyl radical can occur to generate a tertiary alkyl radical via 1,2-hydrogen 
atom shift. Moreover, it is a more challenging substrate to engage using a Suzuki-
Miyaura coupling procedure, with the possibility of β-hydride elimination after the 
transmetallation step. 
Table 3 – Scope of alkyl and aryl potassium trifluoroborates coupled to 4-cyanopyridine (154). 
 
Reactions carried out by following GP(II). Isolated yields unless otherwise stated. *Yield determined by 1H–
NMR analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an internal standard. 
Three other classes of trifluoroborate salts were then tested: allyl, alkyl and aryl 
trifluoroborates (157–160). From these, only tert-butylated pyridine (164) could be 
obtained in a low 15% yield after 72 h of irradiation. No reaction was observed using 
allyl, cyclohexyl or phenyl trifluoroborates (165–167). The reason for these results is 
presumably the higher oxidation potential of those less activated trifluoroborates that are 
unable to quench the excited Ir-3* photocatalyst. To verify this hypothesis, we plotted the 
measured redox potentials (Scheme 27) of these trifluoroborate species against the 
reduction potential of Ir-3* (E1/2
*/red = +1.21 V). These values show that only benzyl (153) 
and tert-butyl trifluoroborates (157) can fit in the reductive quenching redox window of 
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Ir-3. This reactivity cut-off is therefore correlated with the redox potentials cut-off, 
suggesting that a reductive quenching cycle of Ir-3 is probably operative. 
 
Scheme 27 – Oxidation potentials of trifluoroborate species versus the reductive quenching cycle of Ir-3. 
In addition to reactivity issues, problems solubilising these anionic starting materials in 
acetone were also observed, even under very dilute conditions (0.06 M). Solubility issues 
limit the productivity of the reaction and hinder the light absorption by the photocatalyst 
by light-scattering from the insoluble particles. As the reaction proceeds, potassium salt 
precipitation also occurs, making process intensification difficult. To investigate more 
soluble borate salt alternatives, the secondary benzyl diethanolamine borate (168) 
analogue of the highest yielding benzyl trifluoroborate (156), was tested under the 
optimised conditions (Scheme 28). This zwitterionic compound only yielded 43% of 163 
after 16 h of irradiation and is consequently less reactive than its trifluoroborate analogue 
(86% in 3 h). Although no report has been made about the photoredox activation of these 
uncommon organoborates we did not optimise these results further due to commercial 
unavailability of these reagents. 
 
Scheme 28 – Alternative diethanolamine borate salt investigation (following GP(II)). 
The scope of cyanoarenes was then investigated using 4-methoxybenzyl trifluoroborate 
(155) as coupling partner (Table 4). Heteroaromatic nitriles were initially tested. Among 
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cyanopyridines, only the 4-cyanopyridine (154) gave the desired product (162) in a 
productive yield, the more electron-rich 3-position (169) did not react under these 
conditions and 2-cyanopyridine only provided 8% of 170. The two-nitrogen-containing 
2-pyrimidine resulted in a slightly higher yield of the coupling product (171), 30% after 
72 h. 
Table 4 – Scope of cyanoarenes partners with benzylic trifluoroborate salt 155. 
 
Reactions carried out by following GP(II). Isolated yields unless otherwise stated. *Yield determined by 1H–
NMR analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an internal standard. 
Non-heteroaromatic nitrile coupling partners were then examined. Electron-deficient 
benzonitriles were considered as the best potential substrates to start. Unfortunately, the 
4-trifluoromethane benzonitrile (172) was left unreacted using the optimised reaction 
conditions. On the other hand, the 4-cyano and 4-nitro benzonitriles (173 and 174) were 
found to have partially reacted under the standard conditions. As a result, the scope was 
limited to specific cyanoarenes able to engage in single-electron reduction. These 
observations are in line with the previously observed scope of cyanoarenes using a 
postulated radical-radical coupling strategy.[74] 
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2.1.3 Mechanism 
Based on the known oxidative carbon-centred radical generation from organoborates[45,62] 
and reductive generation of radicals from electron-deficient cyanoarenes[74] the following 
reaction mechanism was suggested (Scheme 29). 
 
Scheme 29 – Suggested mechanism for the arylation of benzyl trifluoroborates. 
The reaction starts with the visible light excitation of the photocatalyst to create a highly 
oxidative Ir-3* species (E1/2
*/red = +1.21 V). Based on the redox potential cut-off observed, 
this stable triplet state can then be reductively quenched by the electron-donor benzyl 
trifluoroborate (Eox (155) = +1.10 V)
[45] generating a stabilised benzyl radical (175) and 
liberating BF3. In this process, the reduced Ir-3red (E1/2
gd/red = -1.37 V) is generated. This 
potent one electron reducing species is then believed to donate an electron to the 
4-cyanopyridine (154) to generate the stabilised radical anion (176) and ensure the 
turnover of the catalyst. The persistent radical anion (176)[74] can then engage in 
bimolecular radical-radical coupling with the benzyl radical (175) to form the coupling 
product (162) after the elimination of cyanide sequestered by BF3. The stability of the 
radical anion intermediate (176) is enhanced in the case of para-substitution of the 
aromatic ring by strongly electron-withdrawing groups or the presence of a nitrogen atom 
in a suitable position allowing mesomeric delocalisation of the negative charge. This 
would explain, at least partially, the electronic effects observed by changing the 
substituents on the cyanoarenes. Improvement of the kinetics of the reaction by 
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employing more electron-rich benzyl trifluoroborates can also be rationalised by the fact 
that they will be more readily oxidised by the Ir-3*. This is also a sign that this initial step 
might be the rate-limiting one. 
However, there is an issue with the proposed mechanism. Although a match with the 
oxidation potential of the trifluoroborate and Ir-3* is observed (blue lines, Scheme 30), the 
oxidation potential of Ir-3red (E1/2
gd/red = -1.37 V) is not high enough to enable the 
reduction of 154 (Ered = -1.78 V), as a gap of 0.41 V is separating the two (red lines). 
 
Scheme 30 – Redox potentials of the species involved in the trifluoroborates arylation process relative to the 
reductive quenching cycle redox window of Ir-3. 
As far as the redox potential model is concerned, we are confident that it can serve well to 
illustrate the thermodynamic feasibility of electron transfer mechanisms. Consequently, 
we believe that activation of the 4-cyanopyridine (154) will be required to lead to a 
thermodynamically feasible reduction. This aspect will be discussed in a following 
section (cf. 2.2.4). 
2.1.4 Summary 
In summary, we have investigated a proof-of-concept of a redox-neutral arylation 
between an electron donor and organoboron acceptor using photoredox catalysis. Based 
on known literature examples, we could cross-couple an organoborate “1e- nucleophile” 
and a “1e- electrophile” by the use of a photoredox catalyst, mimicking the concept of 
palladium-catalysed cross-couplings. 
However, as only a limited number of synthetically useful examples could be obtained 
with this method, we decided to further investigate the nucleophiles and electrophiles that 
could be engaged using this rationale. 
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2.2 Boronic esters as electron donors 
We initially investigated the replacement of the trifluoroborate electron donors by more 
attractive boronic esters in our developed redox-neutral coupling (Figure 8). Due to 
solubility issues associated with the use of trifluoroborate salts, the use of polar aprotic 
solvents or solvent mixtures (such as DMF or DMSO) at low concentrations (typically < 
0.05 M) is often required to avoid clogging issues. These diluted conditions result in long 
reaction times (24 to 48 h), low throughput and scale-up difficulties. Moreover, these 
water-soluble, high boiling point solvents pose issues for downstream processing.[208] A 
more soluble source of the organic radical species in a more acceptable solvent would be 
beneficial.[209] 
 
Figure 8 – Comparison between trifluoroborates and boronic esters as electron donors. 
Boronic esters are suitable precursors as they are widely available, both from commercial 
or synthetic sources.[184,210–214] Although organoboron species have been described as a 
tin-free source of alkyl radicals,[186] only a limited number studies have been focused on 
the use of boronic esters as carbon radical precursors, with only catechol boronic esters 
being investigated.[191,215] Despite the growing interest in generating carbon radicals using 
trifluoroborate salts, no reports to date for the activation of boronic esters using 
photoredox catalysis have been made.[204] 
Importantly, solving solubility issues associated with these anionic starting materials 
would enable the use of continuous processing methods which could provide other 
advantages. For instance, more efficient irradiation with microchannel devices and better 
temperature control has been seen to result in faster and cleaner photoreactions in 
flow.[216–219] Additionally, due to the inherent limitation of photon attenuation through 
absorbing media, resulting in a small light penetration depth,[216] batch photoreactors will 
often become inefficient when scaled-up.[220] 
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2.2.1 Optimisation: from batch to flow 
To improve the process productivity, we were interested in irradiating the reaction 
mixture in a flow reactor. We initially tested the reaction developed with the 
trifluoroborate salts (cf. 2.1) in a Vapourtec UV-150 module equipped with blue LEDs 
(17 W at 420 nm). Using the trifluoroborate salt (155), clogging issues were immediately 
observed in the flow equipment due to the rapid precipitation of insoluble potassium salts 
(Table 5). We therefore turned our attention towards the more soluble boronic pinacol 
ester analogue. 
Initial test of the boronic ester starting material (179) in batch revealed the possibility of 
using it as a replacement for trifluoroborate salts. Despite the low yielding reaction (23% 
after 24 h), we were pleased to observe the desired reactivity. More importantly, the fully 
homogeneous solution of the boronic ester (179) in acetone could be eluted through the 
flow photoreactor without blockages, resulting in better result in less time (32% in 
100 min). The faster reaction is not only due to the better design of the reactor but also to 
the significant difference in the light intensity of the two light sources (253 mW in batch 
vs 17 W in flow). Also, the rest of the mass balance was unreacted starting material, 
making further optimisation possible. 
Table 5 – Initial comparison between batch and flow photochemical reactors using 155 and 179. 
 
 
 
aReactions carried out by adapting GP(II) to the conditions described. bReactions carried out by adapting 
GP(III) to the conditions described. 
Based on these preliminary results, we continued the optimisation of this reaction in the 
flow reactor. The desired premixed reaction mixture was eluted at 100 µL/min through a 
10 mL FEP tubing reactor coil[221] irradiated by 17 W blue LEDs at 420 nm (Table 6). The 
[B] [batch]a [flow]b 
BF3K (155) 76% in 16 h Clogging of the reactor 
Bpin (179) 23% in 24 h 32% in 100 min 
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reaction slug was then collected and concentrated to determine the yield by crude 1H-
NMR, using CH2Br2 as an internal standard. Previously optimised conditions were used 
as a starting point using 100 min residence time (maximum possible using this reactor, 
cf. 4.2.4). The effect of concentration was dramatic (cf. 2.2.4) with a doubling of the yield 
by changing from 0.06 M to 0.25 M (entry 1 vs. entry 2). One additional feature of this 
flow setup is the higher degree of temperature control that is not easily achieved with a 
batch photoreactor. Increasing the temperature from 35°C to 60°C (entries 2–4) allowed 
us to bring the reaction to completion at a fixed time of residence and concentration. 
Entry 4 describes optimised conditions yielding 88% of product after 100 min of 
irradiation. Selection of the photocatalyst was also a crucial parameter with the most 
oxidising photocatalysts being more potent.  
Table 6 – Optimisation experiments for the coupling of boronic ester 179 with 154 in flow. 
 
Entry conc. temp. PC additive Yielda 
1 0.06 M 35°C Ir-3 - 32% 
2 0.25 M 35°C Ir-3 - 68% 
3 0.25 M 45°C Ir-3 - 77% 
4 0.25 M 60°C Ir-3 - 88% (81%) 
5 0.25 M 80°C Ir-3 - 88% 
6 0.25 M 60°C Ir-2 - 10% 
7 0.25 M 60°C Mes-Acr-1 - 84% 
8 0.25 M 60°C - - 0% 
9b 0.25 M 60°C Ir-3 - 0% 
10 0.25 M 60°C Ir-3 TEMPO (2.0 equiv.) 0% 
11 0.25 M 60°C no PC AIBN (2.0 equiv.) 0% 
Reactions carried out by adapting GP(III) to the conditions described. aYield in 162 determined by 1H–NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. bIn the dark. Isolated yield in 
parentheses. 
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Interestingly the organic dye Mes-Acr-1 provided 162 in high yield but was less general 
than the iridium-based Ir-3 (see comparison on different substrates in Table 8). Control 
experiments confirmed the necessity of the photocatalyst (entry 8) and light (entry 9) to 
obtain conversion. Stable TEMPO radical additive (entry 10) also inhibited the supposed 
radical reaction and radical initiator AIBN could not trigger a radical chain reaction 
(entry 11). 
2.2.2 Scope investigation 
The scope of this new reaction was then explored starting with the problematic 
cyanoarenes scope observed previously (Table 7). The model substrate, 4-cyanopyridine 
was the most successful cyanoarene of those examined (162). Pleasingly, in addition to 
cyanopyridine, our transformation was successfully applied to several other N-
heterocycles. Variations around the 4-cyanopyridine scaffold were possible with 
4-cyanoquinoline (180) and other nitrile substituted 4-cyanopyridine derivatives (181 and 
182) giving coupled products with selective coupling at the most electron-deficient 
4-position. In these cases, the rest of the mass balance was unreacted cyanoarene. The 
unprotected 4-cyano-7-azaindole (183), commonly used as a bioactive scaffold,[222] was 
also tolerated. The 2-pyridyl position was also reactive with 1-cyanoisoquinoline, 
2-cyanoquinoline and 2-cyanopyridine all providing synthetically useful yields (170, 184 
and 185). 
However, only limited success was obtained with diazines, with pyrimidine, pyridazine, 
and pyrazine (171, 186 and 187) failing to deliver productive yields. Non-nitrogen-
containing cyanoarenes were not coupled (173, 188–190), leaving both the starting 
materials unreacted. Interestingly, N-heterocycles are generally seen as catalyst inhibitors 
for palladium-catalysed cross-couplings[42] but proved to be crucial in our reaction 
(cf. 2.2.4). 
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Table 7 – Scope of cyanoarenes investigated to arylate boronic esters. 
 
Reactions carried out by following GP(III). Isolated yields unless otherwise stated. *Yield determined by 1H–
NMR analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an internal standard. 
Conversion of the corresponding cyanoarene in parentheses. 
The scope of boronic pinacol esters was then investigated. All the primary benzyl boronic 
esters tested were successfully coupled to 4-cyanopyridine (154). We compared the 
efficiency of the organic dye Mes-Acr-1 on three examples (161, 162 and 191), showing 
the lower efficiency of the dye when less reactive boronates were used (161 and 191). The 
low conversions associated with these reactions in addition to the discolouration 
(photobleaching) of the solutions appeared to suggest that instability of the dye is 
responsible for its lower activity. Hence, we continued investigating the scope with the 
more stable Ir-3 catalyst. In addition to 4-cyanopyridine (154), the 1-cyanoisoquinoline 
(184) resulted in comparable isolated yields of coupling products. More challenging 
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secondary benzylic boronic esters also proceeded in high yields (192, 194 and 195). In 
addition to the electron-rich methoxy and methyl groups, the benzyl boronates could be 
substituted with electron-withdrawing fluoro and trifluoromethyl groups in the para, 
meta, and ortho position of the -CH2Bpin without losing reactivity (196 to 198). 
We then explored the reactivity of non-benzylic boronic esters and found that unlike with 
trifluoroborate salts (cf. Table 3), allyl boronic pinacol ester (165) was reactive under 
these reaction conditions. However, less activated cyclohexyl and tert-butyl boronic 
esters (164 and 166) were unreactive under these reaction conditions. The same 
observation was found for phenyl pinacol boronic ester (167), which did not react after 
100 min of irradiation. 
Table 8 – Scope of boronic esters to be arylated. 
 
Reactions carried out by following GP(III). Isolated yields unless otherwise stated. *Yield determined by 1H–
NMR analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an internal standard. aMes-
Acr-1 was used instead of Ir-3. Conversion of the corresponding cyanoarene in parentheses. 
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Starting from this observation, we could develop an optimised allylation protocol of 
heteroaromatic nitriles after optimisation of concentration, stoichiometry and residence 
time. This reaction would be problematic using an electrophilic allylation approach of a 
metallated aromatic ring due to the electron-deficiencies of the 2 and 4 positions of the 
pyridine rings and the competitive nucleophilicity of nitrogen-containing heterocycles. 
Using commercially available allyl boronic pinacol ester, the efficient synthesis of 
allylated heterocycles could be performed in only 50 min residence time (Table 9). 
Surprisingly only two protocols were described[223,224] for the synthesis of 4-allylpyridine 
(165, sold at more than $1500/g)[225] and no protocol for the preparation of 201 and 202 
could be found. Our method allowed the synthesis of these three allylated heterocycles in 
70% yield. 
Table 9 – Scope of cyanoarenes allylation in flow. 
 
Reactions carried out by following GP(IV). Isolated yields unless otherwise stated. *Yield determined by 1H–
NMR (tentative assignment) analysis of crude reaction mixture using CH2Br2 as an internal standard. 
Conversion of the corresponding cyanoarene in parentheses. 
However, some substrates that were found suitable for the benzylation protocol were less 
successful partners using this allylation method (203–205). The reason for this is probably 
the longer irradiation time required to fully convert these less reactive starting materials. 
We did not further optimise the reaction conditions to accommodate these less reactive 
partners. 
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2.2.3 Larger scale reaction 
Intensified conditions obtained with the optimised allylation protocol (0.5 M 
concentration and 50 min residence time) encouraged us to investigate the stability of the 
process when running the reaction for a longer time (Scheme 31).  
 
Scheme 31 – Larger scale reaction conditions and setup (adapting GP(IV)). 
Using the optimised conditions on 30 mmol scale, by eluting 60 mL of the reaction 
solution for 5 hours, 3.55 g of the allylated product was obtained. In theory, this process 
could deliver a throughput of 17 g d-1 of 201 using a 10 mL reactor. This productivity 
translates to a space-time yield (STY) of 420 mmol h-1 LR
-1 meaning that using a visible 
light-modified Firefly reactor (120 mL internal volume) could potentially deliver a 
reasonable 200 g (or 1.2 mol) of product per day.[226] 
re la tiv e  t im e  (m in )
A
b
s
o
r
b
a
n
c
e
0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0
0 .0
0 .1
0 .2
0 .3
0 .4
P e a k  a t 1 5 9 0  c m -1
P e a k  a t 1 5 3 0  c m -1
 
Graph 2 – In-line IR reaction monitoring spectra (1590 cm-1 for 201 and 1530 cm-1 for 206). 
The consistency of the production could be monitored by in-line IR spectroscopy (Graph 
2).[227] Product formation was observed with an intense band at 1590 cm-1 (aromatic C=C 
stretching of 201) while no substantial residual cyanoarene starting material was observed 
(little peak at 1530 cm-1 accounting for the aromatic C=C stretching of 206). No pressure 
issues were seen, and no particle generation was observed. Consequently, this process 
could be considered as stable and potentially scalable. 
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2.2.4 Mechanistic investigation using DFT§ 
To gain a better understanding of the mechanism of this new reaction we decided to 
investigate the feasibility of this transformation using calculations performed at DFT 
level. 
 
Scheme 32 – The single-electron oxidation/reduction reactions of starting materials used with Ir-3 (Gibbs 
energies for single-electron transfer reactions). 
Our starting hypothesis is that the photocatalyst Ir-3 reacts as an excited state oxidant. 
This is, in fact, often postulated[62,118] as Ir-3 is a strong single-electron oxidant 
(E1/2
*/red (Ir-3) = +1.21 V) at the excited state and a poorer single-electron reductant 
(E1/2
ox/* (Ir-3) = -0.89 V). In this system, we are not using a single-electron donor capable 
to oxidise Ir-3* (e.g. 4-cyanopyridine, Ered
 (154) = -1.78 V). We therefore initially 
postulated that Ir-3 follows a reductive quenching cycle, being quenched by good single-
electron donors present in solution, as we postulated with the benzyl trifluoroborate salts 
previously (Eox (153) = +1.10 V). 
Using this rationale, we initially calculated the standard reaction Gibbs energy for SET 
events of the starting materials (51, 153, 154, 179, 206, 209 and 210) with iridium species 
§
This work was conducted in the Ley Group in collaboration with Dr. Mikhail Kabeshov. 
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from the reductive quenching cycle of Ir-3 (Scheme 32). Single-electron oxidation of 
boronic species (in blue) was initially investigated. Equation (I) shows that our model 
predicts the thermodynamic feasibility (negative ΔrG) of the reductive quenching of Ir-3* 
with trifluoroborate salt (153) to spontaneously generate the dissociated benzyl radical 34 
and BF3 (207). However, under the same conditions, the single-electron oxidation of 
benzyl pinacol boronic ester 179 (equation (II)) was not calculated to lead to a dissociation 
and was attributed with a positive reaction Gibbs energy, meaning that the process is not 
thermodynamically favourable. 
On the single-electron reduction side (in red), all cyanoarenes computed (51, 154, 206, 209 
and 210) are unable to accept an electron from the highly reducing Ir-3red (equation (III)). It 
can be noted that in his arylation methods employing cyanoarenes, MacMillan employed 
the more potent single-electron donors such as Ir-1[74,96] to reduce similar cyanoarenes 
(E1/2
ox/* (Ir-1) = -1.73 V for Ered (51) = -1.61 V). 
These initial calculations informed us that the starting materials used cannot react 
favourably in SET reactions with the photoredox catalyst as such. These calculations are 
also in line with the redox potential comparison method that would predict the same 
outcome. Also, we started to think of more favourable reaction pathways. 
When investigating the scope of this transformation (Table 7), we observed that only 
nitrogen-containing cyanoarenes were reactive in couplings with 179. We consequently 
proposed that interactions between the heterocyclic compounds and the boronic ester 
(179) could be responsible for this significant reactivity difference. The reactive 
characteristic of the boronic ester functional group is its Lewis acidity (cf. 1.3.1). Since 
nitrogen-containing heteroaromatics are Lewis basic, we postulated that a Lewis acid-
base adduct could be formed between the two starting materials and result in their 
activation towards single-electron transfers. 
Complexations of model boronic ester (179) with various Lewis bases, either cyanoarenes 
used in the reaction (LB = 154, 206, 209, 210) or other pyridine derived Lewis bases 
(LB = 214–216), were then modelled (Scheme 33). 
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Scheme 33 – A favourable single-electron oxidation/reduction cascade pathway (reaction Gibbs energies for 
single-electron transfer reactions; mixture 179 + LB is set as a ground state for all the transformation). 
Ease of complex formation (217–223) greatly depended on the Lewis basicity of pyridine-
derived ring. With respect to 179, the most favourable calculated complexation partner is 
the electron-rich DMAP (cf. 223 in Figure 9) and the least favourable is the sterically 
hindered 2,6-lutidine (221) whose 2- and 6-methyl groups clash with the methyl groups 
of the pinacol ligand of 179. 
Complexation events, although being endergonic, are equilibria and could be driven 
forward if consecutive reactions are favourable. We therefore calculated the Gibbs 
energies for single-electron oxidations of the complexes instead of 179 alone (blue 
arrow). Despite the instability of the intermediate radical cation produced (224–230), these 
oxidations allow a subsequent thermodynamically favourable C-B cleavage to the radical 
7 and the cationic intermediates (232–238). C–B bond cleavage is characterised by a low 
barrier (1.7 kcal mol-1 for LB = 4-cyanopyridine, 224-TS ) thus occurring spontaneously 
after the single-electron oxidation step. These possible dissociations significantly 
transform the reaction energy profile of the oxidation (blue sequence) compared to the 
non-activated case ((II) in Scheme 32 vs. 231 + 232–238 in Scheme 33). 
Complex formation equilibria will then be driven forward as a result of the 
thermodynamically favourable C–B cleavage to the radical 231. As the formation of 
231 + 238 is the most favourable (ΔrG = –18.5 kcal mol-1), DMAP is expected to be the 
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most efficient Lewis base among those tested to activate 179 towards single-electron 
oxidation. 
Figure 9 – Calculated structure of the complex 223 between 179 and DMAP. 
This pathway also produces heterocyclic cationic adducts 232–235 (after C–B cleavage), 
which are more electron-deficient and consequently easier to reduce than the neutral 
cyanoarenes. Therefore, we tested a subsequent single-electron reduction from the Ir-3red 
species (red arrow). Formation of the radicals 239–242 from the cationic intermediates 
232–235 was calculated to be extremely favourable (Scheme 32). 
As a result, complex formation not only activated the boronic ester towards single-
electron oxidation but also significantly activated Lewis basic cyanoarenes towards 
single-electron reduction.  
To better illustrate the transformation, potential energy surface for the reaction of 179 
with 154 was plotted representing the energies of all the intermediates and transition 
states involved in the calculated mechanism (Scheme 35). No transition states for pure 
single-electron transfer events (217 to 224 and 231 + 232 to 231 + 239) were located as 
these steps only consist of a pure vertical excitation with minimal nuclear rearrangements. 
From this diagram, it can be seen that the oxidative fragmentation of the complex (217 to 
231 + 232) is the rate-determining step of the reaction (224-TS  having the highest energy 
on the potential energy surface). Both the initial complex formation and electronics of the 
boronic species will play a role in this critical step. Subsequent single-electron reduction 
from the pyridinium intermediate (232) is favourable (red dotted line), leading to two 
radicals (231 + 239) that can engage in radical-radical coupling to finally lead to the 
coupling product. These final steps will be exergonic from the radical intermediates. 
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With this model in mind, we can try to explain the effects observed earlier. Increase in the 
concentration of starting materials would increase the concentration of the complex 217 
involved in the rate determining step (cf. Table 6). Temperature increase leads to 
increasing reaction rate to allow completion within the residence time of the reactor (cf. 
Table 6). Less Lewis basic heterocycles lead to less efficient couplings because of poorer 
complex formation, whilst and non-Lewis basic ones are not coupled at all due to the 
absence of the redox-activating adduct formation (cf. Table 7). 
 
Scheme 34 – Potential energy surface of reaction between 179 and 154. 
To see if the rationalisation using redox potentials is also applicable, we estimated the 
standard reduction potentials of the species involved in the mechanism. This was 
achieved by calibrating the computed Gibbs reaction energies for electron transfer 
reactions against measured redox potentials of potassium benzyl 
trifluoroborate  (Eox (153) = +1.10 V)
[62] and 1,4-dicyanobenzene (Ered (51) = -1.61 V)
[74] 
as two structurally similar experimental reference points. Using these estimated 
potentials, we could describe the thermodynamic feasibility of the coupling between 
4-cyanopyridine (154) and the boronic ester (179) using the calculated redox potentials 
(Scheme 35). 
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Scheme 35 – Proposed mechanistic description for the photoredox net-neutral coupling of cyanoarenes with 
boronic esters. 
As described earlier, 154 and 179 can form a complex 217 (Scheme 35). This complex 
formation facilitates the single-electron oxidation of 179 (Eox (217) = +0.73 V vs. 
Eox (179) = +1.57 V).
 This value makes this SET event possible within the reductive 
quenching cycle of Ir-3. Based on our assumption, the excited Ir-3* species 
(E1/2
*/red = +1.21 V)[228] is first quenched by 217 (Eox = +0.73 V) leading, after rapid C–B 
bond cleavage (1.7 kcal mol-1 barrier), to a carbon-centred radical 231 and the pyridinium 
232. The Ir-3red (E1/2
gd/red = -1.37 V)[228] species thus generated can reduce the activated 
pyridinium 232 (Ered
 = -0.32 V) in a cascade fashion, generating the radical 239 that 
quickly couples with 231 to form an intermediate (243) that eliminates a boron-cyano 
species (244) to give the coupled product (162). The aqueous washing layer of the 
reaction workup was tested negative to cyanide with a commercial Quantofix® cyanide 
test (1 mg/L lower sensitivity). 
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Scheme 36 – Calculated reduction potentials of the species involved in the boronic ester arylation against 
the reductive quenching cycle redox window of Ir-3. 
Again, the redox window of the reductive quenching cycle of Ir-3 is depicted in 
Scheme 36 to better visualise the feasibility of the transformations described. The 
discovery that pyridinium species (232) are more easily reduced suggests that the 0.41 V 
difference observed in the trifluoroborate arylation (i.e. Scheme 30) could be easily 
overcome by complexation of the 4-cyanopyridine with BF3 (liberated by oxidation of 
155). 
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2.3 Aryl bromide electrophiles: a Lewis base additive 
We were interested to investigate if our newly discovered photoredox activation of 
boronic esters could be used with a wider range of aryl electrophiles. Scope limitations 
associated with cyanoarene coupling partners encouraged us to investigate aryl bromides 
as alternative electrophilic coupling partners. However, it was initially observed that they 
could not be engaged as “one-electron electrophiles” using the conditions previously 
developed for their cyanoarene homologues (Scheme 37, A). To cope with this reactivity 
mismatch, we decided to investigate the conditions used by Molander[45] making use of an 
additional nickel catalyst to activate aryl bromides in a two-electron fashion (Scheme 37, 
B and 1.2.3.2 d). 
 
Scheme 37 – Proposed rationale to use aryl bromides as alternative electrophilic partners. 
2.3.1 Optimisation 
To begin this study, reaction conditions similar to those reported by Molander[45] were 
examined with the exception that Ir-3 was used instead of Ir-4 as the initial photoredox 
catalyst in acetone (Table 10). Using the trifluoroborate salt (155), clogging issues were 
immediately observed in the flow equipment due to the rapid precipitation of insoluble 
potassium salts (entry 1). When switching to the commercial boronic pinacol ester (179), 
a fully homogeneous solution in acetone was obtained, but we failed to observe any 
cross-coupling product with the model aryl bromide (246). (entry 2). 
Based on our calculations unveiling the effect of Lewis acid-base complexations on 
boronic ester single-electron oxidation (cf. 2.2.4), we changed the predicted non-active 
2,6-lutidine additive (used by Molander) to a more coordinating Lewis base. Again, we 
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could observe a dramatic effect of the pyridine-derived Lewis base on the yield of the 
reaction. Without any base additive (entry 3) or using 2,6-lutidine (entry 2), no product 
formation was observed, while using the less sterically hindered pyridine or the more 
electron-rich DMAP resulted in a greatly enhanced formation of product (entries 4 and 5).  
Table 10 – Effect of the pyridine-derived base additive on the dual Ir/Ni-catalysed cross-coupling using 
benzyl boronic esters in flow. 
 
Entry [B] LB additive Keqa Yieldb 
1 BF3K 2,6-lutidine n/a clogging 
2 Bpin 2,6-lutidine 5.1 x 10-12 0% 
3 Bpin none n/a 0% 
4 Bpin Pyridine 8.1 x 10-4 47% 
5 Bpin DMAP 0.30 87% (82%) 
Reactions carried out by adapting GP(V) to the conditions described. aCalculated equilibrium constant 
between 179 ([B] = Bpin) and the base additive at 298 K in acetone using B97xD/cc-PVTZ+SMD-solvation 
level of theory (cf. 2.2.4). bYield in 173 determined by 1H–NMR analysis of crude reaction mixture using 
CH2Br2 as an internal standard. Isolated yield in parentheses. 
This behaviour correlates with our postulate that a Lewis acid-base adduct needs to form 
between the Lewis base additive and 179 to enable reactivity. We could estimate 
equilibrium constants of the corresponding Lewis bases complexing with 179 using the 
rG = -RTln(Keq) relationship with the computed complexation reactions (column 4). 
With these values, it becomes more apparent that complexation is playing a critical role in 
this transformation. Additionally, in silico studies of the resulting complexes confirmed, 
that complexation of 179 with pyridine or DMAP has a favourable single-electron 
oxidation pathway with Ir-3* (cf. 236–238 in Scheme 33). 
Since we were satisfied with the 82% isolated yield in 173 using the boronic ester 179, we 
have not re-optimised all parameters that were previously optimised by Molander. 
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As control experiments, Ni(acac)2 could be used as a more practical nickel source 
(entry 2, Table 11) but resulted in a lower conversion after 50 min (rest of the mass 
balance being unreacted 246). 
Table 11 – Control experiments for the dual Ir/ Ni-catalysed benzyl pinacol ester arylation with aryl bromides 
in flow. 
 
Entry Variation from SC Yielda 
1 none 87% 
2 Ni(acac)2 instead of Ni(COD)2 56% 
3 no Ni(COD)2 0% 
4 no Ir-3 0% 
5 no light 0% 
6 no dtbpy 52% 
Reactions carried out by adapting GP(V) to the conditions described. aYield in 173 determined by 1H–NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
Control experiments were then carried out. The absence of nickel, photocatalyst or light 
led to no product formation (entry 3 to 5). It was possible to observe a substantial amount 
of product without dtbpy probably because DMAP can act as a ligand (albeit less 
effective) to stabilise the Ni0 active species (entry 6). 
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2.3.2 Scope of  the transformation 
Based on these promising preliminary results, we explored the scope of boronic esters to 
be arylated with this method and compared it with the existing batch method[45] using 
trifluoroborate salts (Table 12). 
Table 12 – Scope of the dual Ir/Ni-catalysed benzyl boronic ester arylation in flow (boronate partner). 
 
Reactions carried out by following GP(V). Isolated yields. aIsolated yield reported by Molander for the 
product.[45] 
In general, the flow process using boronic esters resulted in slightly lower yields than the 
previously reported examples (173, 247 and 248). However, the reaction time is 
dramatically decreased, from 24 h in batch (with trifluoroborate salts)[45] to 50 min in 
flow, thus significantly increasing the productivity. As an example, space-time-yield 
(STY) of 173 with regard to the batch conditions is 2 mmol.h-1.L-1 (with 26 W CFL lamp) 
whereas the use of a flow photoreactor, allows us to reach an increased STY of 
100 mmol.h-1.L-1 in 173. This clearly shows the intensification of the process due to the 
improved solubility and more efficient light absorption. 
The reaction scope revealed that electron-rich organoboron compounds proceeded in 
good to excellent yields (173, 247 and 250) whereas compounds bearing electron-
withdrawing substituents were associated with slightly lower isolated yields of coupled 
products (248, 249 and 251). This observation is consistent with the putative single-
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electron oxidation mechanism since higher electron-density will make the boronates more 
reactive towards oxidation. 
Table 13 – Scope of the dual Ir/Ni-catalysed benzyl boronic ester arylation in flow (aryl bromide partner). 
 
Reactions carried out by following GP(V). Isolated yields. aIsolated as the phenol (257) after oxidation of the 
aryl boronic pinacol ester with H2O2/NaOH (256 was difficult to purify using standard silica gel column 
chromatography). 
The aryl bromide coupling partners could also be varied, (Table 13) tolerating the 
presence of sensitive aldehyde (252), alkene (254) and alkyne (255) groups. Remarkably 
an ortho-substituent (253) is also well tolerated. The use of a boronic ester containing an 
aryl bromide (256) served to confirm the orthogonality between the C(sp2) and the C(sp3) 
coupling events. This observation means that subsequent orthogonal cross-couplings 
become a possible strategy.[229] 
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2.3.3 Mechanistic experiments for DMAP activation 
To validate our postulate of Lewis base activation discovered with DFT calculations, we 
decided to study experimentally the complex formation and the change of redox 
potentials that it induces. 
2.3.3.1 Complexation study using NMR 
A complexation study was carried out using 1H-NMR spectroscopy. When studying the 
1H-NMR spectrum of the mixture 179 and DMAP in acetone-d6, we could observe that 
gradually increasing the total concentration of DMAP ([DMAP]t) had a shielding effect 
on the signals of 179, in particular for the benzylic CH2 signal (δobs in Graph 3). This is an 
evidence for a fast, dynamic complex formation where weighted average signals of the 
complex 223 and independent 179 and DMAP signals are observed.[230] We also tried to 
separate signals at a lower temperature (at 228 K and 213 K) but signals were still fully 
averaged at this temperature meaning that the equilibrium is faster than the timescale of 
NMR measurement, even at these low temperatures. 
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Graph 3 – Complexation study between 179 and DMAP using 1H-NMR. 
Photoredox arylations: from trifluoroborates to boronic esters 70 
 
Following the protocol described by Espenson,[230] we were able to extrapolate the 
equilibrium constant (Kmeasured = 0.8 vs. Kcalculated = 0.3) and the chemical shift of the 
complex (223 = 1.6 ppm). This experiment allowed us to validate the theory that complex 
formation was occurring in the reaction solvent between the boronic ester starting 
material (179) and Lewis base activator (DMAP). This also informs us that this 
equilibrium is fast compared to the time needed for the reaction to complete. Therefore, 
more of the complex will rapidly form when consumed to drive the reaction forward. 
2.3.3.2 Redox study using cyclic voltammetry 
The DFT calculations previously performed (2.2.4) predicted that the oxidation potential 
of the boronic ester 179 would be significantly reduced by the coordination of DMAP. 
Cyclic voltammetry measurements were then carried out to study the effect of the Lewis 
base complexation on the redox potential of the boronic pinacol ester (Graph 4).  
Due to the generation of radicals during oxidation of the analytes, which undergo further 
reactions, all cyclic voltammograms showed an asymmetric shape describing the 
irreversibility of the oxidation. Small deviations of the oxidation traces from the baseline 
(DMAP and 179 measurements) were justified as an effect of the electrolyte solution. 
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Graph 4 – Oxidation traces of the cyclovoltammograms with boronic ester 179 and DMAP. 
The redox potentials of DMAP (Eox = +1.24 V) and the model boronic ester 
(Eox
 (179) = +1.43 V) were initially quantified (dark and light grey lines respectively). 
The first maximum in the measurement with the ester 179 corresponds to the formation of 
the benzylic radical and the second maximum is assumed to refer to its oxidation to the 
Photoredox arylations: from trifluoroborates to boronic esters 71 
 
benzylic cation.[231] Then a 1:1 mixture of DMAP and the boronic ester 179 was measured 
(black curve). Apart from the oxidation waves of residual DMAP and 179 there is a new 
local maximum at a lower potential, which could be attributed to the oxidation of the 223 
zwitterionic complex in the mixture. The measured potential (Eox) for this maximum is 
+0.81 V and corresponds to the previously calculated value for a similar complex in 
acetone (Eox (227) = +0.73 V). The appearance of this new maximum in addition to the 
NMR complexation study consequently confirms the calculations previously described. 
 
Scheme 38 – Oxidation potentials of the species resulting from the 179 and DMAP mixture versus the 
reductive quenching cycle of Ir-3. 
The presence of DMAP in the mixture allows the formation of a more readily oxidised 
complex (223, Scheme 38). The excited state of the photocatalyst (E1/2
*/red (Ir-3) 
= +1.21 V)[228] can be preferentially quenched with 223 (Eox = +0.81 V) and not 179 
(Eox = +1.43 V) nor DMAP (Eox = +1.24 V) to initiate the radical reaction. It can be noted 
that this oxidation potential is even lower than the trifluoroborate equivalent 
(Eox (153) = +1.10 V) making boronic ester complexes more reactive than commonly 
used trifluoroborate salts. 
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2.3.4 Proposed mechanism 
This transformation is believed to proceed via a similar mechanism as the one using 
trifluoroborate salts disclosed by Molander.[45] The main difference comes from the initial 
radical formation, as observed in the NMR experiment, a fast, dynamic complexation 
happens in solution between the DMAP additive and 179. The resulting complex is then 
readily oxidised by the Ir-3* excited photoredox catalyst to form the radical 231 and the 
pyridinium 238 as previously explained in 2.3.3. 
 
Scheme 39 – Proposed mechanistic description for the dual nickel and photoredox-catalysed coupling of 
aryl bromides with boronic esters. 
This radical (231) is then engaged in a “one-electron transmetallation” with the Ni0 
species (71) to lead to a NiI complex (258), which is able to undergo oxidative addition 
with an aryl bromide (259).[120] The NiIII complex (260) can then undergo reductive 
elimination to provide the coupled product (261). This process generates a NiI species 
(262) that is reduced back to the active Ni0 catalyst (71) by the action of the Ir-3red 
complex, thereby closing both catalytic cycles by regenerating the nickel and iridium 
catalysts. 
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2.3.5 Summary and conclusions 
In summary, we have demonstrated a new activation mode of boronic esters that allow 
them to react under photoredox conditions by the formation of a complex with a pyridine-
based Lewis base. This modification not only enhanced the existing chemistry with 
trifluoroborate salts but also facilitated its application to flow chemistry. These results 
enabled the development of a new and efficient C(sp2)–C(sp3) photoredox coupling 
process using heteroaromatic nitriles and pinacol boronic esters, whereby no additive 
other than the photoredox catalyst is required.[232] This method allowed us to identify 
nitrogen-containing heteroarenes as key activators of the boronic ester partners. An 
external Lewis base additive (e.g. DMAP) could be used to activate benzylic boronic 
esters towards photoredox methods. However, this additive is used in stoichiometric 
quantities and is not “redox-innocent” (cf. 2.3.3.2). Further development of this method is 
therefore desirable to access a wider range of coupled products. 
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3 Photoredox alkylations of  boronic esters and 
acids: a Lewis base catalyst 
3.1 Optimisation 
Having proved that alkyl boronic esters were conveniently arylated in a redox-neutral 
setting, we decided to investigate if these could be efficiently alkylated using photoredox 
catalysis. The addition of electron-rich carbon-centred radicals onto electron-deficient 
olefins, also known as “Giese-type” additions, is a powerful method to form C–C bonds 
in a redox-neutral fashion (cf. 1.2.3.2 a). We initially subjected the model boronic ester 
(179) to an excess of methyl acrylate (35) in the presence of 1.5 equiv. of DMAP additive 
and the Ir-3 photoredox catalyst (Table 14) that was already shown to be quenched by 
DMAP activated 179 (cf. 2.3.3). 
Table 14 – Solvent and catalyst optimisation for radical addition to methyl acrylate (35). 
 
Entry PC Solvent Yielda 
1 Ir-3 Acetone 54% 
2 Ir-3 Acetonitrile 62% 
3 Ir-3 MeOH 74% (69%) 
4 Ir-3 Acetone:MeOH (95:5) 66% 
5 Ir-3 Acetone:MeOH (1:1) 77% (74%) 
6 Ir-4 Acetone:MeOH (1:1) 86% (75%) 
7 Ir-2 Acetone:MeOH(1:1) 71% 
8 Ir-1 Acetone:MeOH(1:1) 0% 
9 Mes-Acr-1 Acetone:MeOH(1:1) 23% 
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Reactions carried out by adapting GP(VI) as described. aYield in 263 determined by 1H–NMR analysis of 
crude reaction mixture using CH2Br2 as an internal standard. Isolated yields in parentheses. 
Irradiation of this mixture in acetone with blue LEDs for 24 h readily led to 54% yield of 
the coupling product (263) (Table 14, entry 1). Initial solvent screening revealed that the 
use of methanol provided a clean reaction (entry 3 vs. entries 1 and 2). This solvent was 
mixed with acetone in 1:1 proportions to obtain the best solvent system (entry 5). The 
photocatalyst also played a key role in the outcome of the reaction. While strongly 
oxidative iridium catalysts (Ir-3 and Ir-4, entries 5 and 6) revealed to be the most efficient 
of the ones tested, the strongly reducing Ir-1 could not catalyse the reaction at all (entry 
8). The Mes-Acr-1 organic dye (entry 9) was not suitable for this transformation either. 
Despite having selective reaction conditions to perform this radical addition, the reaction 
conditions still use 150 mol% of DMAP additive to activate the boronic ester (179). In 
order to improve the practicality of the reaction conditions, we considered reducing the 
amount of Lewis base additive used. Lewis base catalysis was introduced as a concept by 
Denmark to enhance the reactivity of electrophilic n*, π* and σ* orbitals.[233] Based on 
this knowledge, we hypothesised that the use of a catalytic amount of an organic Lewis 
base would be a viable option for the photoredox activation of boronic esters. In fact, 
activation of diboron compounds using Lewis base catalysts have already been 
reported,[234] however, the concept has never been applied for the activation of 
organoboron compounds. 
Pleasingly, reducing DMAP catalyst loading to 20 mol% still provided 75% yield of 263 
(Table 15, entry 1), with the remaining mass balance resulting from oligomerisation due to 
multiple acrylate additions. Pleased by this level of catalytic activity, we decided to 
investigate a wider range of Lewis bases (Table 16). 
 According to Denmark’s theory, n-n* interactions are the most productive type of 
interactions for a Lewis base catalyst activity,[233] so a range of commercial neutral Lewis 
bases with an available non-bonding n orbital was screened at 20 to 50 mol% loading 
(Table 15). While other members of the pyridine family performed poorly (entries 2 
and 3), quinine and quinidine delivered synthetically interesting yields (entries 4 and 5). 
This finding led us to screen other bases having a strongly Lewis basic[235] quinuclidine-
like scaffold. In this family, DABCO, quinuclidine, and quinuclidin-3-ol were identified 
as excellent catalysts, leading up to 80% yield of 263 (entries 6 to 8). 
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Table 15 – Lewis base catalyst optimisation. 
 
Entry Lewis Base (LB) Loading Yielda 
1 DMAP 20 mol% 75% 
2 4-MePyr 20 mol% 7%  
3 4-PhPyr 20 mol% 12%  
4 Quinine 20 mol% 65% 
5 Quinidine 20 mol% 53%  
6 DABCO 20 mol% 65% 
7 Quinuclidine 20 mol% 77% 
8 Quinuclidin-3-ol 20 mol% 80% 
9 Quinuclidinone 20 mol% 43% 
10 Quinucl-3-OMe 20 mol% 7% 
11 Quinucl-3-OAc 20 mol% 65% 
12 4-CN-quinucl 20 mol% 42% 
13 4-Ph-quinucl 20 mol% 73% 
14 DBN 50 mol% 54% 
15 DBU 50 mol% 16% 
16 Et3N 50 mol% 44% 
17 DIPEA 50 mol% 22% 
18 TMG 50 mol% 0% 
19 PPh3 20 mol% 75% 
20 Ph3PO 20 mol% 0% 
21 PPh2Me 20 mol% 53% 
22 PPhMe2 20 mol% 80% 
23 PhMe2PO 20 mol% 0% 
Reactions carried out by adapting GP(VI) to the conditions described. aYield in 263 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
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Other commonly employed nitrogenous bases were tested (entries 14 to 18) but did not 
show comparable activity, probably because of their lower Lewis basicity.[235] 
Phosphine-derived Lewis bases were then investigated with triphenylphosphine (PPh3) 
and dimethylphenylphosphine (PPhMe2) showing both good activities (entries 19 and 22). 
However, the ease of oxidation of PPhMe2 coupled to the inactivity of its corresponding 
phosphine oxide (entry 23) led us to consider other Lewis bases as cheap and easily 
handled catalysts. 
Table 16 – Structures and names of Lewis base catalysts investigated. 
 
Once suitable Lewis bases were identified, a final optimisation was performed against our 
best conditions using quinuclidin-3-ol as the Lewis base catalyst (Table 17). While 
increasing the photocatalyst loading to 3 mol% slightly increased the reaction yield from 
80% to 84% (entry 2 vs. entry 1), a photocatalyst loading of 2 mol% was utilised for the 
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remaining experiments to conserve the precious iridium photocatalyst. Ir-3 could also be 
used instead of Ir-4 without a major effect on the reaction yield (entry 3). 
Table 17 – Final optimisation and control experiments for the Lewis base-catalysed alkylation of boronic 
esters. 
 
Entry Variation from SC Yielda 
1 none 80% (75%) 
2 3 mol% Ir-4 83% 
3 Ir-3 instead of Ir-4 79% 
4 Acetone as solvent 8% (20% conv.) 
5 Acetone:MeOH (9:1) as solvent 42% (54% conv.) 
6 non-degassed 40% 
7 0.2 mmol of 35 65% 
8 10 mol% Quinuclidin-3-ol 71% 
9 5 mol% Quinuclidin-3-ol 53% 
10 reaction time = 6 h 73% (92% conv.) 
11 no photocatalyst 0% 
12 no light 0% 
13 no Lewis base 0% 
Reactions carried out by adapting GP(VI) to the conditions described..aYield in 263 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. Isolated yield or conversion in 
parentheses. 
Interestingly, the use of acetone as the only solvent resulted in only 20% of conversion of 
179 and a poor reaction yield (entry 4). This observation suggested that the methanol is 
important for turnover of the Lewis base catalyst since 20 mol% of Lewis base catalyst 
resulted in 20% conversion without methanol. Degassing of the solvents was identified as 
a critical parameter to efficiently reproduce the results, probably because of competitive 
quenching of the photocatalyst by dioxygen (entry 6). Reducing the amount of olefin 
(entry 7) or Lewis base catalyst (entries 8 and 9) was not beneficial either. Finally, control 
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experiments revealed the independent importance of the photocatalyst, light and Lewis 
base for the reaction to lead to any product formation (entries 11 to 13). 
3.2 Scope of  the transformation 
With an optimised set of reaction conditions identified, we then investigated the scope of 
this optimised transformation (Figure 10). To perform this reaction scope, we kept in 
mind that various Lewis bases were identified as powerful catalysts at 20 mol% loading 
and could perform differently when using different boronic esters. 
 
Figure 10 – Optimised conditions summary for “Giese-type” addition of boronic ester 179 on 35 including 
selected Lewis base catalysts (LB). 
3.2.1 Scope of  alkenes 
We initially assessed the scope of alkenes to be engaged in radical coupling with boronic 
ester 179 using quinuclidin-3-ol as the Lewis base catalyst (Table 18). In addition to 
methyl acrylate, tert-butyl and benzyl acrylates were also successful coupled partners 
(263–265). Methyl vinyl ketone (MVK) was identified as the best coupling partner with 
conjugate addition product isolated in 82% yield (266). Pleasingly, acrolein and 
acrylonitrile coupled products (267 and 268) were also obtained in high yields, thereby 
expanding the range of functional groups tolerated with this method. gem-Disubstituted 
olefins also reacted in a radical conjugate addition fashion, with methyl methacrylate 
(270), a conjugated lactam (271) and two cyclic enones (272 and 273) selectively coupled 
in 58% to 68% yield. 
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Table 18 – Scope of alkenes to couple with boronic ester 179. 
 
Reactions carried out by following GP(VI). Isolated yields. aSimilar yields were obtained without LB. bfrom 
TMS-enol ether. cZ/E isomerisation of the double bond of thapsigargin was observed as the only product. 
*Yield determined by 1H-NMR analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an 
internal standard. 
Interestingly, 2- and 4-vinyl pyridines were successfully alkylated at the β-carbon (275 
and 276) providing examples of challenging N-heteroaromatics. These results could be 
extended to a 2-pyridyl-containing 1,1-disubstituted olefin partner (277), showcasing the 
possibility to generate pheniramine analogues and the potential application of the method 
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for antihistaminic drug discovery.[236] Pentafluoro styrene was also identified as a 
successful olefinic trap (278). Flavone-derived molecules could be alkylated, albeit in 
lower yields (279 and 280). 
By investigating this scope, we could confirm that only electron-deficient olefins were 
successfully alkylated, probably because of the nucleophilic nature of the carbon radical 
intermediate (cf. 1.2.3.1). Indeed, electron-neutral styrene resulted in a disappointing 10% 
yield of the coupled product 281 and the more electron-rich silyl enol ether was unable to 
form any coupling product 282. Finally, we tested the natural product thapsigargin as a 
radical trap, but the angelate residue failed to trap any radical (283). Instead, E/Z 
isomerisation of the angelate double bond was observed presumably via a triplet-triplet 
energy transfer from the photoredox catalyst. 
3.2.2 Scope of  boronic esters 
We next turned our attention to establishing the scope of boronic ester coupling partners 
using methyl vinyl ketone (MVK, 284) as a radical trap (Table 19). 
All the primary benzylic pinacol esters tested were selectively coupled to MVK using 
quinuclidin-3-ol as the Lewis base catalyst (285–288). Interestingly, primary alkyl boronic 
esters α to heteroatoms were also coupled in high yields (289–291, 86% to 91%). For α-
amino products (290 and 291), triphenylphosphine was identified as the most efficient 
Lewis base catalyst. 
More sterically demanding secondary benzylic esters were more complicated partners. 
Initial treatment of these with the standard quinuclidin-3-ol Lewis base only resulted in 
poor conversions and low yields (292 and 293 with LB = quinuclidin-3-ol). When 
changing the Lewis base to the comparatively flatter DMAP, significantly higher yields 
were obtained. These observations highlight the effect of the steric hindrance on the 
required initial complexation between boronic esters and Lewis base. While methyl (292 
and 293) and benzyl (294) were well tolerated, the presence of larger isopropyl (295) 
group led to less efficient couplings. In this case (295), only low conversion of the 
boronic ester starting material was observed presumably because of the poorer 
coordination of DMAP to the boron atom. The phenyl group (296) was also identified as a 
poor substituent, but for a different reason. The diphenyl boronic ester starting material 
was fully converted but the mixture contained over 70% of protodeborylated starting 
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material. In this case, the radical intermediate probably formed but its doubly stabilised 
character (doubly benzylic position) resulted in a significantly lowered nucleophilic 
character and a less efficient trapping with MVK. Therefore, the long-lived radical could 
be reduced to the anion by the photocatalyst and protonated by methanol to lead to the 
protodeborylated product. 
Table 19 – Scope of boronic pinacol esters to couple with alkene 284. 
 
Reactions carried out by following GP(VII). Isolated yields. Isolated yields. *Yield determined by 1H-NMR 
analysis (tentative assignment) of crude reaction mixture using CH2Br2 as an internal standard. 
Lastly, tertiary boronic esters were explored (297–299). Despite the well-known difficulty 
of these boronic esters to be efficiently activated and engaged in C–C bond forming 
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processes,[64,127] DMAP enabled clean activation to form quaternary carbon centres in 
respectable yields even from commercial and less activated tert-BuBpin (3pd). 
3.2.3 Scope of  boronic acids 
In an effort to extend the scope of boronic esters to react in this radical alkylation 
reaction, the use of aryl boronic esters was investigated. However, engaging aryl pinacol 
boronic ester (305), in the optimised reaction conditions, only led to a poor conversion 
(31%) of the starting material after 17 h of irradiation (Table 20). This low reactivity led 
us to survey a wider range of aryl boronic starting materials. As a control, the 
trifluoroborate salt (307) did not show any conversion, confirming the inability of these 
salts to act as aryl radical precursors.[62] In the boronic ester series, less hindered 
neopentyl (304) and glycol (303) boronic esters were to found to be more reactive than 
their pinacol (305) counterpart, probably because of more favoured complexation with the 
Lewis base catalyst. 
Table 20 – Aryl boronic species screening. 
 
Reactions carried out by adapting GP(VI) to the conditions described. Conversions determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. aReaction performed without Lewis 
base. 
Unexpectedly, aryl boronic acid (301) was identified as the best aryl boronic starting 
material. The commercial boronic acid (301) and its corresponding boroxine (302) were 
both converted efficiently to the coupling product (300). This finding led us to assess a 
series of commercially available boronic acids in this reaction (Table 21). 
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Table 21 – Scope of aryl boronic acids to couple with alkene 284. 
 
Reactions carried out by following GP(VIII). Isolated yields. *Yield determined by 1H-NMR analysis (tentative 
assignment) of crude reaction mixture using CH2Br2 as an internal standard. 
Prior to this study, only strongly oxidising stoichiometric oxidants were employed to 
oxidise aryl boronic acids (cf. 1.3.2.3) with single-electrons. In contrast, this method 
allows a wide range of electron-rich aryl boronic acids to be oxidised under extremely 
mild conditions and to be used in a redox-neutral setting. 
The reaction tolerates oxygen (308), sulphur (309) and nitrogen (310 and 311) para-
substituted phenyl boronic acids. Meta- and ortho-substitution with the same heteroatoms 
also results in high yields of the alkylated phenyl rings (312–314). Oxygen-containing 
heterocycles derived from catechol could be incorporated into the substrates (315 and 
316). Unprotected 5- and 6-indoyl boronic acids (317 and 318) were also successfully 
functionalised in the presence of the nucleophilic NH and C3 residues. However, the use 
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of less electron-rich aryl boronic acids was inefficient, for example, 4-
methoxycarbonylphenyl boronic acid and electron-deficient heteroaromatic boronic acids 
were alkylated in poor yields (320–323). Since these less electron-rich starting materials 
were mostly fully converted, it is believed that the low yields are a result of the reduced 
nucleophilicity of the radical intermediates, as postulated for 296 (cf. Table 19). 
The enhanced reactivity observed with boronic acids relative to the boronic pinacol esters 
encouraged us to attempt to use unactivated alkyl boronic acids as starting materials. An 
initial Lewis base catalyst screening revealed that DMAP gave slightly higher yields than 
quinuclidin-3-ol with cyclohexyl boronic acid starting material. These conditions were 
therefore applied to a wider range of commercially available alkyl boronic acids (Table 
22). 
Table 22 – Scope of alkyl boronic acids to couple with alkene 284. 
 
Reactions carried out by following GP(VIII). Isolated yields. *Yield determined by 1H-NMR analysis of crude 
reaction mixture using CH2Br2 as an internal standard. 
Pleasingly, unactivated primary alkyl boronic acids were successfully coupled to MVK 
(324–326), showcasing the utility of the method to generate functional unstabilised alkyl 
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radicals.[55]. Contrary to their boronic pinacol ester counterparts, secondary alkyl boronic 
acids were efficiently oxidised and coupled (327 and 328). Secondary α-amino boronic 
acids derived from amino acids[237] were also well tolerated with proline-derived (329) as 
well as the peptide drug ixazomib transformed in high yield (330), illustrating the 
potential application to late-stage functionalisation. In the latter example, starting from 
the enantiopure boronic acid or pinanediol boronic ester (Bpnd) resulted in a racemic 
product (330). These observations are in line with the postulated radical intermediate and 
are an area for potential further improvement of this method. 
3.3 Mechanistic understanding 
Pleased by the generality of our findings, we decided to further explore the mechanism of 
these transformations with a focus on the unprecedented photoredox activation of boronic 
acid species. 
3.3.1 Mechanistic experiments 
Our experience with Lewis acidity of aryl boronic acids led us to propose that the reactive 
species in solution was more likely to be the trimeric boroxine than the monomeric 
boronic acid species.[183] Indeed, complexes of pyridine-derived Lewis bases and aryl 
boronic acids already have been isolated and characterised.[238] Moreover, thermodynamic 
studies of these equilibria in solution are reported and explain the favoured complexation 
of Lewis bases with boroxines rather than boronic acids.[239] To study this complexation 
event, NMR experiments were conducted in the reaction solvent mixture 
(acetone:methanol (1:1)). 
Complexation experiments on aryl boronic acids showed a greater effect than the one on 
boronic ester 179 (cf. 2.3.3.1). Initial 1H-NMR measurement (Figure 11) of commercial 4-
methoxyphenyl boronic acid (301) in the deuterated reaction solvent mixture revealed the 
presence of two species in solution, 301 and its corresponding trimeric boroxine 302. The 
two distinct set of signals observed for 301 and 302 are a proof of a slow equilibrium 
(relative to NMR measurement time-scale) between the two species in the solvent 
mixture. 
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Figure 11 – 301 in acetone-d6/methanol-d4 (1:1) with (red) and without (blue) quinuclidin-3-ol = LB. 
When adding 1 equiv. of quinuclidin-3-ol (LB), all peaks merged into a single set of 
signals, meaning a fast equilibrium between 301, 302 and 331 and potentially the boronic 
acid and quinuclidine-3-ol complex (not shown). As known from previous literature,[239] 
the boroxine complex is likely to be more favoured than the complex with monomeric 
boronic acid (301). To check this hypothesis, we developed the following experiments 
where we could observe equilibrium between the species and the LB but no fast 
equilibrium between 301 and 302. 
To deconvolute the equilibrium between 301 and 302 from the ones involving the Lewis 
base, we ran the same experiment in acetone-d6 as sole solvent. The absence of protic 
solvent was found to suppress the fast equilibrium between 301 and 302 in the presence of 
LB. In this initial measurement (Figure 12, blue line), the slow equilibrium between 301 
and 302 is still observed (albeit being more shifted on the monomeric boronic acid side). 
Addition of 1 equiv. of LB (Figure 12, green line) only affected the peaks of 302 (in fast 
equilibrium with the 331 complex) and left the 301 peaks unshifted (despite a change in 
the proportions of the equilibrium). This suggested that the theoretical complex between 
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LB and the boronic acid was not forming. Addition of 10 equiv. of methanol-d4 resulted 
in a similar result to the red line in Figure 11, where all the species are in fast equilibrium. 
 
Figure 12 – From top to bottom, 301 in acetone-d6, addition of quinuclidin-3-ol = LB then methanol-d4. 
 
Figure 13 – From top to bottom, 302 in acetone-d6, addition of quinuclidin-3-ol = LB then methanol-d4. 
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As a control, we performed the same experiment using the pure boroxine (302) prepared 
by azeotropic removal of water from 301 (cf. Figure 13). In acetone-d6, only boroxine 
peaks were observed (blue line, Figure 13). Addition of the LB led again to a change in the 
shift of the boroxine peaks with the formation of 331 (green line). Addition of 10 equiv. 
of methanol-d4 resulted in a similar result to the red lines in Figure 11 and Figure 12, 
where all the species are in fast equilibrium. 
These experiments suggested that in the case of boronic acid starting materials (301), 
complex formation with LB is preferred from the most Lewis acidic trimeric boroxine 
species (302). We also observed that methanol acts as a proton source to enable a fast, 
dynamic equilibrium between 301 and 302 when LB is present. This finding explains why 
starting from only boroxine starting materials gives the same results as the commercial 
boronic acid (cf. Table 20) in the reaction conditions where both methanol and LB are 
present. 
From these observations, it was postulated that as in the case of the boronic esters (cf. 
2.3.3.2), this 332 complex will have a lower Eox value than the free boroxine and boronic 
acid and is the species that undergoes single-electron oxidation by the excited photoredox 
catalyst (Scheme 40). 
 
Scheme 40 – Summary of the postulated boronic acid reactivity in the reaction solvent. 
To further confirm this hypothesis, cyclic voltammetry studies on this system were 
carried out (Graph 5). These measurements revealed the presence of a new irreversible 
oxidation trace of the boronic acid (301) when DMAP was added (black curve, Graph 5). 
This trace probably corresponds to the oxidation of the 332 adduct observed by NMR 
(with LB = DMAP instead of quinuclidin-3-ol). However, since three equilibria are now 
operative in the solution, the oxidation trace is broad and diffuse and does not show a 
distinct maximum. Due to this broad shape, no value for the oxidation potential could be 
determined for the boroxine and DMAP adduct 332, but it appears to be the same range as 
the boronic ester and DMAP complex (cf. 2.3.3.2). 
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Graph 5 – Oxidation traces of the cyclovoltammograms with boronic acid 301 and DMAP. 
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3.3.2 Proposed mechanism 
According to NMR studies, a fast, dynamic equilibrium occurs between the boroxine 
(118) derived from boronic acid (119) or the boronic ester (125) and the Lewis base 
catalyst (LB) in the reaction solvent mixture (Scheme 41). 
 
Scheme 41 – Proposed mechanistic description for the Lewis base and photoredox-catalysed “Giese-type” 
addition of boronic acid derivatives. 
Cyclic voltammetry measurements informed us that complex 335 undergo single-electron 
oxidation (Eox (223) = +0.81 V) within the reductive quenching cycle of Ir-4 (E1/2
*/red = 
+1.21 V). The carbon radical thus generated (11) undergoes a radical addition with 16 to 
form the intermediate radical (37), which can then be reduced and quenched by a proton 
from methanol to lead to coupling product (39) (cf. 1.2.3.2 a). The resulting methanolate 
(337) can then be used to regenerate the LB from 336. The Lewis base catalyst recycling 
process is favoured by the formation of a stronger B–O (~124 kcal/mol) in 338 at the 
expense of the weaker B–N (~100 kcal/mol) in 336.[186] 
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3.4 Summary and conclusions 
To conclude, this chapter demonstrates a novel set of reaction conditions to generate 
primary, secondary and tertiary alkyl or aryl radicals from boronic acid derivatives. 
Building on our previous study, we could take advantage of the Lewis acidity of boronic 
esters and boroxines (from boronic acids) to form in situ redox-active complexes of these 
with a Lewis base catalyst. These complexes could undergo single-electron oxidation by a 
photoredox catalyst to generate carbon radicals. These intermediates were engaged in 
redox-neutral C–C couplings with electron-deficient olefins forming a wide range of new 
C(sp3)–C(sp3) and C(sp2)–C(sp3) cross-coupled products.[240] Over 50 examples of 
structurally and functionally diverse products were successfully synthesised. This new 
activation method should enable the use of boronic acids and esters in a wide range of 
other radical-based reactions. Applications and further developments of this method are 
presented in the next chapter. 
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4 Applications to APIs synthesis in flow 
4.1 Synthetic studies towards γ-amino acids 
4.1.1 Introduction to GABAs 
𝛾-amino butyric acid (GABA) is the most important inhibitory neurotransmitter in the 
human central nervous system. There are two main classes of GABA receptors, GABAA 
and GABAB, both inhibiting signal transduction in the neuronal system (Figure 14).
[241] 
 
Figure 14 – Structures of GABA and its potent analogues. 
Because of the key role of GABA (339) in the central nervous system, GABA analogues 
are forefront pharmaceutical ingredients indicated against neuropathic pain, epilepsy and 
anxiety.[242] For example, pregabalin (342, Lyrica®(Pfizer)) was eleventh on the highest 
selling drugs in the world in 2016.[243] Other members of this family share the same 𝛾-
amino acid backbone: baclofen (340, Lioresal®(Novartis)), gabapentin (52, 
Neurontin®(Pfizer)), and phenibut (341, Anvifen®(Anvi)). Even though they belong to the 
same family of GABA derivatives, their pharmacological mode of action is different. 
Whereas baclofen (340) and phenibut (341) are GABAB agonists, the inhibitory effects of 
pregabalin (342) and gabapentin (343) are mainly caused by the inhibition of voltage-
gated calcium channels, which must be activated for sufficient neurotransmitter release 
into the synaptic cleft. As a result, these different drugs are prescribed to treat different 
symptoms.[244] 
4.1.2 Proposed synthesis strategy 
A retrosynthetic analysis of the general GABA analogues motif (344) is proposed in 
Scheme 42. The β/γ disconnection is a sensible approach to this motif, leading to two 
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synthons 345 and 346 to be assembled via a conjugate addition. While the electrophilic 
synthon (347) is stable, and accessible by Knoevenagel condensation of a carbonyl 
compound (349) with diethyl malonate (348), the nucleophilic synthon (345) is 
destabilised by the adjacent donating amino group. Therefore, the common polar 
approach to this condensation makes use of cyanide (350)[245] or nitromethane anion 
(351)[246] to introduce the nitrogenous moiety. These highly oxidised groups have to be 
subsequently reduced to reveal the target amino acid (344). On the other hand, when using 
a radical approach, the α-amino radical species (352) is already stabilised and is perfectly 
suited to engage in radical conjugate addition with these malonate derived olefins (347).  
 
Scheme 42 – Retrosynthetic planning for GABA analogues syntheses. 
Using our method, this radical could be derived from a α-amino boronic ester species 
(353). Also, it was decided to test the usefulness of our recently developed coupling 
method for the synthesis of active pharmaceutical ingredients (APIs) from the GABA 
family. Although similar radical approaches have already been reported for the synthesis 
of baclofen[95] and pregabalin[96], we aimed to synthesise all four analogues to investigate 
the robustness and applicability of our photoredox method. 
This approach would use the Boc-protected amino boronic ester (354) as the amino 
radical building block (Scheme 43). It would undergo our recently developed Lewis base 
and photoredox dual catalysed addition to diethyl malonate-derived olefins (347). The 
resulting coupled product (355) could then be deprotected, hydrolysed and decarboxylated 
using aqueous 6 M HCl and heating to reveal the amino acid hydrochloride (356).[95] 
To be able to compete with the large production volumes of industrial scale processes, we 
aimed to investigate the potential telescoping (using it without isolation) of the 355 
intermediate. This protocol would allow a continuous flow production of these 
pharmaceutical ingredients by running the two steps consecutively.[246–248] 
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Scheme 43 – Proposed protocol for the synthesis of GABA analogues. 
The photochemical nature of the first step means it would highly benefit from being 
carried out in a micro to meso scale reactor. Shorter path lengths in smaller dimension 
tubing increase the light harvesting efficiency, leading to higher yields and shortened 
reaction times in micro-structured reactors.[216–218,220,249] Also, the second step could 
benefit from the possibility to use “super-heated” conditions. The high pressures 
reachable in the flow reactors allows reaching higher temperatures without boiling the 
solvent off.[250,251] 
To investigate the feasibility of this flow process, the conditions for the photoredox 
coupling and workup procedures were initially optimised in batch mode. 
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4.1.3 Photoredox coupling optimisation 
The reaction towards the synthesis of baclofen was chosen as a model system to 
investigate the photoredox coupling reaction (Table 23). Only a slight modification from 
the already optimised conditions (cf. 3.1) was made. Since the olefin partner (357) is not 
volatile (i.e. not easily removed), it was decided to use it as the limiting reagent with a 
slight excess of the boronic ester (354). 
Table 23 – Lewis base screening for baclofen precursor (361) synthesis. 
 
Entry Lewis base (LB) Yielda 
1 Quinuclidin-3-ol 52% 
2 Quinuclidine 58% 
3 DABCO 44% 
4 DMAP 79% 
5 PPh3 60% 
Reactions carried out by adapting GP(IX) to the conditions described. aYield in 361 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
The standard conditions with quinucidin-3-ol resulted in a decent 52% yield of the 
coupled product (361) with some unconverted alkene (357) (entry 1). A Lewis base 
catalyst screening was then carried out with the selected Lewis bases. While DABCO 
(entry 3) did not outperform quinulcidin-3-ol; quinuclidine (entry 2), DMAP (entry 4) and 
PPh3 (entry 5) all resulted in an enhanced product formation. Because of its significantly 
higher coupling product yield, DMAP was chosen as the optimised Lewis base catalyst. 
With this catalyst, full conversion of the alkene (357) is observed after the 18 h. 
To verify the generality of these reaction conditions, this photoredox coupling was tested 
for the synthesis of the precursors of phenibut (362), pregabalin (363) and gabapentin 
(364) (Table 24). 
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Table 24 – NMR yields for drug precursors coupling products (361–364). 
 
Reactions carried out by adapting GP(IX) to the conditions described. *Yields determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
Pleasingly, these optimised conditions efficiently delivered the phenibut and pregabalin 
precursors (362 and 363). However, the quaternary olefin (360) only resulted in 32% yield 
of the gabapentin precursor (364). Also, further optimisation of this specific coupling was 
initiated (Table 25). 
Table 25 – Optimisation of the gabapentin precursor (364) synthesis. 
 
Entry Loading of 354 Lewis base (LB) Time Yielda 
1 1.2 equiv. DMAP 18 h 32% 
2 1.2 equiv. DMAP 48 h 50% 
3 1.2 equiv. quinclidin-3-ol 48 h 33% 
4 1.2 equiv. quinuclidine 48 h 56% 
5 1.5 equiv. DMAP 48 h 65% 
6 1.5 equiv. quinuclidine 48 h 60% 
7 2.0 equiv. DMAP 48 h 57% 
8 2.0 equiv. quinuclidine 48 h 66% 
Reactions carried out by adapting GP(IX) to the conditions described. aYield in 364 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
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Since the alkene 360 was not fully converted after 18 h, a longer irradiation time was 
initially tested, resulting in an increased product yield (entry 2). To verify that DMAP 
was the most active catalyst, further Lewis base screening was conducted. Quinuclidine 
was identified as a possible replacement for DMAP (entry 4 vs. 2). As we observed that 
the remaining mass balance still was unreacted alkene (360), the stoichiometry of boronic 
ester (354) was gradually increased from 1.2 to 2.0 equivalents (entries 4 to 8) to drive the 
reaction to completion. The highest yield in the coupling product (364) with the least 
excess of starting materials was obtained using DMAP as Lewis base, 1.5 equiv. of 
boronic ester (354) and 48 h irradiation time (entry 5). Considering that the coupling is 
forming a quaternary carbon, these conditions delivered a satisfactory 65% yield. 
4.1.4 Workup procedure optimisation towards a flow process 
With optimised conditions for all the photoredox couplings in hand, we started to 
investigate the next step, consisting of successive deprotection, hydrolysis, and 
decarboxylation. At this stage, the treatment of the crude mixture after the photoredox 
coupling have to be defined. 
4.1.4.1 Telescoped process investigation 
To best mimic a flow process, a telescoped approach was initially tested by directly 
adding an aqueous 6 M HCl solution to the crude photoredox coupling mixture (without 
intermediate treatment, Scheme 44). After refluxing the mixture for 24 h, the solvents 
were removed under reduced pressure. The residue was suspended in water and the 
aqueous layer was extracted with chloroform (Ia) to remove non-water-soluble impurities 
(target product 365 is insoluble in chloroform). Removal of water in vacuo afforded a 
yellow (residual Ir-4) sticky residue, whose composition was determined by HRMS and 
NMR analysis. While the product (365) was the main component of the mixture (crude 
A), it was contaminated with DMAP and traces of a DMAP-adduct (369) side-product 
(Scheme 44). This side-product originates from the attack of the DMAP-derived α-amino 
radical (cf. 1.2.2) on the olefin (competitive DMAP attack). 
To remove DMAP and the side-product (369) from the aqueous layer, both acidic (Ib) and 
basic (Ic) workup procedures were tested. With a pKa of 9.7,
[252] the concentration of 
DMAP in the aqueous layer was significantly reduced under basic conditions, but at the 
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same time, most of the product (365) was lost in the organic layer. Under acidic 
conditions, DMAP was completely protonated (370) and therefore only found in the 
aqueous layer, but the protonated amino-group (pKa = 10.2) of the coupling product (365) 
prevented it from being sufficiently extracted into the organic layer. Because of the 
multiple acidities of the product (365), none of the tested aqueous workup conditions 
showed an efficient separation. 
 
Scheme 44 – Fully telescoped process impurities and tested purification methods. 
We next attempted to separate the impurities by solid-supported scavenging with ion-
exchange resins (II).[253] These recyclable, polymer-based materials can reversibly bind 
compounds by ionic interactions and have been widely used in continuous processes to 
remove trace metals, switch between different solvent systems, or act as solid-supported 
reagents.[254,255] 
An acidic QP-TSA (TsOH) resin was initially used (Ia). We rationalised that the sulfonate 
groups could favourably interact with protonated amino residue. The product (365) was 
successfully bound to the resin under acidic conditions, as it was not detected in the 
obtained eluent fraction. However, some product was already released during the 
following neutral wash with water. The residual material was released with aqueous 1 M 
ammonia wash and contained product (365), side-product (369), and residual DMAP 
(370), which could also interact in their protonated form with the cation-exchanger. 
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To circumvent this issue, we then used a basic anion-exchanger Amberlite IRA-400 
(NR4
+) (IIb). This material carries quaternary ammonium functionalities on its surface, 
which can potentially interact with the negatively charged carboxylate groups (pKa = 4.2). 
After the immobilisation on the ion-exchange resin under basic (pH = 9.8) or neutral 
conditions (pH = 7.0), the product (365) did not bind strongly enough to the material and 
was partially released during the aqueous wash. Changing the washing solvent from water 
to THF did not result in any improvement. Although DMAP was not present in the 
release fraction (using 3 M HCl), the product (365) was still contaminated with the side-
product (369), due to their structural similarities. 
4.1.4.2 Intermediate treatment investigation 
Since, it appeared that purification is a problem at the final product stage, a fully 
telescoped process cannot provide high-purity product. We decided to test an intermediate 
aqueous workup to remove the problematic DMAP-impurities before engaging the 
mixture in the second step. In contrast to chromatographic separation, an aqueous workup 
could still be integrated into a continuous process by using an in-line phase 
separator.[256,257] 
Initial investigations showed that DMAP was effectively removed by treating the crude 
mixture with aqueous ammonium chloride solution (pH 5-6) and extracting the product 
with ethyl acetate. 
Table 26 – NMR yields for drug precursor coupling products after acidic aqueous workup. 
 
Reactions carried out by adapting GP(IX) to the conditions described. *Yield determined by 1H-NMR analysis 
of the reaction mixture after an acidic aqueous workup with CH2Br2 as an internal standard. 
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The yields in coupling products after the aqueous workup (Table 26) match those obtained 
without any treatment (cf. Table 24). This observation suggests that the Boc-amino 
coupling products are not deprotected using this mildly acidic treatment. 
We then turned our attention to the second step using baclofen as the model system 
(Scheme 45). The residue was dissolved in acetone and 6 M HCl before to be refluxed 
overnight. After solvents removal, the residue was dissolved in water and washed with 
chloroform to remove non-polar impurities. The 1H-NMR was clean, with only the side-
product (369 < 5%) as a minor impurity (crude B). Despite its higher purity than in crude 
A, the amino acid (365) did not crystallise from the mixture. Several drying and 
crystallisation conditions in water, methanol, 2-propanol, CH2Cl2 and combinations 
thereof were tested, but none of them resulted in a crystalline product. 
 
Scheme 45 – Intermediate workup approach and tested purification methods. 
Thus, we decided to subject the crude B to a chromatographic separation. Due to their 
high polarity, both product (365) and side-product (369) interact strongly with silica, 
which makes them unlikely to be separated by regular phase silica chromatography. To be 
able to visualise product-containing fractions from chromatographic separations with 
modified silica stationary phases, we tested different polar solvent systems on TLC plates. 
Neither highly polar solvent mixtures of chloroform and methanol, nor pure methanol or 
mixtures of n-BuOH and acetic acid could elute the compounds on silica gel. Only a 
complex eluent mixture containing EtOAc, CHCl3, MeOH, water and formic acid 
(40:30:20:5:5) resulted in an acceptable separation.[258] However, this separation was not 
suitable for isolating the product by preparative TLC. 
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We further tested conditions for the purification on reverse phase silica (C-18, IIIa). 
Because of the insolubility of the amino acid product in acetonitrile, we used different 
concentrations of water in methanol as the mobile phase, but neither highly polar 
(H2O:MeOH 80:20) eluent systems, nor pure methanol showed sufficient separation. 
Instead, the compound mixture was found unseparated in the first few fractions. We 
concluded that the interaction of the charged compounds with the non-polar phase was 
too weak in comparison to their high solubility in the solvent system. 
We therefore decided to try a more polar solid phase for the separation by hydrophilic 
interaction liquid chromatography (HILIC).[259] These materials allow the separation of 
products with regular phase solvent systems, which are strongly retained on silica and 
weakly retained under reversed phase conditions. The modified stationary phase strongly 
interacts with the polar component of the solvent system (usually water), which forms a 
thin hydrophilic layer on the surface. Hence polar compounds in the mobile phase are 
retained by both ionic and hydrophilic liquid-liquid interactions.[260] 
Initial tests with EtOAc and MeOH (1:1) as mobile phase on spherical modified silica 
(Claricep-HILIC®, Agela) showed promising separation. Further optimisation revealed a 
mixture of acetonitrile, methanol, and water (90:10:3) as a suitable solvent system and 
afforded the product 365 (purity > 90% by 1H-NMR). 
Although suitable conditions for purifying these compounds were finally obtained, we 
also had to keep the cost efficiency in mind. Besides the valuable separation capacity and 
recyclability of the HILIC stationary phase, its high price (one thousand pounds per 
kilogram) limits its larger scale applications. 
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4.1.5 A batch route 
Since an expensive stationary phase was required for the purification of the free amino 
acid, we decided to divide the synthesis route into a two-step process, with an 
intermediate purification by silica gel chromatography after the photoredox coupling step 
(Table 27). 
Column chromatography on silica gel afforded the coupling products (361–364) in good 
to excellent yields. The isolated drug precursors were then subjected to deprotection, 
hydrolysis, and decarboxylation using aqueous 6 M HCl. While phenibut (366) was 
obtained without residual lactam after only 1 h of reflux, the other precursors required 
prolonged heating (24 h) to fully hydrolyse their corresponding γ-lactams to the final 
crystalline APIs as hydrochloride salts (365, 367, and 368). 
Table 27 – Isolated yields for the drugs and their precursors in batch. 
 
Step 1 carried out by following GP(IX). Isolated yields. Yields in parentheses are calculated over both steps. 
aDeviating from standard conditions, 0.60 mmol of 354 and 48 h of irradiation. bDeviating from standard 
conditions, only 1 h of refluxing is necessary. 
To conclude, we could obtain all desired APIs in a crystalline form with a concise two-
steps method using our developed photoredox method as a key step. The yields over the 
two steps are good to excellent and are competitive with already reported yields for these 
molecules.[95,96,246,247] 
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4.2 Organic photoredox catalysis 
The popularity of organic photocatalysts has raised considerably over the past decade, as 
they hold great promises to replace transition metal based photocatalysts (cf. 1.1.3.1).[17] 
With the pharmaceutical industry starting to adopt processes based on this 
technology,[22,23] we thought it would be desirable to show the possibility to perform our 
methodologies without any added metal. Our photoredox methods would greatly benefit 
from such an approach. Firstly, in terms of catalyst costs and secondly in terms of 
products purifications, circumventing any possibility of residual metal contamination. 
Therefore, it was decided to investigate the possible replacement of Ir-4 photocatalyst in 
our latest developed method by an organic one (Table 28). Furthermore, this organic 
catalyst could also be tested in the latest developed APIs syntheses (cf. Table 27) to 
further highlight the relevance of this method for the pharmaceutical industry. 
Table 28 – Commonly used organic dyes. 
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4.2.1 Photocatalyst optimisation 
To start this investigation, a range of commercially available or easily accessible visible 
light absorbing organic photocatalysts (Table 28) were screened using a model reaction. 
Following our optimised conditions (cf. Table 19), we subjected the boronic ester 179 and 
the alkene 284 to the series of photoredox catalysts in the presence of catalytic amount of 
quinuclidin-3-ol and under blue light irradiation to produce the coupled product 266 
(Table 29). 
Table 29 – Organic photocatalyst screening with boronic ester 179. 
 
Entry PC Yielda Comment 
1 Ir-4 86%  
2 Ru-2 31%  
3 DCA 0% Photobleached 
4 TPP 0% Photobleached 
5 FL 11% Photobleached 
6 RB 74%  
7b EY 15% Photobleached 
8 Mes-Acr-1 67%  
9 Mes-Acr-2 58% Photobleached 
10 Mes-Acr-3 62%  
11 Mes-Acr-4 83%  
12 4CzlPN 52%  
Reactions carried out by adapting GP(VI) to the conditions described. aYield in 266 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. bGreen LEDs were used instead (14 
W @540 nm). 
The results of this screening showed the crucial effect of the photocatalyst on the 
reaction. Importantly, some dyes were found unstable to the reaction conditions (entries 3 
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to 5, 7 and 9) as they were decolourised during the irradiation process (photobleached). 
The reason for this might be the decomposition of the dyes with intense light, or with 
reactive radical intermediates. We can observe that in this category, only Mes-Acr-2 
resulted in significant product formation (entry 9), the four others producing between 0% 
(entries 3 and 4) and 15% of product (entry 7). Among the stable dyes, results disparities 
were also observed. While the ruthenium-based Ru-2 photocatalyst did not provide 
efficient yields (entry 2), the donor-acceptor dyes scaffolds (entries 8 to 12) were found to 
successfully catalyse the transformation. Rose Bengal (RB) and the mesityl acridinium 
dye Mes-Acr-4 were identified as the best performing organic catalysts of this screening. 
To our delight, Mes-Acr-4 yield was comparable (entry 11) to that of our optimised 
iridium-based catalyst (Ir-4). 
In order to verify the reproducibility and robustness of this initial screening, we 
subsequently engaged the stable photocatalysts in a different test reaction. This time, 
cyclohexyl boronic acid (371) was used as a substrate. The results of this second 
screening are summarised in Table 30. 
Table 30 – Organic photocatalyst screening with boronic acid 371. 
 
Entry PC Yielda 
1 Ir-4 90% 
2 Ru-2 26% 
3 RB 59% 
4 Mes-Acr-1 15% 
5 Mes-Acr-3 36% 
6 Mes-Acr-4 95% 
7 4CzlPN 83% 
Reactions carried out by adapting GP(VIII) to the conditions described. aYield in 328 determined by 1H-NMR 
analysis of crude reaction mixture using CH2Br2 as an internal standard. 
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Interestingly, a similar reactivity trend was observed with this reaction. This time, RB was 
not as efficient, giving slightly more than 59% yield in 328 (entry 3). Again, Mes-Acr-4 
gave an excellent yield (entries 6). To finish, 4CzlPN led to comparable results to the 
iridium-based catalyst (entry 7 vs. 1). To conclude these screenings, we have identified 
Mes-Acr-4 as a potential organic-based replacement to Ir-4 in our latest developed 
photoredox- and Lewis base-catalysed coupling. 
4.2.2 Organic dye performance assessment 
To assess the generality of this new catalyst, we initially tested it in a variety of cross-
coupling reactions and compared its performance against the previously used Ir-4 catalyst 
(Table 31). As far as the cross-coupled products yields are concerned, the performance of 
the Mes-Acr-4 dye was often equivalent to the Ir-4 photocatalyst.  
Table 31 – Performance of Mes-Acr-4 against Ir-4 for several alkylations of boronic acid derivatives. 
 
Reactions carried out by following GP(VII) or GP(VIII) using Mes-Acr-4 instead of Ir-4. Isolated yields. 
aDMAP was used as a Lewis base. Yield obtained with Ir-4 for the same product in parentheses. 
While 328 and 266 gave the same isolated yields with both photocatalysts, the organic dye 
was superior to the iridium one for 324 and 315. However, in some cases, inferior yields 
were observed with the organic dye (326, 289, and 299). Although no apparent correlation 
between the structure of the boronic acid derivative and their reactivity could be drawn, 
no reactivity shutdown was observed even in the case of the challenging 299. 
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To more finely compare the two catalysts, a reaction profile of the conjugate addition of 
the cyclohexyl boronic acid (371) was recorded by following the reaction using NMR 
spectroscopy (Scheme 46). 
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Scheme 46 – Reaction following, comparison between Mes-Ar-4 (dots) and Ir-4 (squares). Carried out by 
adapting GP(VIII). 
To do this, reagents were dissolved in a deuterated solvent mixture and irradiated inside 
an NMR tube. At different time points, the light was turned off, thereby putting the 
reaction on hold to conduct a 1H-NMR measurement. Using 1,3,5-trimethoxy benzene as 
an internal standard, it was possible to work out the yield in the deuterated product (372) 
and conversion of starting materials (371 and 284) over time. Using this method, we were 
able to conveniently monitor the reaction progress with minimal material use (0.05 mmol 
scale). 
While the two catalysts performed equally after 24 h of irradiation (cf. Table 31), they do 
not share the same kinetic profile (Scheme 46). Although the two curves seem to follow a 
similar initial kinetic (almost linear slope between 0 and 30 min), the Ir-4 curve “breaks” 
after 30 min while the other continues to follow a pseudo first-order shape. We believe 
that this behaviour is a sign of a catalyst deactivation pathway. Radical alkylation of the 
polypyridyl ligands has already been observed on similar iridium-based photoredox 
catalysts.[261] Also bpy ligand removal in acetonitrile solvent was identified as another 
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deactivation pathway for these photocatalysts.[262] We therefore believe that strongly 
nucleophilic DMAP may result in bpy displacement on the iridium centre and lead to 
catalyst deactivation. Moreover, the Mes-Acr-4 catalysts have already proven to be stable 
under similar conditions.[35] 
This deactivation pathway is responsible for a significant rate reduction of the Ir-4 
catalysed reaction. While the full conversion was not reached after 180 min of irradiation 
with the iridium catalyst, the reaction completed in 70 min with the acridinium dye. 
Although increasing the Ir-4 loading could help to cope with this effect, the Mes-Acr-4 
catalyst brings faster kinetics at the same loading and is therefore the most efficient for 
this reaction. 
4.2.3  A residence time “simulation” method 
Having developed a straightforward NMR monitoring method, we sought to use it for 
other purposes. Since we were still interested to perform the photochemical step of the γ-
amino acids synthesis in flow, we aimed to develop an expeditious method to determine 
the residence times needed for these photoreactions to be complete. 
Photoredox reactions are slow reactions, usually requiring from hours to days to 
complete. Moreover, a continuous flow process productivity decreases with increased 
reaction time, making this technology less attractive for long reactions (typically 
exceeding two hours). Therefore, having a knowledge of the residence time needed to 
perform a reaction is crucial to decide on the viability of a continuous process. This is 
usually done by testing one residence time at a time for the flow process, or by acquiring 
the kinetic data and simulating the flow conditions. When working in a chemistry 
laboratory the first option is often the only one available. This task is often time and 
material consuming. 
In stark contrast, reaction kinetics in the hour range are more efficiently studied with a 
batch method because only one batch experiment is required to record all the desired time 
points. However, observed kinetics for photoreactions limited by photon flux are often 
significantly different in a large batch vessel than in the small channels of a photo flow 
reactor.[219] 
With these problems in mind, we decided to compare the kinetics observed in the small 
dimension NMR tube to those observed in the photo flow reactor. If both match, we will 
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be able to predict the residence time needed for other photo flow reactions to complete by 
using a simple NMR study. 
To test this hypothesis, we compared the reaction yield of our model reaction after a 
certain residence time (flow mode) and compared this outcome to the reaction profile 
obtained using the NMR tube (batch mode) method (Scheme 47). 
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Scheme 47 –Comparison between batch (dots, adapting GP(VIII)) and flow (triangles, adapting GP(X)) 
modes. 
Although the flow reaction gave slightly higher yields in 328 at a given time point, this 
comparison clearly shows a good fitting of the two curves, and hence validates our 
postulate. While obtaining of the four data points of the flow curve required two days of 
experimentation and consumed 2.0 mmol of the limiting boronic acid reagent (371), the 
NMR monitoring only required 2.5% of this material demand and half a day of 
acquisition to optimise the residence time. 
4.2.4 Organic catalyst for APIs synthesis in flow 
With these encouraging results, we decided to apply this “transition metal free” 
methodology to the flow synthesis of the active pharmaceutical ingredients (APIs) from 
the γ-aminobutyric acid (GABA) family. At this point, it must be specified that at a fixed 
reactor volume, the flow rate determines the residence time of the reaction. However, the 
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peristaltic pump we are using is not accurate for flow rates under 100 μL/min, indicating 
that with our largest 10 mL reactor coil, reactions taking longer than 100 minutes are not 
desirable. Also, with this residence time limitation, the synthesis of the gabapentin 
precursor (364) was impossible to achieve (48 h of irradiation required). 
Therefore, we limited our investigation to the synthesis of the three other drug precursors 
(361–363). The suitability of the Mes-Acr-4 photocatalyst in the synthesis of the phenibut 
precursor (362) was initially investigated in batch (Table 32). To our delight, high yields 
in coupling product (362) were also obtained with the organic dye (entry 2 vs. entry 1). 
Because of the workup issues posed by DMAP during the previous optimisations (cf. 
Scheme 44 and Scheme 45), we explored again the use of PPh3 as an alternative Lewis 
base catalyst (entry 3). We could observe that using PPh3, only 82% of the starting 
material (358) was converted after 16 h of irradiation. Increasing the irradiation time to 
40 h did not result in a full conversion of 358 either (entry 4). 
Table 32 – Initial batch optimisation of phenibut precursor (362) synthesis. 
 
Entry PC LB Time Yielda Conversiona 
1 Ir-4 DMAP 16 h 79% 100% 
2 Mes-Acr-4 DMAP 16 h 76% 100% 
3 Mes-Acr-4 PPh3 16 h 62% 82% 
4 Mes-Acr-4 PPh3 40 h 77% 89% 
Reactions carried out by adapting GP(IX) to the conditions described. aYield in 362 and conversion of 358 
are determined by 1H-NMR analysis of crude reaction mixture using CH2Br2 as an internal standard. 
As already mentioned, a fast photoreaction is the key to transferring it in a flow process. 
Based on these initial results, we compared the reaction profiles obtained with both Lewis 
bases for this transformation (Scheme 48). 
Observing these reaction profiles, it is apparent that DMAP leads to enhanced kinetics. 
After the 100 min reaction time limit, PPh3 only delivers 45% of the deuterated product 
(373) while DMAP results in 80% yield of the same product. 
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Therefore, even if the PPh3 can result in better yields than DMAP for prolonged 
irradiations, its use in the continuous flow photoreactor remains inefficient. 
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Scheme 48 – Lewis base effect, comparison between DMAP (squares) and PPh3 (triangles) (carried out by 
adapting GP(IX)). 
With this final optimised parameter, we could record the reaction profile of the two other 
targeted drug precursors using the Mes-Acr-4 and DMAP dual catalysed system (Scheme 
49). These profiles allowed us to finely tune the residence time needed for each partner. 
While the deuterated phenibut precursor (373) required 80 min of irradiation, the baclofen 
(374) and pregabalin (375) ones could be synthesised efficiently in 60 min and 40 min 
respectively. 
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Scheme 49 – Coupling kinetics observed in NMR tube for the three APIs precursors (adapting GP(IX)). 
Using these predicted residence times in a flow photoreactor setup resulted in finely tuned 
conditions for these APIs precursors coupling reactions (Table 33). Pleasingly, all the 
targeted compounds were successfully obtained in high yields after purification (361–
363). 
Table 33 – Final flow synthesis of drug precursors 361 to 363 with the optimised flow conditions. 
 
Reactions carried out by following GP(X). Isolated yields. 
Although yields were consistently lower than those obtained with the batch protocol and 
the Ir-4 photocatalyst (cf. Table 27), these experiments finally confirm the feasibility of the 
initial photoredox coupling step in a flow reactor. 
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4.3 Summary and conclusions 
As a summary, the synthetic utility of our methodology could be further demonstrated by 
the two-step syntheses of four approved central nervous system drugs from the GABA 
family. Utilising 353 in presence of malonate-derived olefins (357–360 as limiting 
reagents), we could obtain high yields of the coupled products (361–364) in batch mode 
using the Ir-4 photocatalyst (cf. Table 27). All these were deprotected and decarboxylated 
using 6 M HCl in excellent yields to deliver baclofen, phenibut, pregabalin, and 
gabapentin as their corresponding hydrochloride salts (365–368). 
We also identified the organic dye Mes-Acr-4 as a promising alternative to iridium 
photocatalyst Ir-4. This organic photocatalyst have shown similar to better activity than Ir-
4 in our photoredox couplings as well as enhanced stability under our reaction conditions. 
Mes-Acr-4 could also sucessfully replace Ir-4 in the synthesis of the pharmaceutical 
ingredients previously described. Using this “transition metal free” conditions we could 
carry out the synthesis of the precursors of baclofen, phenibut and pregabalin in a flow 
photoreactor (361–364 in Table 33). Although telescoping in the second step proved to be 
problematic, we believe that the first step alone would benefit from being run 
continuously if a larger amount of these compounds are to be made. 
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5 Experimental 
5.1 General information 
5.1.1 General experimental and analytical methods 
General methods: All reactions, unless otherwise noted, were performed magnetically 
stirred under Ar atmosphere using standard Schlenk techniques. Reaction temperatures 
were electronically monitored as external heating block temperatures. Reagents were 
purchased from different commercial sources and used without further purification. The 
removal of solvent under reduced pressure was carried out on a standard rotary 
evaporator. 
Solvents: Et2O and THF were distilled with sodium and benzophenone under inert gas 
prior to use. Degassed solvents were degassed by purging with Ar for at least 20 min. 
Solvents for flash column chromatography and crystallisations were distilled under 
reduced pressure. Iso-hexane mentioned as petrol ether (PE) consist of the boiling 
fractions between 40 and 50°C. 
Chromatography: Analytical thin-layer chromatography (TLC) was carried out on pre-
coated glass plates (silica gel 60 F254) from Merck. Compound spots were visualised 
under ultraviolet (UV) light (254 nm or 365 nm for fluorescent compounds), ceric 
ammonium molybdate (CAM), ninhydrin or KMnO4 stain solutions. For flash column 
chromatography silica gel 60 from Merck, with a particle size between 40 and 63 µm, 
was used. Crudes were often loaded onto columns using dry loading technique with 
ISOLUTE® HM-N. 
NMR spectroscopy: 1H-NMR spectra were recorded on a Bruker Avance DPX-400 or 
DRX-600 spectrometer at 400 and 600 MHz respectively and are reported as follows: 
chemical shift δ in ppm (multiplicity, coupling constants J in Hz, number of protons, 
assignment). The multiplicity and shape of the 1H signals are designated by the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septet, m 
= multiplet, br = broad, or combinations thereof. These chemical shifts δ are reported to 
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the nearest 0.01 ppm with the residual solvent peak as the internal reference (CDCl3 = 
7.26 ppm, methanol-d4 = 3.31 ppm, water-d2 = 4.79 ppm). 
13C-NMR spectra were 
recorded on the same spectrometers at 100 and 150 MHz with 1H decoupling. All 
13C resonances are reported to the nearest 0.1 ppm with the central resonance of the 
solvent peak as the internal reference (CDCl3 = 77.16 ppm, methanol-d4 = 49.00 ppm). 
The 13C signal of the carbon bonded to boron was not observed in some cases due to 
quadrupolar relaxation. 19F-NMR spectra were recorded on a Bruker DPX-400 
spectrometer at 376 MHz with 1H decoupling. All chemical shifts δ are reported to the 
nearest 0.1 ppm with CFCl3 as the external standard (CFCl3 = 0.0 ppm). 
11B-NMR NMR 
spectra were recorded on a Bruker DPX-400 or DRX-600 spectrometer at 128 MHz and 
193 MHz respectively with 1H decoupling. All chemical shifts δ are reported to the 
nearest 0.1 ppm with BF3∙OEt2 as the external standard (BF3∙OEt2 = 0.0 ppm). Spectra are 
assigned using 1H-COSY, 13C-DEPT-135, HSQC and HMBC where appropriate to 
facilitate structural determination. The numbering of the proton and carbon atoms does 
not match the IUPAC nomenclature. Diastereotopic protons in the 1H-NMR spectra are 
referenced with a and b, nomenclature is arbitrarily and does not correspond to the spin 
system. 
Infrared spectroscopy: Infrared spectra were recorded neat on a Perkin-Elmer Spectrum 
One FT-IR spectrometer using Universal ATR sampling measuring unit. Selected peaks 
are reported in wavenumbers (cm-1) of absorption. 
High-resolution mass spectrometry (HRMS) was performed using a Waters Micromass 
LCT Premier™ spectrometer using time of flight (TOF) mass detection and positive ESI 
ionization method. Unless otherwise stated, reported mass correspond to the parent 
molecular ion associated with a proton [M+H]+ or a sodium cation [M+Na]+ (23Na 
isotope). All m/z values are reported to four decimal places and within ± 5 ppm of the 
calculated value. 
Melting points (m.p.) were recorded on a Stanford Research Systems OptiMelt 
Automated Melting Point System calibrated against vanillin (m.p. 83°C), phenacetin 
(m.p. 136°C) and caffeine (m.p. 237°C). 
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5.1.2 Photochemical and optimisation experiments 
Batch photochemical experiments were performed magnetically stirred in 5 mL glass 
test tubes or microwave vials, sealed with a rubber septum. The tubes/vials were 
externally irradiated with blue light either using a coiled commercial LED strip (Ledxon, 
14.4 W at 470 nm) or a LED torch (Thorlabs, 253 mW at 470 nm). To maintain a 
constant reaction temperature of 30°C, the setup was cooled by a constant air flow from a 
clip fan (Figure 15).  
 
Figure 15 – Typical batch photoreactor setup. 
Flow photochemical experiments were performed using a Vapourtec E-series unit 
equipped with a UV-150 module with blue LEDs (17 W at 420 nm). The pumps used on 
this equipment are peristaltic pumps (SF-10 type) allowing to deliver accurate flow rates 
between 100 µL/min and 10 mL/min. The reactor coil (10 mL) is made of FEP tubing 
with thin walls (outer diameter: 1.6 mm, inner diameter: 1.3 mm). The system was 
pressurised at 100 psi by the use of a BPR at the end of the line. 
Optimisation experiments were carried out using adapted protocols from the mentioned 
general procedures (GP). Optimisation yields were determined by using the 1H-NMR 
integration of an internal standard as reference, added to the crude mixture after the 
reaction workup. 
  
Experimental 120 
 
NMR following experiments were carried out by adapting the mentioned GP(n) to a 
0.05 mmol scale, employing the corresponding deuterated solvents and 1,3,5-
trimethoxybenzene as internal standard. After being prepared in a separate vial, the 
reaction mixture was transferred in an NMR tube under argon. An initial 1H-NMR 
measurement (time zero) was made before the tube was irradiated. Irradiation times were 
accurately measured by the use of a stopwatch. Integrating the product and starting 
material peaks against the internal standard gave access to conversions and yields over 
time. 
5.1.3 Computational methods 
Geometries of all structures (minima and saddle points) were optimised at the 
ωB97xd/cc-pVDZ level[263–265] in acetone as a solvent (using the SMD solvation 
model[266] ε = 20.493) using Gaussian 09 software (revision D.01)[267], subsequent 
vibrational frequency calculations were performed at the same level for all calculated 
structures. Transition states found possess exactly one negative Hessian eigenvalue, while 
all other stationary points were confirmed to be genuine minima on the potential energy 
surface. Intrinsic reaction coordinate analysis was performed to unambiguously assign 
located transition states when needed. Electronic energies were obtained by performing 
single point calculations at the ωB97xd/cc-pVTZ level in solvent. Gibbs energies were 
calculated as ΔrG = ΔrH – TΔrS at 298 K where enthalpies and entropies were obtained by 
using standard statistical mechanical formulae for the ideal gas, rigid rotor, and harmonic 
oscillator approximations following the normal-mode analysis in vacuum. A correction of 
(1.9∙n) kcal mol-1 (corresponding to the difference between the concentration of the 
ideal gas at 298 K and 1 atm and its 1 mol L-1 concentration; n is the change in number 
of moles in the reaction) has been applied in order that the computed values refer to 
1 mol L-1 standard state. 
Calculated redox potentials are relative and were obtained using single-electron oxidation 
of potassium benzyltrifluoroborate (Eox = +1.10 V)
[62] and single-electron reduction of 
1,4-dicyanobenzene (Ered = –1.61 V)[74] as two experimental reference points describing 
redox properties of the structurally similar compounds. 
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5.1.4 Electrochemical measurements 
Cyclic voltammetry experiments were conducted on a Palmstat EmStat 3 potentiostat 
with a glassy carbon working, a platinum mesh counter and a Ag/AgCl reference 
electrode, referenced to SCE using ferrocene as an internal standard (0.42 V vs. SCE).[37] 
In the standard procedure 0.02 mmol substrate were dissolved in 10 mL of a 0.1 M 
[N(Bu)4]PF6 electrolyte solution in degassed acetonitrile. The reactor was sealed with a 
rubber septum and degassed by purging the solution with nitrogen for 10 min. Each 
measurement was conducted with a new glassy carbon working electrode and a scan rate 
of 100 mV/s at room temperature under nitrogen atmosphere without stirring. The half-
peak oxidation potentials (E1/2) were determined as the voltage at half the current of the 
local maximum current using QTI-Plot to analyse the data.[37] Due to the generation of 
radicals during oxidation of the analytes, which undergo further reactions, all cyclic 
voltammograms showed an asymmetric shape describing the irreversibility of the 
oxidation. 
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5.2  Experimental data for Chapter 2 
5.2.1 Synthetic procedures and characterisation for starting 
materials 
5.2.1.1 Boronic esters starting materials 
 
GP(I): A 100 mL round-bottom flask equipped with a magnetic stir bar was charged with 
magnesium turnings (290 mg, 12 mmol, 1.2 equiv.) and was activated by addition of 
iodine crystals and warming until iodine sublimed. The flask was cooled to 25°C and was 
purged with argon. THF (25 mL) was added to the flask, followed by the addition of neat 
pinacolborane (1.2 mL, 12 mmol, 1.2 equiv.). Benzylic bromide compound (10 mmol, 
1.0 equiv.) diluted in 5 mL of THF was then added dropwise over 10 min with constant 
stirring at 25°C. After stirring the reaction mixture at room temperature for 3 h, it was 
cooled to 0°C and acidified with 3 M aqueous HCl (15 mL) (Caution, H2 generation). 
After 10 min of stirring the reaction mixture was warmed to 25°C and stirred for an 
additional 30 min. The reaction mixture was then transferred to a separatory funnel and 
extracted with diethyl ether (3 × 15 mL). The combined organic layers were dried over 
MgSO4, filtered, and dried in vacuo. Residue was then purified over silica gel flash 
column chromatography (5% EtOAc in hexane) to deliver the pure boronic ester. 
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2-(3,5-dimethoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless oil (1.25 g, 4.47 mmol) in 45% yield. 1H-NMR 
(600 MHz, CDCl3) δ 6.37 (d, J = 2.1 Hz, 2H, H7), 6.27 (t, J = 2.1 Hz, 1H, H5), 3.78 (s, 
6H, H8), 2.26 (s, 2H, H3), 1.26 (s, 12H, H1). 13C-NMR (151 MHz, CDCl3) δ 160.6 (C6), 
140.9 (C4), 107.1 (C5), 97.3 (C7), 83.4 (C2), 55.2 (C8), 24.7 (C1) 11B-NMR (193 MHz, 
CDCl3) δ 33.1. IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2929, 2222, 1623, 1608, 1508, 1467, 1433, 
1376, 1274, 1161, 1116, 898. HRMS for [C15H24O411B]+ calculated 279.1762 found 
279.1764. Rf (1:9 EtOAc/hexane) = 0.19. 
methyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzoate 
 
Obtained following GP(I) as a colourless oil (1.84 g, 6.65 mmol) in 67% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz, 2H, H6), 7.25 (d, J = 8.3 Hz, 2H, H5), 3.89 (s, 
3H, H9), 2.36 (s, 2H, H3), 1.23 (s, 12H, H1). 13C-NMR (151 MHz, CDCl3) δ 167.3 (C8), 
144.7 (C4), 129.6 (C6), 128.9 (C5), 126.9 (C7), 83.6 (C2), 51.9 (C9), 24.7 (C1). 11B-NMR 
(193 MHz, CDCl3) δ 32.5. HRMS for [C15H22O411B]+ calculated 277.1611 found 
277.1621. Rf (1:4 EtOAc/hexane) = 0.33. Spectroscopic data were consistent with 
literature values.[268] 
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2-(3,5-bis(trifluoromethyl)benzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless oil (1.98 g, 5.98 mmol) in 60% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.65 (s, 1H, H7), 7.64 (s, 2H, H5), 2.42 (s, 2H, H3), 1.25 (s, 12H, 
H1). 13C-NMR (151 MHz, CDCl3) δ 141.3 (C4), 131.2 (q, J = 32.8 Hz, C8), 129.1 (q, J = 
2.5 Hz, C5), 123.5 (q, J = 270 Hz, C8), 119.0 (sept, J = 3.8 Hz, C7), 84.0 (C2), 24.7 (C1). 
11B-NMR (193 MHz, CDCl3) δ 32.8. 19F-NMR (376 MHz, CDCl3) δ -62.9. HRMS for 
[C15H18O211BNa]+ calculated 355.1304 found 355.1287. Rf (1:9 EtOAc/hexane) = 0.40. 
Spectroscopic data were consistent with literature values.[269]  
2-(4-fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless oil (1.21 g, 5.09 mmol) in 51% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.13 (dd, J = 8.3, 5.6 Hz, 2H, H5), 6.93 (t, J = 8.7 Hz, 2H, H6), 2.26 
(s, 2H, H3), 1.24 (s, 12H, H1).13C-NMR (151 MHz, CDCl3) δ 160.7 (d, J = 244 Hz, C7), 
134.1 (d, J = 3.1 Hz, C4), 130.2 (d, J = 7.6 Hz, C5), 114.9 (d, J = 21 Hz, C6), 83.5 (C2), 
24.7 (C1). 11B-NMR (193 MHz, CDCl3) δ 33.1 19F-NMR (376 MHz, CDCl3) δ -62.90 
HRMS for [C13H19O2F11B]+ calculated 237.1457 found 237.1456. Rf (1:9 
EtOAc/hexane) = 0.33. Spectroscopic data were consistent with literature values [212] 
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2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless oil (2.15 g, 8.21 mmol) in 82% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H, H5), 6.83 (d, J = 8.6 Hz, 2H, H6), 3.79 (s, 
3H, H8), 2.39 (q, J = 7.5 Hz, 1H, H3), 1.31 (d, J = 7.5 Hz, 3H, H9), 1.23 (s, 6H, H1 or H1'), 
1.22 (s, 6H, H1 or H1'). 13C-NMR (151 MHz, CDCl3) δ 157.2 (C7), 137.0 (C4), 128.6 
(C5), 113.8 (C6), 83.2 (C2), 55.2 (C8), 24.6 (C1 and C1'), 17.4 (C9). 11B-NMR (193 MHz, 
CDCl3) δ 32.9. HRMS for [C15H23O311BNa]+ calculated 285.1632 found 285.1621. Rf 
(1:9 EtOAc/hexane) = 0.58. Spectroscopic data were consistent with literature values. [212] 
4,4,5,5-tetramethyl-2-(1-phenylethyl)-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless oil (1.56 g, 6.71 mmol) in 67% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.27 (t, J = 7.5 Hz, 2H, H6), 7.23 (d, J = 7.2 Hz, 2H, H5), 7.14 (t, J 
= 7.2 Hz, 1H, H7), 2.44 (q, J = 7.4 Hz, 1H, H3), 1.34 (d, J = 7.5 Hz, 3H, H8), 1.22 (s, 6H, 
H1 or H1'), 1.21 (s, 6H, H1' or H1). 13C-NMR (151 MHz, CDCl3) δ 145.0 (C4), 128.3 (C6), 
127.8 (C5), 125.0 (C7), 83.3 (C2), 24.6 (C1 or C1'), 24.5 (C1' or C1), 17.0 (C8). 11B-NMR 
(193 MHz, CDCl3) δ 33.2. HRMS for [C14H21O211B23Na]+ calculated 255.1527 found 
255.1515. Rf (1:9 EtOAc/hexane) = 0.62. Spectroscopic data were consistent with 
literature values.[211] 
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2-benzhydryl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane  
 
Obtained following GP(I) as a white solid (709 mg, 2.40 mmol) in 24% yield. 1H-NMR 
(600 MHz, CDCl3) δ 7.30 (br s, 8H, H6 and H5), 7.20 (br s, 2H, H7), 3.91 (s, 1H, H3), 
1.27 (s, 12H, H1). 13C-NMR (151 MHz, CDCl3) δ 142.1 (C4), 129.1 (C6 or C5), 128.4 (C5 
or C6), 125.6 (C7), 83.7 (C2), 24.6 (C1). 11B-NMR (193 MHz, CDCl3) δ 33.1. HRMS for 
[C19H230211B23Na]+ calculated 317.1683 found 317.1671. Rf (1:9 EtOAc/hexane) = 0.39. 
M.p. 76–78°C. Spectroscopic data were consistent with literature values.[270] 
2-(2,6-difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a yellowish oil (492 mg, 1.93 mmol) in 19% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.10 – 7.04 (m, 1H, H7), 6.83 (t, J = 7.5 Hz, 2H, H6), 2.24 (s, 
2H, H3), 1.25 (s, 12H, H1). 13C-NMR (151 MHz, CDCl3) δ 126.1 (C7), 110.7 (C6), 110.6 
(C4), 83.7 (C2), 24.6 (C1) 11B-NMR (193 MHz, CDCl3) δ 33.1 HRMS for 
[C13H18O2F211B]+ calculated 255.1362 found 255.1377. Rf (1:9 EtOAc/hexane) = 0.47. 
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2-(1-(3-Methoxyphenyl)-2-methylpropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
 
Obtained following GP(I) as a colourless (1.23 g, 4.22 mmol) in 42% yield. 1H-NMR 
(400 MHz, CDCl3) δ 7.15 (t, J = 7.8 Hz, 1H, H7), 6.84 – 6.75 (m, 2H, H8 and H10), 6.68 
(dd, J = 8.2, 1.9 Hz, 1H, H6), 3.78 (s, 3H, H11), 2.16 – 2.03 (m, 1H, H3), 1.94 (d, J = 10.4 
Hz, 1H, H4), 1.20 (s, 6H, H13 or H14), 1.18 (s, 6H, H13 or H14), 1.02 (d, J = 6.5 Hz, 3H, H1 
or H2), 0.74 (d, J = 6.5 Hz, 3H, H1 or H2). 13C-NMR (151 MHz CDCl3) δ 159.5 (C9), 
144.1 (C5), 129.0 (C7), 121.8(C6), 114.7 (C10), 110.8 (C8), 83.3 (C12), 55.1 (C11), 31.1 
(C3), 24.8 (C13 or C14), 24.7 (C13 or C14), 23.2 (C1 or C2), 22.1 (C1 or C2). 11B-NMR (128 
MHz, CDCl3) δ 32.9. IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2975, 1598, 1581, 1486, 1465, 1380, 
1353, 1318, 1258, 1214, 1139, 1139, 1113, 1047, 971, 865, 848, 777, 714, 694, 672. 
HRMS for [C17H28O311B]+ calculated 291.2126 found 291.2115. Rf (1:10 
EtOAc/hexane) = 0.57. 
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5.2.1.2  Borate starting materials 
Potassium trifluoro(4-methoxybenzyl)borate (155) 
 
A 100 mL round-bottom flask equipped with a magnetic stir bar was charged with 2-(4-
methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.16 g, 8.71 mmol, 1.0 equiv.) 
and THF (20 mL) under air at room temperature, then, KHF2 (3.85 g, 49.3 mmol, 5.6 
equiv.) dissolved in H2O (10 mL) was added dropwise to the reaction mixture. The 
resulting reaction solution was stirred at room temperature for 2 hours. The mixture was 
then concentrated in vacuo and dried under high vacuum overnight. The residue was 
dissolved in hot acetone and filtered. The filtrate was concentrated to yield a mixture of 
potassium trifluoroborate and pinacol. The crude product was washed with cold ether for 
several times to afford 155 (1.58 g, 7.00 mmol) as a white solid in 82% yield. 
1H-NMR (600 MHz, methanol-d4) δ 7.03 (d, J = 8.4 Hz, 2H, H3), 6.69 (d, J = 8.6 Hz, 
2H, H4), 3.72 (s, 3H, H6), 1.63 (d, J = 6.5 Hz, 2H, H1). 13C-NMR (151 MHz, methanol-
d4) δ 155.9 (C5), 137.5 (C2), 129.1 (C3), 112.6 (C4), 54.2 (C6). 19F-NMR (376 MHz, 
methanol-d4) δ -143.6. 11B-NMR (128 MHz, methanol-d4) δ 5.0. HRMS for 
[C8H9O11BF339KNa]+ calculated 251.0228 found 251.0224. Spectroscopic data were 
consistent with literature values.[62] 
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Potassium trifluoro(1-(3-methoxyphenyl)-2-methylpropyl)borate (156) 
 
A 25 mL round-bottom flask equipped with a magnetic stir bar was charged with 2-(1-(3-
methoxyphenyl)-2-methylpropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (523 mg, 
1.8 mmol, 1.0 equiv.) and THF (6.0 mL) under air at room temperature, then, KHF2 
(888 mg, 11.4 mmol, 6.3 equiv.) dissolved in H2O (3.0 mL) was added dropwise to the 
reaction mixture. The resulting reaction solution was stirred at room temperature for 14 h. 
The mixture was then concentrated in vacuo and dried under high vacuum overnight. The 
residue was dissolved in hot acetone and filtered. The filtrate was concentrated to yield a 
mixture of potassium trifluoroborate and pinacol. The crude product was washed with 
cold ether for several times to afford 156 (195 mg, 0.72 mmol) as a white solid in 40% 
yield. 
1H-NMR (600 MHz, methanol-d4) δ 7.01 (t, J = 7.8 Hz, 1H, H7), 6.74 – 6.72 (m, 2H, H8 
and H10), 6.54 (ddd, J = 8.1, 2.6, 0.9 Hz, 1H, H6), 3.74 (s, 3H, H11), 1.99 (dsept, J = 9.1, 
6.6 Hz, 1H, H3), 1.36 (dd, J = 8.8 Hz, J = 5.5 Hz, 1H, H4), 1.01 (d, J = 6.6 Hz, 3H, H1 or 
H2), 0.67 (d, J = 6.6 Hz, 3H, H1 or H2). 13C-NMR (151 MHz, methanol-d4) δ 158.9 (C9), 
151.2 (C5), 127.3 (C7), 122.0 (C6), 114.6 (C10), 108.2 (C8), 53.9 (C11), 30.4 (C3), 22.6 (C1 
and C2). 19F-NMR (376 MHz, methanol-d4) δ -141.8. 11B-NMR (128 MHz, methanol-
d4) δ 5.5. IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2984, 2948, 2861, 1604, 1575, 1484, 1263, 1152, 
1065, 971, 943, 923, 786, 763, 739, 707. HRMS for [C11H15O11BF339KNa]+ calculated 
293.0697 found 293.0691. M.p. = 165–167°C. 
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8-(1-(3-methoxyphenyl)-2-methylpropyl)hexahydro-1,3,2-oxazaborolo[2,3-b]-1,3,2-
oxazaborol-4-ium-8-uide (168) 
 
A 25 mL round-bottom flask equipped with a magnetic stir bar was charged with 2-(1-(3-
methoxyphenyl)-2-methylpropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (523 mg, 
1.8 mmol, 1.0 equiv.) and Et2O (6.0 mL) under air at room temperature, then 
diethanolamine (210 mg, 2.0 mmol, 1.1 equiv.) was added in one portion to the reaction 
mixture. The resulting reaction solution was stirred at room temperature until a white 
precipitate formed. After 2 h the precipitate was filtered, washed with Et2O (10 mL) and 
dried in vacuo to afford 168 (448 mg, 1.62 mmol) as a white solid in 90% yield. 
1H-NMR (400 MHz, CDCl3) δ 7.15 (t, J = 8.0 Hz, 1H, H7), 6.82 – 6.74 (m, 2H, H8 and 
H10), 6.63 (dd, J = 8.0, 3.0 Hz, 1H, H6), 4.05 – 3.87 (m, 4H, H12 and H16), 3.78 (s, 3H, 
H11), 3.52 (br s, 1H, H14), 3.22 – 3.06 (m, 1H, H13a or H15a), 2.63 – 2.32 (m, 3H, H13b, 
H15b and H15a or H13a), 2.17 (dsept, J = 10.5, 6.5 Hz, 1H, H3), 1.51 (d, J = 10.5 Hz, 1H, 
H4), 1.16 (d, J = 6.5 Hz, 3H, H1 or H2), 0.71 (d, J = 6.5 Hz, 3H, H2 or H1). 13C-NMR (151 
MHz, CDCl3) δ 159.7 (C9), 151.6 (C5), 129.4 (C7), 120.5 (C6), 113.5 (C10), 109.6 (C8), 
63.3 (C12 or C16), 63.2 (C16 or C12), 55.1 (C11), 52.1 (C13 or C15), 51.8 (C15 or C13), 30.8 
(C3), 23.7 (C1 or C2), 23.4 (C2 or C1). 11B-NMR (128 MHz, CDCl3) δ 13.1. IR (ATR – 
neat) ?̃? (𝑐𝑚−1) = 3280, 2985, 2945, 1601, 1579, 1485, 1320, 1262, 1152, 1051, 972, 923, 
778, 751, 720, 704. HRMS for [C15H24O3N11BNa]+ calculated 300.1741 found 
300.1744. M.p. = 157–159°C. 
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5.2.2 Synthetic procedures and characterisation for coupling 
products 
5.2.2.1  Arylation of  benzyl potassium trifluoroborates 
 
GP(II): A 5 mL microwave vial equipped with a magnetic stir bar was charged with the 
cyanoarene (0.15 mmol, 1.0 equiv.), the potassium benzyltrifluoroborate salt (0.18 mmol, 
1.2 equiv.) and the photoredox catalyst [Ir(dF(CF3)ppy)2(dtbpy)]PF6 (Ir-3, 0.9 mg, 
0.5 mol%). The vial was sealed and evacuated/backfilled with argon three times. Then 
2.5 mL of degassed acetone was added through the septum to obtain a clear yellow 
transparent 0.06 M solution. The vial was then irradiated for the indicated time with 
Thorlab blue LEDs generating about 35°C temperature. The crude mixture was  then 
concentrated in vacuo and the residue purified by flash column chromatography on silica 
gel (Et2O/EtOAc/hexane/Et3N, 1:1:2:0.04) to yield the pure product. 
4-benzylpyridine (161) 
 
161 was obtained following GP(II) as a colourless oil (21 mg, 0.12 mmol) in 81% yield 
after 48 h of irradiation. 1H-NMR (600 MHz, CDCl3) δ 8.53 (br s, 2H, H1), 7.33 (t, J = 
7.5 Hz, 2H, H7), 7.26 (t, J = 7.4 Hz, 1H, H8), 7.18 (d, J = 7.4 Hz, 2H, H6), 7.15 (d, J = 4.4 
Hz, 2H, H2), 3.99 (s, 2H, H4). 13C-NMR (151 MHz, CDCl3) δ 150.6 (C1), 149.3 (C3), 
138.7 (C5), 129.0 (C6), 128.8 (C7), 126.7 (C8), 124.4 (C2), 41.3 (C4). HRMS for 
[C12H12N]+ calculated 170.0970 found 170.0977. Rf (1:1 EtOAc/hexane) = 0.12. 
Spectroscopic data were consistent with literature values.[207] 
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4-(4-methoxybenzyl)pyridine (162) 
 
162 was obtained following GP(II) as a colourless oil (22 mg, 0.11 mmol) in 76% yield 
after 16 h of irradiation. 1H-NMR (600 MHz, CDCl3) δ 8.49 (d, J = 5.8 Hz, 2H, H1), 
7.13 – 7.07 (m, 4H, H2 and H6), 6.86 (d, J = 8.7 Hz, 2H, H7), 3.91 (2H, s, H4), 3.80 (s, 
3H, H9). 13C-NMR (151 MHz, CDCl3) δ 158.4 (C8), 150.6 (C3), 149.7 (C1), 130.9 (C5), 
130.0 (C2), 124.1 (C6), 114.1 (C7), 55.3 (C9), 40.3 (C4). HRMS for [C13H14NO]+ 
calculated 200.1075 found 200.1078. Rf (1:1 EtOAc/hexane) = 0.13. Spectroscopic data 
were consistent with literature values.[271] 
4-(1-(3-methoxyphenyl)-2-methylpropyl)pyridine (163) 
 
163 was obtained following GP(II) as a yellowish solid (33 mg, 0.14 mmol) in 86% yield 
after 3 h of irradiation. Also obtained using 168 as starting material in 43% yield. 1H-
NMR (600 MHz, CDCl3) δ 8.47 (d, J = 5.1 Hz, 2H, H14), 7.23 – 7.18 (m, 3H, H13 and H7 
), 6.86 (br d, J = 7.7 Hz, 1H, H6), 6.82 – 6.80 (m, 1H, H10), 6.73 (dd, J = 8.2, 2.5, 1H, H8), 
3.78 (s, 3H, H11), 3.36 (d, J = 10.8 Hz, 1H, H4), 2.47 (dsept, J = 10.8, 6.6 Hz, 1H, H3), 
0.90 (d, J = 6.5 Hz, 3H, H1 or H2), 0.87 (d, J = 6.5 Hz, 3H, H1 or H2). 13C-NMR (151 
MHz, CDCl3) δ 159.7 (C9), 153.6 (C5), 149.8 (C14), 144.6 (C12), 129.6 (C7), 123.4 (C6), 
120.4 (C13), 114.4 (C10), 111.2 (C8), 60.2 (C4), 55.1 (C11), 31.4 (C3), 21.6 (C1 or C2), 21.5 
(C1 or C2). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2988, 2972, 2902, 1592, 1557, 1484, 1466, 
1452, 1438, 1408, 1393, 1385, 1277, 1260, 1242, 1232, 1148, 1066, 1048, 889, 880, 833, 
820, 780, 761, 737, 700. HRMS for [C16H20NO]+ calculated 242.1545 found 242.1549. 
Rf (1:1 EtOAc/hexane) = 0.16. M.p. = 47–49°C. 
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4-(4-methoxybenzyl)benzonitrile (173) 
 
173 was obtained following GP(II) as a colourless oil (14 mg, 0.065 mmol) in 43% yield 
after 16 h of irradiation. 1H-NMR (600 MHz, CDCl3) δ 7.57 (d, J = 8.2 Hz, 2H, H3), 
7.28 (d, J = 8.3 Hz, 2H, H4), 7.08 (d, J = 8.5 Hz, 2H, H8), 6.86 (d, J = 8.6 Hz, 2H, H9), 
3.98 (s, 2H, H6), 3.80 (s, 3H, H11). 13C-NMR (151 MHz, CDCl3) δ 158.4 (C10), 147.2 
(C7), 132.3 (C5), 131.4 (C3), 129.9 (C4), 129.5 (C8), 119.0 (C1), 114.2 (C9), 109.9 (C2), 
55.3 (C4), 41.1 (C6). HRMS for [C15H14NO]+ calculated 224.1075 found 224.1072. Rf 
(1:1 EtOAc/hexane) = 0.51. Spectroscopic data were consistent with literature values.[271] 
2-(4-methoxybenzyl)pyrimidine (171)  
 
171 was obtained following GP(II) as a colourless oil (8.5 mg, 0.042 mmol) in 28% yield 
after 72 h of irradiation. 1H-NMR (600 MHz, CDCl3) δ 8.68 (d, J = 4.9 Hz, 2H, H2), 
7.29 (d, J = 8.6 Hz, 2H, H6), 7.12 (t, J = 4.9 Hz, 1H, H1), 6.86 (d, J = 8.7 Hz, 2H, H7), 
4.24 (s, 2H, H4), 3.78 (s, 3H, H9). 13C-NMR (151 MHz, CDCl3) δ 170.4 (C3), 158.3 (C8), 
157.3 (C2), 130.3 (C5), 130.1 (C6), 118.6 (C1), 114.0 (C7), 55.2 (C9), 45.2 (C4) IR (ATR – 
neat) ?̃? (𝑐𝑚−1) = 2988, 2972, 2902, 1611, 1571, 1561, 1511, 1415, 1394, 1382, 1301, 
1248, 1178, 1076, 1066, 1056, 892, 879, 809. HRMS for [C12H13N2O]+ calculated 
201.1028 found 201.1028. Rf (1:1 EtOAc/hexane) = 0.09. 
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5.2.2.2 Arylation of  boronic esters with cyanoarenes in flow 
 
GP(III): A 5 mL conical shape microwave vial was charged with the cyanoarene 
(0.25 mmol, 1.0 equiv.), the benzyl pinacol boronic ester (0.30 mmol, 1.2 equiv), and the 
photoredox catalyst [Ir(dF(CF3)ppy)2(dtbpy)]PF6 (Ir-3, 3.0 mg, 1.0 mol%). Then 1.0 mL 
of acetone was added to obtain a clear yellow transparent 0.25 M solution after sonication 
for 1 min. The clear yellow solution was then pumped at 100 µL/min through a 
Vapourtec UV-150 photochemical reactor (10 mL reactor coil, FEP tubing, τ = 100 min) 
held at 60°C. Once the reaction mixture has fully be taken up by the pump, the input was 
swapped to acetone solvent to push the rest of the reaction mixture through the reactor. 
When the reaction plug was exiting the output stream (yellow to orange colour), the 
totality of the plug was collected in a vial wrapped in aluminium foil and concentrated in 
vacuo. The residue was then purified by Bioatage flash column chromatography on KP-
NH modified silica gel cartridge (0% to 20% EtOAc in hexane gradient) to yield the pure 
product. 
4-(4-methoxybenzyl)pyridine (162) 
 
162 was obtained following GP(III) as a pale yellow oil (40 mg, 0.20 mmol) in 81% 
yield. 1H-NMR (600 MHz, CDCl3) δ 8.49 (d, J = 5.8 Hz, 2H, H1), 7.13 – 7.07 (m, 4H, 
H2 and H6), 6.86 (d, J = 8.7 Hz, 2H, H7), 3.91 (2H, s, H4), 3.80 (s, 3H, H9). 13C-NMR 
(151 MHz, CDCl3) δ 158.4 (C8), 150.6 (C3), 149.7 (C1), 130.9 (C5), 130.0 (C2), 124.1 
(C6), 114.1 (C7), 55.3 (C9), 40.3 (C4). HRMS for [C13H14NO]+ calculated 200.1075 
found 200.1078. Rf (1:1 EtOAc/hexane) = 0.13. Spectroscopic data were consistent with 
literature values.[271] 
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4-(4-methylbenzyl)pyridine (191) 
 
191 was obtained following GP(III) as a colourless oil (32 mg, 0.17 mmol) in 70% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.49 (d, J = 5.3 Hz, 2H, H1), 7.13 (d, J = 7.8 Hz, 2H, H7), 
7.10 (d, J = 5.5 Hz, 2H, H2), 7.07 (d, J = 7.8 Hz, 2H, H6), 3.93 (s, 2H, H4), 2.34 (s, 3H, 
H9).13C-NMR (151 MHz, CDCl3) δ 150.3 (C3), 149.8 (C1), 136.3 (C5), 135.8 (C8), 129.4 
(C7), 128.9 (C6), 124.1 (C2), 40.8 (C4), 21.0 (C9). HRMS for [C13H14N]+ calculated 
184.1121 found 184.117. Rf (1:1 EtOAc/hexane) = 0.13. Spectroscopic data were 
consistent with literature values.[272] 
4-(benzyl)pyridine (161) 
 
161 was obtained following GP(III) as a colourless oil (28 mg, 0.16 mmol) in 66% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.53 (br s, 2H, H1), 7.33 (t, J = 7.5 Hz, 2H, H7), 7.26 (t, J 
= 7.4 Hz, 1H, H8), 7.18 (d, J = 7.4 Hz, 2H, H6), 7.15 (d, J = 4.4 Hz, 2H, H2), 3.99 (s, 2H, 
H4). 13C-NMR (151 MHz, CDCl3) δ 150.6 (C1), 149.3 (C3), 138.7 (C5), 129.0 (C6), 128.8 
(C7), 126.7 (C8), 124.4 (C2), 41.3 (C4). HRMS for [C12H12N]+ calculated 170.0970 found 
170.0977. Rf (1:1 EtOAc/hexane) = 0.13. Spectroscopic data were consistent with 
literature values.[207] 
4-(1-(4-methoxyphenyl)ethyl)pyridine (192) 
 
192 was obtained following GP(III) as a colourless oil (44 mg, 0.21 mmol) in 83% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.49 (d, J = 5.9 Hz, 2H), 7.16 – 7.05 (m, 4H, H6 and H2), 
6.85 (d, J = 8.6 Hz, 2H, H7), 4.07 (q, J = 7.2 Hz, 1H, H4), 3.79 (s, 3H, H9), 1.61 (d, J = 
7.2 Hz, 3H, H10). 13C-NMR (151 MHz, CDCl3) δ 158.3 (C8), 155.5 (C3), 149.8 (C2), 
136.5 (C5), 128.5 (C6), 122.9 (C2), 114.0 (C7), 55.2 (C9), 43.4 (C4), 21.2 (C10). HRMS for 
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[C12H12N]+ calculated 214.1226 found 214.1220. Rf (1:1 EtOAc/hexane) = 0.12. 
Spectroscopic data were consistent with literature values.[273] 
1-(4-methoxybenzyl)isoquinoline (184) 
 
184 was obtained following GP(III) as a pale green oil (47 mg, 0.19 mmol) in 75% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.50 (d, J = 5.7 Hz, 1H, H2), 8.17 (d, J = 8.5 Hz, 1H, H8), 
7.81 (d, J = 8.2 Hz, 1H, H5), 7.64 (ddd, J = 8.1, 7.0, 1.0 Hz, 1H, H6), 7.56 (d, J = 5.7 Hz, 
1H, H3), 7.53 (ddd, J = 8.5, 6.9, 1.1 Hz, 1H, H7), 7.21 (d, J = 8.7 Hz, 2H, H12), 6.80 (d, J 
= 8.7 Hz, 2H, H13), 4.62 (s, 2H, H10), 3.75 (s, 3H, H15). 13C-NMR (151 MHz, CDCl3) δ 
160.5 (C1), 158.0 (C14), 142.0 (C2), 136.6 (C4), 131.6 (C11), 129.8 (C7), 129.5 (C12), 127.3 
(C6), 127.1 (C5), 127.0 (C9), 125.8 (C8), 119.7 (C3), 113.9 (C13), 55.2 (C15), 41.2 (C10). 
HRMS for [C17H16ON]+ calculated 250.1226 found 250.1216. Rf (1:1 EtOAc/hexane) = 
0.48. Spectroscopic data were consistent with literature values.[274] 
1-(1-phenylethyl)isoquinoline (194) 
 
194 was obtained following GP(III) as a white solid (44 mg, 0.19 mmol) in 75% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.59 (d, J = 5.7 Hz, 1H, H2), 8.19 (d, J = 8.6 Hz, 1H, H8), 
7.79 (d, J = 8.2 Hz, 1H, H5), 7.60 (t, J = 7.5 Hz, 1H, H6), 7.55 (d, J = 5.7 Hz, 1H, H7), 
7.49 (t, J = 7.8 Hz, 1H, H3), 7.33 (d, J = 7.5 Hz, 2H, H13), 7.26 (t, J = 7.6 Hz, 2H, H14), 
7.16 (t, J = 7.3 Hz, 1H, H15), 5.10 (q, J = 7.0 Hz, 1H, H10), 1.87 (d, J = 7.0 Hz, 3H, H11). 
13C-NMR (151 MHz, CDCl3) δ 162.9 (C1), 145.9 (C2), 141.7 (C12), 136.5 (C4), 129.5 
(C6), 128.5 (C14), 127.6 (C13), 127.4 (C8), 127.0 (C7), 126.2 (C15), 125.3 (C5), 120.0 (C3), 
43.2 (C10), 21.9 (C11). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3060, 3020, 2968, 2925, 1619, 1584, 
1560, 1491, 1354, 1140, 876. HRMS for [C17H16N]+ calculated 234.1277 found 
234.1266. Rf (1:1 EtOAc/hexane) = 0.32. M.p. 59–62°C.  
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1-(4-methylbenzyl)isoquinoline (193) 
 
193 was obtained following GP(III) as a colourless oil (43 mg, 0.18 mmol) in 74% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.51 (d, J = 5.7 Hz, 1H, H2), 8.17 (d, J = 8.5 Hz, 1H, H8), 
7.81 (d, J = 8.2 Hz, 1H, H5), 7.63 (t, J = 7.5 Hz, 1H, H6), 7.56 (d, J = 5.7 Hz, 1H, H3), 
7.53 (t, J = 7.6 Hz, 1H, H7), 7.19 (d, J = 7.9 Hz, 2H, H12), 7.07 (d, J = 7.9 Hz, 2H, H13), 
4.65 (s, 2H, H10), 2.29 (s, 3H, H15). 13C-NMR (151 MHz, CDCl3) δ 160.4 (C1), 142.0 
(C2), 136.6 (C14), 136.4 (C4), 135.7 (C11), 129.8 (C7), 129.2 (C13), 128.5 (C12), 127.3 (C9), 
127.2 (C5), 125.9 (C8), 119.7 (C3), 41.7 (C10), 21.0 (C15). HRMS for [C17H16N]+ 
calculated 234.1277 found 234.1265. Rf (1:1 EtOAc/hexane) = 0.34. Spectroscopic data 
were consistent with literature values.[275] 
1-benzhydrylisoquinoline (195) 
 
195 was obtained following GP(III) as a white solid (62 mg, 0.21 mmol) in 84% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.56 (d, J = 5.7 Hz, 1H, H2), 8.27 (d, J = 8.6 Hz, 1H, H8), 
7.85 (d, J = 8.2 Hz, 1H, H5), 7.66 (t, J = 7.5 Hz, 1H, H6), 7.57 – 7.54 (m, 2H, H7 and H3), 
7.34 – 7.31 (m, 4H, H13), 7.29 – 7.23 (m, 6H, H12 and H14), 6.52 (s, 1H, H10). 13C-NMR 
(151 MHz, CDCl3) δ 161.9 (C1), 142.8 (C11), 142.0 (C2), 136.6 (C4), 129.6 (C6), 128.3 
(C13), 127.5 (C12), 127.3 (C8 and C9), 126.5 (C7), 125.2 (C14), 119.6 (C5), 54.8 (C10). IR 
(ATR – neat) ?̃? (𝑐𝑚−1) = 3056, 3020, 1621, 1586, 1560, 1495, 1447, 1380, 1344, 1156, 
1029, 826. HRMS for [C22H18N]+ calculated 296.1434 found 296.1421. Rf (1:9 
EtOAc/hexane) = 0.16. M.p. 89–92°C. 
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1-(4-fluorobenzyl)isoquinoline (196) 
 
196 was obtained following GP(III) as an amorphous white solid (39 mg, 0.16 mmol) in 
65% yield. 1H-NMR (600 MHz, CDCl3) δ 8.50 (d, J = 5.6 Hz, 1H, H2), 8.13 (d, J = 8.4 
Hz, 1H, H8), 7.83 (d, J = 8.1 Hz, 1H, H5), 7.65 (t, J = 7.5 Hz, 1H, H6), 7.58 (d, J = 5.7 Hz, 
1H, H3), 7.55 (t, J = 7.6 Hz, 1H, H7), 7.26 – 7.22 (m, 2H, H12), 6.95 (t, J = 8.5 Hz, 2H, 
H13), 4.65 (s, 2H, H10). 13C-NMR (151 MHz, CDCl3) δ 161.4. (d, J = 244 Hz, C14), 159.9 
(C1), 142.0 (C2), 136.6 (C4), 135.0 (d, J = 3.2 Hz, (C11), 129.9 (d, J = 4.6 Hz, C12), 127.4 
(C5), 127.3 (C6), 127.1 (C9), 125.6 (C8), 119.9 (C3), 115.3 (d, J = 21 Hz, C13), 41.1 (C10). 
HRMS for [C16H13NF]+ calculated 238.1027 found 238.1025. Rf (1:1 EtOAc/hexane) = 
0.48. Spectroscopic data were consistent with literature values.[276] 
1-(3,5-bis(trifluoromethyl)benzyl)isoquinoline (197) 
 
197 was obtained following GP(III) as a white solid (48 mg, 0.13 mmol) in 55% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.52 (d, J = 5.7 Hz, 1H, H2), 8.10 (d, J = 8.5 Hz, 1H, H8), 
7.87 (d, J = 8.2 Hz, 1H, H5), 7.78 (s, 2H, H12), 7.73 (s, 1H, H14), 7.70 (t, J = 7.5 Hz, 1H, 
H6), 7.63-7.60 (m, 2H, H7 and H3), 4.78 (s, 2H, H10).13C-NMR (151 MHz, CDCl3) δ 
157.9 (C1), 142.2 (C2), 141.6 (C11), 136.6 (C4), 131.6 (q, J = 33.2 Hz, C13), 130.2 (C6), 
129.0 (q, J = 3.6 Hz, C12), 127.7 (C5 and C7), 126.9 (C9), 124.8 (C8), 123.3 (q, J = 273 Hz, 
C15) 120.5 (sept, J = , 3.8 Hz, C14), 120.4 (C3), 41.0 (C10). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 
3051, 2929, 1621, 1586, 1558, 1506, 1463, 1372, 1280, 1165, 1116, 880, 828. HRMS for 
[C18H12NF6]+ calculated 356.0868 found 356.0858. Rf (1:1 EtOAc/hexane) = 0.67. M.p. 
82–84°C. 
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1-(2,6-difluorobenzyl)isoquinoline (198) 
 
198 was obtained following GP(III) as a white solid (40 mg, 0.16 mmol) in 63% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.42 (d, J = 5.7 Hz, 1H, H2), 8.30 (d, J = 8.4 Hz, 1H, H8), 
7.85 (d, J = 8.1 Hz, 1H, H5), 7.73 – 7.68 (m, 1H, H6), 7.64 (t, J = 7.6 Hz, 1H, H7), 7.54 (d, 
J = 5.7 Hz, 1H, H3), 7.27 – 7.20 (m, 1H, H14), 6.94 (t, J = 7.8 Hz, 2H, H13), 4.73 (s, 2H, 
H10). 13C-NMR (151 MHz, CDCl3) δ 161.7 (dd, J = 248 Hz, J = 8.7 Hz, C12), 157.6 (C1), 
142.0 (C2), 136.2 (C4), 129.8 (C6), 128.2 (t, J = 10.3 Hz, C14), 127.4 (C8), 127.2 (C9), 
126.9 (C7), 124.8 (C5), 119.6 (C3), 114.8 (t, J = 19.9 Hz, C11), 111.1 (dd, J = 20.9, 5.1 Hz, 
C13), 28.4 (C10). 19F-NMR (376 MHz, CDCl3) δ -113.81. IR (ATR – neat) ?̃? (𝑐𝑚−1) = 
2924, 2853, 1623, 1590, 1566, 1465, 1380, 1205, 1019, 1003, 860, 743. HRMS for 
[C16H12NF2]+ calculated 256.0932 found 256.0927. Rf (1:1 EtOAc/hexane) = 0.67. M.p. 
83–85°C. 
1-(3,5-dimethoxybenzyl)isoquinoline (199) 
 
199 was obtained following GP(III) as a pale green oil (46 mg, 0.16 mmol) in 66% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.51 (d, J = 5.7 Hz, 1H, H2), 8.17 (d, J = 8.5 Hz, 1H, H8), 
7.82 (d, J = 8.2 Hz, 1H, H5), 7.65 (t, J = 7.5 Hz, 1H, H6), 7.58 (d, J = 5.7 Hz, 1H, H3), 
7.54 (t, J = 7.6 Hz, 1H, H7), 6.46 (s, 2H, H12), 6.30 (s, 1H, H14), 4.62 (s, 2H, H10), 3.73 (s, 
6H, H15). 13C-NMR (151 MHz, CDCl3) δ 160.8 (C13), 159.8 (C1), 141.9 (C2), 141.8 
(C11), 136.6 (C4), 129.9 (C6), 127.3 (C9 and C8), 127.2 (C7), 125.8 (C5), 119.9 (C3), 106.9 
(C12), 98.1 (C14), 55.2 (C15), 42.3 (C10). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3056, 3000, 2937, 
2837, 1596, 1560, 1500, 1461, 1427, 1383, 1342, 1322, 1288, 1205, 1154, 1058, 822, 
789, 747, 730, 684. HRMS for [C18H18NO2]+ calculated 280.1332 found 280.1328. Rf 
(1:1 EtOAc/hexane) = 0.39. 
Experimental 140 
 
4-(4-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine (183) 
 
183 was obtained following GP(III) (using 3.5 mL of acetone instead of 1.0 mL because 
of the low starting material solubility) as a brownish solid (36 mg, 0.15 mmol) in 60% 
yield. 1H-NMR (600 MHz, CDCl3) δ 11.12 (s, 1H, H1), 8.25 (d, J = 4.8 Hz, 1H, H6), 
7.32 (d, J = 3.0 Hz, 1H, H2), 7.18 (d, J = 8.4 Hz, 2H, H11), 6.87 – 6.84 (m, 3H, H12 and 
H5), 6.51 (d, J = 3.3 Hz, 1H, H3), 4.23 (s, 2H, H9), 3.79 (s, 3H, H14). 13C-NMR (151 
MHz, CDCl3) δ 158.2 (C13), 148.7 (C7), 143.4 (C6), 142.6 (C4), 131.4 (C10), 130.0 (C11), 
124.6 (C2), 120.2 (C8), 116.0 (C5), 114.0 (C12), 99.3 (C3), 55.2 (C14), 38.2 (C9). IR (ATR 
– neat) ?̃? (𝑐𝑚−1) = 3127, 3000, 2929, 2837, 2762, 1592, 1508, 1439, 1348, 1243, 1181, 
1031, 823. HRMS for [C15H15ON2]+ calculated 239.1179 found 239.1179. Rf (1:1 
EtOAc/hexane) = 0.19. M.p. 116–118°C. 
4-(4-methoxybenzyl)quinoline (184) 
 
184 was obtained following GP(III) as a white solid (41 mg, 0.16 mmol) in 66% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.84 (d, J = 4.5 Hz, 1H, H1), 8.12 (d, J = 7.6 Hz, 1H, 
H11), 8.07 (d, J = 7.6 Hz, 1H, H14), 7.73 (t, J = 7.6, 1H, H13), 7.56 (t, J = 7.6, 1H, H12), 
7.17-7.10 (m, 3H, H6 and H2), 6.87 (d, J = 8.65 Hz, 2H, H7), 4.41 (s, 2H, H4), 3.81 (s, 3H, 
H9). 13C-NMR (151 MHz, CDCl3) δ 158.7 (C8), 150.1 (C15), 148.1 (C1), 147.3 (C3), 
130.5 (C5), 130.0 (C13), 129.9 (C14), 129.2 (C6), 127.6 (C10), 126.6 (C12), 123.9 (C11), 
121.7 (C2), 114.2 (C7), 55.3 (C9), 44.3 (C4). HRMS for [C17H16NO]+ calculated 
250.1226 found 250.1227. Rf (1:1 EtOAc/hexane) = 0.75. M.p. 79–81°C. Spectroscopic 
data were consistent with literature values.[271]  
Experimental 141 
 
4-(4-methoxybenzyl)picolinonitrile (181) 
 
181 was obtained following GP(III) as a pale yellow oil (25 mg, 0.11 mmol) in 44% 
yield. 1H-NMR (600 MHz, CDCl3) δ 8.72 (d, J = 5.0 Hz, 1H, H1), 7.34 (d, J = 5.0 Hz, 
1H, H2), 7.30 (s, 1H, H4), 7.17 (d, J = 8.5 Hz, 2H, H9), 6.88 (d, J = 8.6 Hz, 2H, H10), 4.16 
(s, 2H, H7), 3.81 (s, 3H, H12). 13C-NMR (151 MHz, CDCl3) δ 163.3 (C11), 158.6 (C3), 
150.2 (C1), 130.2 (C9), 129.9 (C5), 124.5 (C2), 122.6 (C8), 120.8 (C4), 116.6 (C6), 114.3 
(C10), 55.3 (C12), 43.6 (C7). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2956, 2933, 2238, 1609, 1594, 
1508, 1461, 1395, 1302, 1243, 1177, 1033, 830, 817, 775. HRMS for 
[C14H13N2O]+calculated 225.1022 found 225.1023. Rf (1:1 EtOAc/hexane) = 0.54. 
4-(4-methoxybenzyl)nicotinonitrile (182) 
 
182 was obtained following GP(III) as a colourless oil (36 mg, 0.16 mmol) in 65% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.82 (s, 1H, H1), 8.65 (d, J = 5.2 Hz, 1H, H5), 7.17 (d, J = 
5.2 Hz, 1H, H4), 7.15 (d, J = 8.7 Hz, 2H, H9), 6.88 (d, J = 8.7 Hz, 2H, H10), 4.14 (s, 2H, 
H7), 3.81 (s, 3H, H12).13C-NMR (151 MHz, CDCl3) δ 158.8 (C11), 154.1 (C3), 153.0 (C5), 
152.8 (C1), 130.2 (C9), 128.6 (C8), 124.1 (C4), 116.0 (C6), 114.4 (C2), 110.3 (C10), 55.3 
(C12), 38.9 (C7). HRMS for [C14H13ON2]+ calculated 225.1022 found 225.1019. Rf (1:1 
EtOAc/hexane) = 0.23. 
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2-(4-methoxybenzyl)pyridine (170) 
 
170 was obtained following GP(III) as a pale yellow oil (20 mg, 0.10 mmol) in 40% 
yield. 1H-NMR (600 MHz, CDCl3) δ 8.55 (d, J = 4.5 Hz, 1H, H1), 7.58 (td, J = 7.7, 
1.2 Hz, 1H, H3), 7.19 (d, J = 8.5 Hz, 2H, H8), 7.11 (t, J = 8.2 Hz, 2H, H2 and H4), 6.85 (d, 
J = 8.5 Hz, 2H, H9), 4.11 (s, 2H, H6), 3.79 (s, 3H, H11). 13C-NMR (151 MHz, CDCl3) δ 
161.3 (C10), 158.2 (C5), 149.2 (C2), 136.6 (C3), 131.5 (C7), 130.1 (C8), 123.0 (C4), 121.2 
(C2), 114.0 (C9), 55.2 (C11), 43.7 (C6). HRMS for [C13H14ON]+ 200.1070 found 
200.1071. Rf (1:1 EtOAc/hexane) = 0.36. Spectroscopic data were consistent with 
literature values.[277] 
2-benzhydrylquinoline (185) 
 
185 was obtained following GP(III) as a colourless oil (41 mg, 0.14 mmol) in 55% yield. 
1H-NMR (400 MHz, CDCl3) δ 8.08 (t, J = 7.8 Hz, 2H, H7 and H2), 7.79 (dd, J = 8.1, 1.1 
Hz, 1H, H5), 7.70 (ddd, J = 8.5, 6.9, 1.4 Hz, 1H, H3), 7.51 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H, 
H4), 7.33 – 7.27 (m, 5H, H8 and H12), 7.26 – 7.21 (m, 6H, H13 and H14), 5.94 (s, 1H, H10). 
13C-NMR (151 MHz, CDCl3) δ 163.1 (C9), 147.9 (C1), 142.6 (C11), 136.4 (C7), 129.5 
(C3), 129.5 (C13), 129.4 (C2), 128.4 (C12), 127.5 (C5), 126.8 (C6), 126.6 (C14), 126.3 (C4), 
122.0 (C8), 60.1 (C10). HRMS for [C22H18N]+ calculated 296.1434 found 296.1421. Rf 
(1:1 EtOAc/hexane) = 0.72. Spectroscopic data were consistent with literature values.[278] 
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5.2.2.3 Allylation of  heterocycles in flow 
 
GP(IV): A 5 mL conical shape microwave vial was charged with the cyanoarene 
(1.0 mmol, 1.0 equiv.), the allyl boronic pinacol ester (2.5 mmol, 2.5 equiv), and the 
photoredox catalyst [Ir(dF(CF3)ppy)2(dtbpy)]PF6 (Ir-3, 6.0 mg, 0.5 mol%). Then 1.5 mL 
of acetone was added to obtain a clear yellow transparent 0.5 M solution (2.0 mL overall 
volume) after sonication for 1 min. The clear yellow solution was then pumped at 
200 µL/min through a Vapourtec UV-150 photochemical reactor (10 mL reactor coil, 
FEP tubing, τ = 50 min) held at 60°C. Once the reaction mixture has fully be taken up by 
the pump, the input was swapped to acetone solvent to push the rest of the reaction 
mixture through the reactor. When the reaction plug was exiting the output stream 
(yellow to orange colour), the totality of the plug was collected in a vial wrapped in 
aluminium foil and concentrated in vacuo. The residue was then purified by Bioatage 
flash column chromatography on KP-NH modified silica gel cartridge (0% to 20% EtOAc 
in hexane gradient) to yield the pure product. 
4-allylpyridine (165) 
 
165 was obtained following GP(IV) as a colourless oil (83 mg, 0.70 mmol) in 70% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.50 (d, J = 6.0 Hz, 2H, H1), 7.11 (d, J = 5.8 Hz, 2H, H2), 
5.92 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H, H5), 5.18 – 5.08 (m, 2H, H6), 3.37 (d, J = 6.7 Hz, 
2H, H4). 13C-NMR (151 MHz, CDCl3) δ 149.8 (C1), 148.9 (C3), 135.1 (C5), 123.9 (C2), 
117.4 (C6), 39.3 (C4). HRMS for [C8H10N]+ calculated 120.0808 found 120.0807. Rf (2:1 
EtOAc/hexane) = 0.30. Spectroscopic data were consistent with literature values.[279] 
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1-allylisoquinoline (201) 
 
201 was obtained following GP(IV) as a colourless oil (119 mg, 0.70 mmol) in 70% 
yield. 1H-NMR (600 MHz, CDCl3) δ 8.46 (d, J = 5.7 Hz, 1H, H2), 8.16 (d, J = 8.5 Hz, 
1H, H8), 7.81 (d, J = 8.2 Hz, 1H, H5), 7.67 (t, J = 7.5 Hz, 1H, H6), 7.59 (t, J = 7.7 Hz, 1H, 
H7), 7.53 (d, J = 5.7 Hz, 1H, H3), 6.22 (ddt, J = 16.8, 10.1, 6.5 Hz, 1H, H11), 5.23 – 5.12 
(m, 2H, H12), 4.10 (d, J = 6.5 Hz, 2H, H10). 13C-NMR (151 MHz, CDCl3) δ 159.7 (C1), 
142.1 (C2), 136.3 (C4), 135.4 (C11), 129.9 (C6), 127.3 (C8), 127.1 (C9), 127.0 (C7), 125.4 
(C5), 119.6 (C3), 116.8 (C12), 40.2 (C10). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3055, 1639, 1623, 
1588, 1562, 1500, 1385, 1352, 1340, 1144, 991, 906, 820, 745. HRMS for [C12H12N]+ 
calculated 170.0964 found 170.0959. Rf (EtOAc/hexane, 2:1) = 0.49. 
4-allyl-1H-pyrrolo[2,3-b]pyridine (202) 
 
202 was obtained following GP(IV) (using 5 mL of acetone instead of 1.5 mL because of 
the low starting material solubility) as a white solid (113 mg, 0.71 mmol) in 71% yield. 
1H-NMR (600 MHz, CDCl3) δ 11.88 (s, 1H, H1), 8.30 (d, J = 4.9 Hz, 1H, H6), 7.40 (d, J 
= 3.2 Hz, 1H, H2), 6.96 (d, J = 4.9 Hz, 1H, H5), 6.57 (d, J = 3.3 Hz, 1H, H3), 6.09 (ddt, J 
= 16.8, 10.0, 6.7 Hz, 1H, H10), 5.19 (dd, J = 25.9, 13.5 Hz, 2H, H11), 3.71 (d, J = 6.7 Hz, 
2H, H9). 13C-NMR (151 MHz, CDCl3) δ 148.8 (C7), 142.5 (C6), 141.9 (C4), 135.5 (C10), 
124.7 (C2), 120.2 (C8), 116.8 (C5), 115.5 (C11), 98.9 (C3), 37.4 (C9). IR (ATR – neat) 
?̃? (𝑐𝑚−1) = 3079, 2917, 2829, 1637, 1588, 1493, 1433, 1403, 1340, 1302, 1276, 989, 
902, 809, 719. HRMS for [C10H11N2]+ calculated 159.0917 found 159.0915. Rf (1:1 
EtOAc/hexane) = 0.19. M.p. 79–81°C. 
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5.2.2.4 Arylation of  boronic esters with aryl bromides in flow 
 
GP(V): A 10 mL microwave vial was charged with the aryl bromide (0.50 mmol, 
1.0 equiv.), the photoredox catalyst Ir(dF(CF3)ppy)2(dtbpy)]PF6 (Ir-3, 6.0 mg, 1.0 mol%), 
4,4’-di-tert-butyl-2,2’-bipyridine (6.1 mg, 3 mol%), DMAP (120 mg, 2.0 equiv.) and the 
benzyl pinacol boronic ester (0.60 mmol, 1.2 equiv). The vial was then transferred in a 
glovebox where the Ni(COD)2 (6.0 mg, 3 mol%) was added and sealed with a rubber 
septum. Then 5.0 mL of acetone was added to obtain a clear yellow to brownish 
transparent solution after sonication for 1 to 5 min. The clear solution was then pumped at 
200 µL/min through a Vapourtec UV-150 photochemical reactor (10 mL reactor coil, 
FEP tubing, τ = 50 min) held at 35°C. Once the reaction mixture has fully be taken up by 
the pump, the input was swapped to acetone solvent to push the rest of the reaction 
mixture through the reactor. When the reaction plug was exiting the output stream 
(orange colour), the totality of the plug was collected in a vial wrapped in aluminium foil, 
filtered through a pad of celite® and concentrated in vacuo. The residue was then 
immobilised on ISOLUTE® HM-N for easy dry loading and purified by Biotage flash 
column chromatography on a regular silica gel cartridge (0% to 5% EtOAc in hexane 
gradient) to yield the pure product. 
4-(4-methoxybenzyl)benzonitrile (173) 
 
173 was obtained following GP(V) as a colourless oil (91 mg, 0.61 mmol) in 82% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.57 (d, J = 8.2 Hz, 2H, H3), 7.28 (d, J = 8.3 Hz, 2H, H4), 
7.08 (d, J = 8.5 Hz, 2H, H8), 6.86 (d, J = 8.6 Hz, 2H, H9), 3.98 (s, 2H, H6), 3.80 (s, 3H, 
H11). 13C-NMR (151 MHz, CDCl3) δ 158.4 (C10), 147.2 (C7), 132.3 (C5), 131.4 (C3), 
129.9 (C4), 129.5 (C8), 119.0 (C1), 114.2 (C9), 109.9 (C2), 55.3 (C4), 41.1 (C6). HRMS 
for [C15H14NO]+ calculated 224.1075 found 224.1077. Rf (1:4 EtOAc/hexane) = 0.29. 
Spectroscopic data were consistent with literature values.[271] 
Experimental 146 
 
4-(3,5-dimethoxybenzyl)benzonitrile (247) 
 
247 was obtained following GP(V) as a colourless oil (95 mg, 0.37 mmol) in 75% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.58 (d, J = 8.3 Hz, 2H, H3), 7.30 (d, J = 8.3 Hz, 2H, H4), 
6.35 (t, J = 2.2 Hz, 1H, H10), 6.31 (d, J = 2.2 Hz, 2H, H8), 3.96 (s, 2H, H6), 3.77 (s, 6H, 
H11). 13C-NMR (151 MHz, CDCl3) δ 161.1 (C9), 146.4 (C5), 141.5 (C7), 132.3 (C3), 
129.6 (C4), 119.0 (C1), 110.1 (C2), 107.2 (C8), 98.3 (C10), 55.3 (C11), 42.1 (C6). HRMS 
for [C16H16NO2]+ calculated 254.1181 found 254.1192. Rf (1:4 EtOAc/hexane) = 0.23. 
Spectroscopic data were consistent with literature values.[271] 
methyl 4-(4-cyanobenzyl)benzoate (248) 
 
248 was obtained following GP(V) as a colourless oil (90 mg, 0.36 mmol) in 71% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.99 (d, J = 8.3 Hz, 2H, H9), 7.59 (d, J = 8.2 Hz, 2H, H3), 
7.28 (d, J = 8.3 Hz, 2H, H4), 7.24 (d, J = 8.2 Hz, 2H, H8), 4.09 (s, 2H, H6), 3.91 (s, 3H, 
H12).13C-NMR (151 MHz, CDCl3) δ 166.8 (C11), 145.6 (C7), 144.5 (C5), 132.4 (C3), 
130.1 (C9), 129.7 (C4), 129.0 (C10), 128.7 (C8), 118.8 (C1), 110.4 (C2), 52.1 (C12), 41.9 
(C6). HRMS for [C16H14NO2]+.calculated 252.1025 found 252.1029. Rf (1:4 
EtOAc/hexane) = 0.19. Spectroscopic data were consistent with literature values.[271] 
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4-(3,5-bis(trifluoromethyl)benzyl)benzonitrile (249) 
 
249 was obtained following GP(V) as a colourless oil (100 mg, 0.30 mmol) in 61% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.78 (s, 1H, H1), 7.65 (d, J = 8.2 Hz, 2H, H9), 7.62 (s, 2H, 
H4), 7.30 (d, J = 8.2 Hz, 2H, H8), 4.18 (s, 2H, H6).13C-NMR (151 MHz, CDCl3) δ 144.1 
(C7), 141.7 (C5), 132.6 (C9), 132.1 (q, J = 33.4 Hz, C3), 129.6 (C4), 129.0 (C2), 124.0 (C8), 
120.9 (C1), 118.5 (C11), 111.1 (C10), 41.4 (C6). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2929, 2222, 
1624, 1607, 1508, 1467, 1433, 1376, 1274, 1161, 1116, 898. HRMS for [C16H10NF6]+ 
calculated 330.0717 found 330.0730. Rf (1:4 EtOAc/hexane) = 0.17. 
4-(4-methylbenzyl)benzonitrile (250) 
 
250 was obtained following GP(V) as colourless needles (80 mg, 0.38 mmol) in 77% 
yield. 1H-NMR (600 MHz, CDCl3) δ 7.57 (d, J = 8.3 Hz, 2H, H3), 7.29 (d, J = 8.3 Hz, 
2H, H4), 7.13 (d, J = 7.9 Hz, 2H, H8), 7.06 (d, J = 7.9 Hz, 2H, H9), 4.00 (s, 2H, H6), 2.34 
(s, 3H, H11). 13C-NMR (151 MHz, CDCl3) δ 147.1 (C5), 136.3 (C7 and C10), 132.2 (C4 
and C3), 129.5 (C9), 128.8 (C8), 119.0 (C1), 109.9 (C2), 41.6 (C6), 21.0 (C11). HRMS for 
[C15H14N]+ calculated 208.1126 found 208.1133. Rf (1:4 EtOAc/hexane) = 0.45. M.p. 
58–60°C. Spectroscopic data were consistent with literature values.[280] 
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4-(4-fluorobenzyl)benzonitrile (251) 
 
251 was obtained following GP(V) as a colourless oil (56 mg, 0.26 mmol) in 53% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.59 (d, J = 8.3 Hz, 2H, H3), 7.27 (d, J = 8.3 Hz, 2H, H4), 
7.12 (dd, J = 8.6, 5.4 Hz, 2H, H8), 7.01 (t, J = 8.7 Hz, 2H, H9), 4.01 (s, 3H). 13C-NMR 
(151 MHz, CDCl3) δ 161.7 (d, J = 245 Hz, C10), 146.5 (C5), 135.0 (d, J = 3.3 Hz, C7), 
132.4 (C3), 130.4 (d, J = 7.9 Hz, C8), 129.5 (C4), 118.9 (C1), 115.6, (d, J = 21 Hz, C9), 
110.2 (C2), 41.1 (C6). HRMS for [C14H11NF]+ calculated 212.0876 found 212.0883. 
Rf (1:4 EtOAc/hexane) = 0.42. Spectroscopic data were consistent with literature 
values.[281] 
1-methoxy-4-(4-(trifluoromethyl)benzyl)benzene (172) 
 
172 was obtained following GP(V) as a colourless oil (95 mg, 0.36 mmol) in 71% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.55 (d, J = 8.1 Hz, 2H, H3), 7.30 (d, J = 8.0 Hz, 2H, H4), 
7.11 (d, J = 8.7 Hz, 2H, H8), 6.87 (d, J = 8.7 Hz, 2H, H9), 3.99 (s, 2H, H6), 3.81 (s, 3H, 
H11). 13C-NMR (151 MHz, CDCl3) δ 158.2 (C10), 145.7 (C5), 132.1 (C7), 129.9 (C8), 
129.0 (C4), 128.4 (q, J = 32 Hz, C2), 125.3 (q, J = 3.7 Hz, C3), 124.2 (q, J = 272 Hz, C1), 
114.1 (C9), 55.6 (C11), 40.8 (C6). HRMS for [C15H14OF3]+ calculated 267.0997 found 
267.0989. Rf (1:4 EtOAc/hexane) = 0.46. Spectroscopic data were consistent with 
literature values.[282] 
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4-(4-methoxybenzyl)benzaldehyde (252) 
 
252 was obtained following GP(V) as a colourless oil (96 mg, 0.42 mmol) in 85% yield. 
1H-NMR (600 MHz, CDCl3) δ 9.98 (s, 1H, H12), 7.81 (d, J = 8.0 Hz, 2H, H3), 7.35 (d, J 
= 8.0 Hz, 2H, H4), 7.11 (d, J = 8.7 Hz, 2H, H8), 6.86 (d, J = 8.7 Hz, 2H, H9), 4.01 (s, 2H, 
H6), 3.80 (s, 3H, H11). 13C-NMR (151 MHz, CDCl3) δ 192.0 (C1), 158.3 (C10), 149.0 
(C5), 134.6 (C5), 131.8 (C7), 130.0 (C8), 129.9 (C3), 129.4 (C4), 114.1 (C9), 55.3 (C11), 
41.2 (C6). HRMS for [C15H15O2]+ calculated 227.1072 found 227.1071. Rf (1:4 
EtOAc/hexane) = 0.26. Spectroscopic data were consistent with literature values.[283] 
1-(4-methoxybenzyl)-2-methylbenzene (253) 
 
253 was obtained following GP(V) as a colourless oil (53 mg, 0.25 mmol) in 50% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.20 – 7.13 (m, 3H, H9, H10 and H11), 7.11 – 7.08 (m, 1H, 
H12), 7.05 (d, J = 8.7 Hz, 2H, H4), 6.83 (d, J = 8.7 Hz, 2H, H3), 3.94 (s, 2H, H6), 3.79 (s, 
3H, H1), 2.26 (s, 3H, H13). 13C-NMR (151 MHz, CDCl3) δ 157.8 (C2), 139.3 (C7), 136.5 
(C8), 132.4 (C5), 130.2 (C9), 129.8 (C12), 129.7 (C4), 126.3 (C10), 125.9 (C11), 113.8 (C3), 
55.2 (C1), 38.5 (C6), 19.6 (C13). HRMS for [C15H16O]+ calculated 212.1201 found 
212.1202. Rf (1:4 EtOAc/hexane) = 0.54. Spectroscopic data were consistent with 
literature values.[277] 
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1-methoxy-4-(4-vinylbenzyl)benzene (254) 
 
254 was obtained following GP(V) as a colourless oil (81 mg, 0.36 mmol) in 72% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.36 (d, J = 8.1 Hz, 2H, H3), 7.16 (d, J = 8.1 Hz, 2H, H4), 
7.13 (d, J = 8.7 Hz, 2H, H8), 6.86 (d, J = 8.7 Hz, 2H, H9), 6.71 (dd, J = 17.6, 10.9 Hz, 1H, 
H1), 5.73 (dd, J = 17.6, 0.7 Hz, 1H, H12cis), 5.22 (dd, J = 10.9, 0.7 Hz, 1H, H12trans), 3.94 
(s, 2H, H6), 3.80 (s, 3H, H11).13C-NMR (151 MHz, CDCl3) δ 157.9 (C10), 141.3 (C5), 
136.6 (C1), 135.4 (C2), 133.1 (C7), 129.9 (C8), 129.0 (C4), 126.3 (C3), 113.9 (C9), 113.2 
(C12), 55.3 (C11), 40.8 (C6). HRMS for [C16H17O]+ calculated 225.1279 found 225.1274. 
Rf (1:4 EtOAc/hexane) = 0.51. Spectroscopic data were consistent with literature 
values.[284] 
((4-(4-methoxybenzyl)phenyl)ethynyl)trimethylsilane (255) 
 
255 was obtained following GP(V) as a colourless oil (91 mg, 75% yield). 1H-NMR (600 
MHz, CDCl3) δ 7.39 (d, J = 8.2 Hz, 2H, H9), 7.11 (d, J = 8.2 Hz, 2H, H8), 7.07 (d, J = 8.7 
Hz, 2H, H4), 6.84 (d, J = 8.7 Hz, 2H, H3), 3.92 (s, 2H, H6), 3.79 (s, 3H, H1), 0.25 (s, 9H, 
H13). 13C-NMR (151 MHz, CDCl3) δ 158.1 (C2), 142.2 (C7), 132.6 (C5), 132.1 (C9), 
129.8 (C4), 128.7 (C8), 120.7 (C10), 113.9 (C3), 105.2 (C11), 93.6 (C12), 55.2 (C1), 40.9 
(C6), 0.0 (C13). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2956, 2901, 2155, 1609, 1584, 1510, 1504, 
1455, 1441, 1300, 1243, 1175, 1031, 840, 813, 755. HRMS for [C19H22OSi]+ calculated 
294.1440 found 294.1442. Rf (1:4 EtOAc/hexane) = 0.54. 
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4-(4-methoxybenzyl)phenol (257) 
 
257 was obtained following GP(V) using 2-(4-bromophenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane as arylbromide followed by an NaOH/H2O2 oxidation of the aryl pinacol 
ester product as described by Molander.[229] The corresponding phenol (257) was then 
isolated as a white amorphous solid (76 mg, 0.36 mmol) in 71% yield. 1H-NMR (600 
MHz, CDCl3) δ 7.12 (d, J = 8.7 Hz, 2H, H8), 7.06 (d, J = 8.5 Hz, 2H, H4), 6.86 (d, J = 8.7 
Hz, 2H, H9), 6.77 (d, J = 8.5 Hz, 2H, H3), 5.31 (br s, 1H, H1), 3.88 (s, 2H, H6), 3.81 (s, 
3H, H11).13C-NMR (151 MHz, CDCl3) δ 157.8 (C10), 153.7 (C2), 133.8 (C7 and C5), 
130.0 (C4), 129.8 (C8), 115.3 (C3), 113.9 (C9), 55.3 (C11), 40.1 (C6). HRMS for 
[C14H14O2]+ calculated 214.0994 found 214.0986. Rf (1:4 EtOAc/hexane) = 0.13. 
Spectroscopic data were consistent with literature values.[273] 
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5.3 Experimental data for Chapter 3 
5.3.1 Synthetic procedures and characterisation for starting 
materials 
2-(1-phenylvinyl) pyridine 
 
2-benzylpyridine (95 mg, 0.56 mmol, 1.0 equiv.) was loaded in a 20 mL two-necked flask 
equipped with a reflux condenser along with Cu(OAc)2·H2O (11 mg, 0.056 mmol, 
10 mol%), Na2S2O8 (266 mg, 1.12 mmol, 2.0 equiv.) and dissolved in DMA (2.5 mL). 
The resulting mixture was then stirred under argon at 120°C for 4 h. The reaction mixture 
was then cooled down to room temperature and extracted with ethyl acetate. The organic 
layer was washed with water (3 x 100 mL), dried over MgSO4 and solvents removed in 
vacuo. Column chromatography on silica gel (15% EtOAc in hexane) afforded the title 
compound (65 mg, 0.36 mmol) as a colourless oil in 64% yield.  
1H-NMR (400 MHz, CDCl3) δ 8.64 (d, J = 4.8 Hz, 1H, H1), 7.63 (t, J = 7.7 Hz, 1H, H3), 
7.35 (s, 5H, H8, H9, H10 and H11), 7.27 (d, J = 8.1 Hz, 1H, H4), 7.20 (t, J = 6.3 Hz, 1H, H2), 
5.99 (s, 1H, H7a), 5.61 (s, 1H, H7b). 13C-NMR (151 MHz, CDCl3) 158.5 (C5), 149.4 (C1), 
149.2 (C6), 140.4 (C8), 136.3 (C3), 128.4 (C9), 128.3 (C10), 127.8 (C11), 122.8 (C4), 122.4 
(C2), 117.7 (C7). HRMS for [C13H12N]+ calculated 182.0970 found 182.0966. Rf (1:4 
EtOAc/PE) = 0.58. Spectroscopic data were consistent with literature values.[285] 
tert-butyl dimethylcarbamate 
 
A solution of triethylamine (3.0 mL, 22 mmol, 1.0 equiv.) and dimethylamine 
(40% in H2O, 2.7 mL, 22 mmol, 1.0 equiv.) in THF (10 mL) was cooled to 0°C. Boc2O 
(5.0 mL, 22 mmol, 1.0 equiv.) was added slowly and the reaction mixture was stirred at 
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0°C for 10 min. and for an additional 18 h at room temperature. The solvent was removed 
under reduced pressure and the residue was suspended in water (15 mL). The suspension 
was extracted with EtOAc (3 x 20 mL), the combined organic extracts were dried over 
MgSO4 and concentrated in vacuo. Fractional distillation under reduced pressure afforded 
the title compound (3.1 g, 22 mmol) as a colourless oil in 99% yield. 
1H-NMR (600 MHz, CDCl3) δ 2.85 (s, 6H, H1), 1.45 (s, 9H, H4). 13C-NMR (151 MHz, 
CDCl3) δ 156.2 (C2), 79.3 (C3), 36.3 (C1), 28.6 (C4). HRMS for [C7H15O2NNa]+ 
calculated 168.0995 found 168.0991. B.p. (12 mTorr) = 40°C. Spectroscopic data were 
consistent with literature values.[286]  
tert-butyl methyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
 
A solution of tert-butyl dimethylcarbamate (0.20 g, 1.4 mmol, 1.0 equiv.) and TMEDA 
(0.40 mL, 2.8 mmol, 2.0 equiv.) in Et2O (10 mL) was cooled to -78°C. sec-BuLi (1.4 M in 
hexane, 1.2 mL, 1.7 mmol, 1.2 equiv.) was added dropwise and the mixture was stirred 
at -78°C for 3 h. Then a solution of 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(0.34 mL, 1.7 mmol, 1.2 equiv.) in Et2O (2 mL) was added. After stirring at -78°C for 
1.5 h acetyl chloride (0.12 mL, 1.7 mmol, 1.2 equiv.) was added and the reaction mixture 
was allowed to warm to room temperature. The reaction mixture was concentrated under 
reduced pressure and the residue was suspended in 0.1 M PBS (pH 7, 30 mL) and 
extracted with EtOAc (3 x 40 mL). The combined organic layers were dried over MgSO4 
and the solvents removed in vacuo. Column chromatography on oven-dried silica (20% to 
25% EtOAc in hexane) afforded the product (0.34 g, 1.2 mmol) as a yellowish oil in 90% 
yield. 
1H-NMR (600 MHz, CDCl3) δ 2.77 (s, 3H, H4), 2.34 (s, 2H, H3), 1.43 (s, 9H, H7), 1.14 
(s, 12H, H1) ppm. 13C-NMR (151 MHz, CDCl3) δ 160.7 (C5), 84.7 (C2), 80.7 (C6), 40.7 
(C3), 34.2 (C4), 28.4 (C7), 25.1 (C1). 11B-NMR (193 MHz, CDCl3) δ 17.2. IR (ATR – 
neat) ?̃? (𝑐𝑚−1) = 2976, 1689, 1367, 1335, 1215, 1160, 1139, 968, 879, 846, 771. HRMS 
for [C13H27O4NB]+ calculated 272.2028 found 272.2026. Rf (1:1 EtOAc/PE) = 0.35. 
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tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate (1g) 
 
A solution of NaHMDS (1 M in THF, 5.6 mL, 5.6 mmol, 1.0 equiv.) in THF (30 mL) was 
cooled to -78°C. 2-(chloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(0.98 g, 5.6 mmol, 1.0 equiv.) in THF (6 mL) was added dropwise and the reaction 
mixture was stirred at -78°C for 20 min, before it was allowed to warm to room 
temperature and stirred for additional 2 h. The reaction mixture was then cooled to 0°C 
before MeOH (0.44 mL, 11 mmol, 2.0 equiv.) was added, the mixture was then stirred at 
this temperature for 1 h. Boc2O (1.5 mL, 6.7 mmol, 1.2 equiv.) was then added and the 
mixture was stirred at room temperature for 72 h. The solvent was evaporated and the 
crude mixture was loaded on oven dried silica. Column chromatography on oven-dried 
silica (20% Et2O in PE) afforded the product (1.1 g, 4.3 mmol) as a colourless oil in 77% 
yield. 
1H-NMR (600 MHz, CDCl3) δ 4.63 (s, 1H, NH), 2.77 (d, J = 4.4 Hz, 2H, H3), 1.44 (s, 
9H, H6), 1.27 (s, 12H, H1). 13C-NMR (151 MHz, CDCl3) δ 157.1 (C4), 84.2 (C2), 
79.2 (C5), 28.6 (C6), 24.9 (C1). 11B-NMR (193 MHz, CDCl3) δ 32.6. IR (ATR – neat) 
?̃? (𝑐𝑚−1) = 3376, 2979, 1697, 1506, 1382, 1367, 1335, 1167, 1141, 968, 845, 780. 
HRMS for [C12H24O4NBNa]+ calculated 280.1691 found 280.1686. Rf (1:1 EtOAc/PE) 
= 0.28. 
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5.3.2 Synthetic procedures and characterisation for coupling 
products 
5.3.2.1  Scope of  electron-deficient olefins 
 
GP(VI): A 5 mL glass vial equipped with a magnetic stir bar was charged with 2-(4-
methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50 mg, 0.20 mmol, 1.0 equiv.), 
the photoredox catalyst [Ir(dF(CF3)ppy)2(bpy)]PF6 (Ir-4, 4.0 mg, 2.0 mol%) and 
quinuclidin-3-ol (5.0 mg, 0.04 mmol, 20 mol%). The vial was then sealed with a rubber 
septum and evacuated/backfilled with argon three times. The volatile olefin (0.4–0.8 
mmol, 2.0–4.0 equiv.) was then added followed by 2.0 mL of a degassed 
acetone/methanol (1:1) mixture to lead a clear yellow transparent 0.1 M solution. This 
solution was then stirred while irradiated with a commercial blue LED strip (Ledxon, 
14.4 W, 470 nm) for 24 h, the temperature was maintained at 30°C using a desktop fan. 
The content of the vial was then concentrated in vacuo and immobilised on ISOLUTE® 
HM-N for easy dry loading on flash column chromatography to yield the pure product. 
methyl 4-(4-methoxyphenyl)butanoate (263) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of methyl acrylate. 
Purification by column chromatography on silica gel (3% EtOAc in hexane) afforded 
product 263 (31 mg, 0.15 mmol) as colourless oil in 75% yield.1H-NMR (600 MHz, 
CDCl3) δ 7.09 (d, J = 8.6 Hz, 2H, H6), 6.83 (d, J = 8.6 Hz, 2H, H7), 3.79 (s, 3H, ArOMe), 
3.66 (s, 3H, COOMe), 2.61 – 2.58 (m, 2H, H2), 2.32 (t, J = 7.5 Hz, 2H, H4), 1.95 – 1.89 
(m, 2H, H3). 13C-NMR (151 MHz, CDCl3) δ 174.0 (C1), 157.9 (C8), 133.4 (C5), 129.4 
(C6), 113.8 (C7), 55.2 (ArOMe), 51.5 (COOMe), 34.2 (C4), 33.3 (C2), 26.7 (C3). HRMS 
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for [C12H17O3]+ calculated 209.1172 found 209.1163. Rf (1:4 EtOAc/PE) = 0.38. 
Spectroscopic data were consistent with literature values.[287] 
tert-butyl 4-(4-methoxyphenyl)butanoate (264) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of tert-butyl acrylate. 
Purification by column chromatography on silica gel (7% EtOAc in hexane) afforded 
product 264 (24 mg, 0.096 mmol) as colourless oil in 48% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.10 (d, J = 8.6 Hz, 2H, H6), 6.83 (d, J = 8.6 Hz, 2H, H7), 3.79 (s, 3H, OMe) 
2.58 (t, J = 7.4 Hz, 2H, H2), 2.22 (t, J = 7.5 Hz, 2H, H4), 1.88 (q, J = 7.6 Hz, 2H, H3), 
1.44 (s, 9H, OtBu).  13C-NMR (101 MHz, CDCl3) δ 173.0 (C1), 157.8 (C8), 133.7 (C5), 
129.4 (C6), 113.8 (C7), 80.1 (OC(Me)3), 55.3 (OMe), 34.9 (C4), 34.2 (C2), 28.1 
(OC(Me)3), 27.0 (C3). HRMS for [C15H23O3Na]
+ calculated 273.1464 found 273.1461. 
Rf (1:4 EtOAc/PE) = 0.60. Spectroscopic data were consistent with literature values.
[288] 
benzyl 4-(4-methoxyphenyl)butanoate (265) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of benzyl acrylate. 
Purification by column chromatography on silica gel (7% EtOAc in hexane) afforded 
product 265 (27 mg, 0.10 mmol) as colourless oil in 47% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.41 – 7.28 (m, 5H, H11, H12, and H13), 7.07 (d, J = 8.2 Hz, 2H, H6), 6.81 (d, J = 
8.2 Hz, 2H, H7), 5.11 (s, 2H, H9), 3.78 (s, 3H, OMe), 2.58 (t, J = 7.5 Hz, 2H, H4), 2.36 (t, 
J = 7.5 Hz, 2H, H2), 1.94 (p, J = 7.5 Hz, 2H, H3). 13C-NMR (101 MHz, CDCl3) δ 173.4 
(C1), 157.9 (C8), 136.0 (C10), 133.4 (C5), 129.4 (C6), 128.6 (C12), 128.2 (C13), 127.7 (C11), 
113.8 (C7), 66.2 (C9), 55.3 (OMe), 34.2 (C4), 33.6 (C2), 26.7 (C3). HRMS for 
[C18H21O3Na]+ calculated 308.1385 found 308.1389. Rf (1:4 EtOAc/PE) = 0.82. 
Spectroscopic data were consistent with literature values.[289] 
  
Experimental 157 
 
5-(4-methoxyphenyl)pentan-2-one (266) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of methyl vinyl ketone. 
Purification by column chromatography on silica gel (10% EtOAc in hexane) afforded 
product 266 (32 mg, 0.16 mmol) as colourless oil in 82% yield. Repeating the same 
procedure with Mes-Acr-4 instead of Ir-4 afforded the same product in 78% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.08 (d, J = 8.6 Hz, 2H, H6), 6.83 (d, J = 8.6 Hz, 2H, H7), 
3.79 (s, 3H, OMe), 2.56 (t, J = 7.5 Hz, 2H, H4), 2.42 (t, J = 7.5 Hz, 2H, H2), 2.11 (s, 
3H, COMe), 1.87 (p, J = 7.5 Hz, 2H, H3).13C-NMR (151 MHz, CDCl3) δ 209.0 (C1), 
158.0 (C8), 133.7 (C5), 129.5 (C6), 113.9 (C7), 55.4 (OMe), 42.9 (C2), 34.2 (C4), 30.1 
(COMe), 25.6 (C3). HRMS for [C12H17O2]+ calculated 193.1223 found 193.1228. Rf (1:4 
EtOAc/PE) = 0.38. Spectroscopic data were consistent with literature values.[287] 
4-(4-methoxyphenyl)butanal (267) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of acrolein. Purification by 
column chromatography on silica gel (10% EtOAc in hexane) afforded product 267 
(22 mg, 0.16 mmol) as colourless oil in 63% yield. 1H-NMR (400 MHz, CDCl3) δ 9.75 
(s, 1H, CHO), 7.09 (d, J = 8.2 Hz, 2H, H6), 6.83 (d, J = 8.2 Hz, 2H, H7), 3.79 (s, 3H, 
OMe), 2.60 (t, J = 7.5 Hz, 2H, H2), 2.44 (t, J = 7.5 Hz, 1H, H4), 1.93 (p, J = 7.5 Hz, 2H, 
H3). 13C-NMR (101 MHz, CDCl3) δ 202.5 (C1), 158.0 (C8), 133.3 (C5), 129.4 (C6), 113.9 
(C7), 55.3 (OMe), 43.1 (C2), 34.1 (C4), 23.9 (C3). HRMS for [C11H15O2]+ calculated 
179.1067 found 179.1060. Rf (1:4 EtOAc/PE) = 0.30. Spectroscopic data were consistent 
with literature values.[290]  
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4-(4-methoxyphenyl)butanenitrile (268) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of acrylonitrile. 
Purification by column chromatography on silica gel (10% EtOAc in hexane) afforded 
product 268 (27 mg, 0.15 mmol) as colourless oil in 77% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.10 (d, J = 8.2 Hz, 2H, H6), 6.85 (d, J = 8.2 Hz, 2H, H7), 3.79 (s, 3H, OMe), 
2.72 (t, J = 7.4 Hz, 2H, H4), 2.30 (t, J = 7.1 Hz, 2H, H2), 1.94 (p, J = 7.3 Hz, 2H, H3). 
13C-NMR (101 MHz, CDCl3) δ 158.3 (C8), 131.7 (C5), 129.4 (C6), 119.6 (C1), 114.1 
(C7), 55.3 (OMe), 33.5 (C4), 27.1 (C3), 16.3 (C2). HRMS for [C11H14NO]+ calculated 
176.1070 found 176.1077. Rf (1:4 EtOAc/PE) = 0.50. Spectroscopic data were consistent 
with literature values.[287] 
1-methoxy-4-(3-(phenylsulfonyl)propyl)benzene (269) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of acrylonitrile. 
Purification by column chromatography on silica gel (12% EtOAc in hexane) afforded 
product 269 (30 mg, 0.10 mmol) as white solid in 51% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.88 (d, J = 7.6 Hz, 2H, H9), 7.65 (t, J = 7.5 Hz, 1H, H11), 7.56 (t, J = 7.6 Hz, 
2H, H10), 7.01 (d, J = 8.1 Hz, 2H, H5), 6.80 (d, J = 8.1 Hz, 2H, H6), 3.78 (s, 3H, OMe), δ 
3.11 – 3.01 (m, 1H, H1), 2.64 (t, J = 7.5 Hz, 2H, H3), 2.01 (p, J = 7.6 Hz, 2H, H2). 13C-
NMR (101 MHz, CDCl3) δ 158.2 (C7), 139.1 (C8), 133.6 (C4), 131.8 (C11), 129.3 (C5), 
129.3 (C6), 128.0 (C19), 114.0 (C6), 55.4 (C1), 55.3 (OMe), 33.2 (C3), 24.4 (C2). HRMS 
for [C16H19O3S]+ calculated 291.1049 found 291.1044. Rf (1:4 EtOAc/PE) = 0.25. M.p. 
60–62oC. Spectroscopic data were consistent with literature values.[9] 
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methyl 4-(4-methoxyphenyl)-2-methylbutanoate (270) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of methyl methacrylate. 
Purification by column chromatography on silica gel (10% EtOAc in hexane) afforded 
product 270 (28 mg, 0.13 mmol) as colourless oil in 64% yield. 1H-NMR (600 MHz, 
CDCl3) δ 7.10 (d, J = 8.5 Hz, 2H, H7), 6.83 (d, J = 8.5 Hz, 2H, H6), 3.79 (s, 3H, OMe), 
3.68 (s, 3H, COOMe), 2.56 (t, J = 7.9 Hz, 2H, H4), 2.48 (h, J = 7.0 Hz, 1H, H2), 2.04 – 
1.94 (m, 1H, H3), 1.69 (dq, J = 14.2, 7.7 Hz, 1H, H3), 1.19 (d, J = 7.0 Hz, 3H, H7). 13C-
NMR (151 MHz, CDCl3) δ 177.0 (C1), 157.8 (C8), 133.7 (C5), 129.3 (C6), 113.8 (C7), 
55.2 (OMe), 51.5 (COMe), 38.9 (C2), 35.6 (C4), 32.5 (C3), 17.1 (C9). HRMS for 
[C13H19O3]+ calculated 223.1329 found 223.1328. Rf (1:4 EtOAc/PE) = 0.31. 
Spectroscopic data were consistent with literature values.[287] 
3-(4-methoxyphenethyl) dihydrofuran-2(3H)-one (271) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of 3-
methylenedihydrofuran-2(3H)-one. Purification by column chromatography on silica gel 
(10% EtOAc in hexane) afforded product 271 (28 mg, 0.13 mmol) as colourless oil in 
68% yield. 1H-NMR (600 MHz, CDCl3) δ 7.11 (d, J = 8.6 Hz, 2H, H7), 6.83 (d, J = 8.6 
Hz, 2H, H6), 4.33 (td, J = 8.8, 2.8 Hz, 1H, H10a), 4.15 (td, J = 9.4, 6.7 Hz, 1H, H10b), 3.78 
(s, 3H, OMe), 2.70-2.77 (m, 1H, H4a), 2.69 – 2.61 (m, 1H, H4b), 2.53 – 2.44 (m, 1H, H2), 
2.40 – 2.33 (m, 1H, H9a), 2.16-2.23 (m, 1H, H9b), 1.94 (ddd, J = 18.6, 12.5, 10.0 Hz, 1H, 
H3a), 1.72 (dtd, J = 14.6, 8.9, 5.9 Hz, 1H, H3b). 13C-NMR (151 MHz, CDCl3) δ 179.5 
(C1), 158.1 (C8), 132.8 (C5), 129.4 (C6), 114.0 (C7), 66.5 (C10), 55.3 (OMe), 38.4 (C2), 
32.5 (C4), 32.2(C3), 28.9 (C9). IR (ATR – neat) ?̃? (𝑐𝑚−1) 2914, 1763, 1611, 1510, 1374, 
1243, 1023, 824. HRMS for [C13H17O3]+ calculated 221.1172 found 221.1156. Rf (1:4 
EtOAc/PE) = 0.32. 
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2-(4-methoxybenzyl)cyclopentanone (272) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of cyclopent-2-en-1-one. 
Purification by column chromatography on silica gel (15% EtOAc in hexane) afforded 
product 272 (25 mg, 0.12 mmol) as yellowish oil in 62% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.08 (d, J = 8.2 Hz, 2H, H6), 6.84 (d, J = 8.2 Hz, 2H, H7), 3.79 (s, 3H, OMe), 
2.68 (d, J = 6.2 Hz, 2H, H4), 2.44 (sept, J = 7.3 Hz, 1H, H3), 2.31 (ddd, J = 16.6, 10.0, 6.7 
Hz, 2H, H2a, H9a), 2.21–2.00 (m, 2H, H9b, H10a), 1.90 (dd, J = 18.0, 9.7 Hz, 1H, H2b), 1.67 
– 1.54 (m, 1H, H10b).13C-NMR (101 MHz, CDCl3) δ 219.4 (C1), 158.1 (C8), 132.1 (C5), 
129.7 (C6), 113.8 (C7), 55.3 (OMe), 44.9 (C4), 40.6 (C2), 39.0 (C9), 38.3 (C3), 29.0 (C10). 
IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2920, 1691, 1603, 1460, 1116, 892, 765. HRMS for 
[C13H17O2]+ calculated 205.1223 found 205.1220. Rf (1:4 EtOAc/PE) = 0.57. 
3-(4-methoxybenzyl)cyclohexanone (273) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of cyclohex-2-en-1-one. 
Purification by column chromatography on silica gel (15% EtOAc in hexane) afforded 
product 273 (25 mg, 0.12 mmol) as yellowish oil in 58% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.04 (d, J = 8.1 Hz, 2H, H6), 6.83 (d, J = 8.1 Hz, 2H, H7), 3.79 (s, 3H, OMe), 
2.57 (d, J = 4.8 Hz, 2H, H4), 2.39-2.21 (m, 3H, H2a, H3, H9a), 2.10–1.96 (m, 3H, H2b, H9a, 
H11a), 1.92-1.81 (m, 1H, H10a), 1.63–1.54 (m, 1H, H10b), 1.40-1.30 (m,1H, H11b). 13C-
NMR (101 MHz, CDCl3) δ 211.8 (C1), 158.0 (C8), 131.5 (C5), 130.0 (C6), 113.8 (C7), 
55.3 (OMe), 47.8 (C2), 42.0 (C9), 41.4 (C4), 41.1 (C3), 30.8 (C11), 25.1 (C10). HRMS for 
[C14H19O2]+ calculated 219.1380 found 219.1375. Rf (1:4 EtOAc/PE) = 0.58. 
Spectroscopic data were consistent with literature values.[287] 
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diethyl 2-(4-methoxybenzyl)succinate (274) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of diethyl fumarate. 
Purification by column chromatography on silica gel (10% EtOAc in hexane) afforded 
product 274 (46 mg, 0.16 mmol) as yellowish oil in 78% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.08 (d, J = 8.6 Hz, 2H, H6), 6.82 (d, J = 8.6 Hz, 2H, H7), 4.12 (q, J = 7.1 Hz, 
2H, H9 or H12), 4.09 (q, J = 7.1 Hz, 2H, H12 or H9), 3.78 (s, 3H, OMe), 3.06 (dddd, J = 
9.2, 8.1, 6.5, 4.9 Hz, 1H, H2), 2.98 (dd, J = 13.6, 6.5 Hz, 1H, H4a), 2.75 – 2.59 (m, 2H, 
H4b and H2a), 2.38 (dd, J = 16.7, 5.0 Hz, 1H, H2b), 1.22 (t, J = 7.1 Hz, 3H, H10 or H13), 
1.20 (t, J = 7.1 Hz, 3H, H13 or H10). 13C-NMR (101 MHz, CDCl3) δ 174.3 (C11), 171.9 
(C1), 158.4 (C8), 130.3 (C5), 130.0 (C6), 113.9 (C7), 60.7 (C12 or C9), 60.6 (C9 or C12), 
55.3 (OMe), 43.3 (C3), 37.0 (C4), 35.2 (C2), 14.2 (C10 or C13), 14.1 (C13 or C10). HRMS 
for [C16H23O5]+ calculated 295.1540 found 295.1543. Rf (1:4 EtOAc/PE) = 0.50. 
Spectroscopic data were consistent with literature values.[292] 
4-(3-(4-methoxyphenyl)propyl)pyridine (275) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of 4-vinyl pyridine. 
Purification by column chromatography on silica gel (15% EtOAc in hexane) afforded 
product 275 (20 mg, 0.09 mmol) as colourless oil in 45% yield. 1H-NMR (600 MHz, 
CDCl3) δ 8.49 (d, J = 6.1 Hz, 2H, H10), 7.13 – 7.07 (m, 4H, H6 and H9), 6.84 (d, J = 8.6 
Hz, 2H, H7), 3.79 (s, 3H, OMe), 2.62 (t, J = 7.7 Hz, 2H, H4), 2.60 (t, J = 7.7 Hz, 2H, H2), 
1.94 (p, J = 7.7 Hz, 2H, H3). 13C-NMR (151 MHz, CDCl3) δ 157.9 (C8), 151.3 (C1), 
149.6 (C10), 133.6 (C5), 129.3 (C6), 123.9 (C9), 113.8 (C7), 55.2 (OMe), 34.5 (C2), 34.3 
(C4), 32.0 (C3). HRMS for [C15H18NO]+ calculated 228.1383 found 228.1380. Rf (1:4 
EtOAc/PE) = 0.50. Spectroscopic data were consistent with literature values.[287] 
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2-(3-(4-methoxyphenyl)propyl)pyridine (276) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of 2-vinyl pyridine. 
Purification by column chromatography on silica gel (20% EtOAc in hexane) afforded 
product 276 (35 mg, 0.15 mmol) as yellowish oil in 77% yield. 1H-NMR (400 MHz, 
CDCl3) δ 8.53 (ddd, J = 4.9, 1.7, 0.8 Hz, 1H, H12), 7.58 (td, J = 7.6, 1.9 Hz, 1H, H10), 
7.16 – 7.06 (m, 4H, H6, H9 and H11), 6.82 (d, J = 8.6 Hz, 2H, H7), 3.78 (s, 3H, OMe), 2.81 
(t, J = 7.8 Hz, 2H, H4), 2.63 (t, J = 7.5 Hz, 2H, H2), 2.03 (p, J = 7.8 Hz, 2H, H3). 13C-
NMR (101 MHz, CDCl3) δ 162.0 (C1), 157.7 (C8), 149.2 (C12), 136.3 (C10), 134.2 (C5), 
129.3 (C6), 122.8 (C9), 121.0 (C11), 113.7 (C7), 55.3 (OMe), 37.8 (C2), 34.6 (C4), 31.7 
(C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2926, 2854, 1510, 1434, 1242, 1176, 1035, 828, 748. 
HRMS for [C15H18NO]+ calculated 228.1383 found 228.1382. Rf (1:4 EtOAc/PE) = 
0.30. 
2-(3-(4-methoxyphenyl)-1-phenylpropyl)pyridine (277) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of 2-(1-phenylvinyl) 
pyridine (2o). Purification by column chromatography on silica gel (7% EtOAc in 
hexane) afforded product 277 (32 mg, 0.10 mmol) as colourless oil in 52% yield. 1H-
NMR (400 MHz, CDCl3) δ 8.57 (d, J = 4.8 Hz, 1H, H12), 7.55 (t, J = 7.7 Hz, 1H, H10), 
7.37 – 7.26 (m, 4H, H9, H11 and H15), 7.19 (t, J = 7.0 Hz, 1H, H16), 7.13 (d, J = 7.9 Hz, 
1H, H14a), 7.10 – 7.04 (m, 3H, H6 and H14b), 6.81 (d, J = 8.1 Hz, 2H, H7), 4.06 (t, J = 
7.4 Hz, 1H, H2), 3.78 (s, 3H, OMe), 2.59 – 2.49 (m, 3H, H4, H3a), 2.38 (dd, J = 11.7, 
7.5 Hz, 2H, H3b). 13C-NMR (101 MHz, CDCl3) δ 163.7 (C1), 157.7 (C8), 149.3 (C12), 
143.6 (C13), 136.4 (C10), 134.1 (C5), 129.4 (C6), 128.5 (C11), 128.1 (C15), 126.4 (C14), 
122.8 (C16), 121.3 (C9), 113.7 (C7), 55.3 (OMe), 52.9 (C2), 36.8 (C4), 33.0 (C3). IR (ATR 
– neat) ?̃? (𝑐𝑚−1) = 3003, 2929, 2833, 1610, 1568, 1431, 1242, 1176, 1033, 827, 746, 
699, 536. HRMS for [C21H22NO]+ calculated 304.1696 found 304.1694. Rf (1:4 
EtOAc/PE) = 0.80.  
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1,2,3,4,5-pentafluoro-6-(3-(4-methoxyphenyl)propyl)benzene (278) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of 1,2,3,4,5-pentafluoro-6-
vinylbenzene. Purification by column chromatography on silica gel (5% EtOAc in 
hexane) afforded product 278 (40 mg, 0.13 mmol) as colourless oil in 64% yield. 1H-
NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.6 Hz, 2H, H6), 6.83 (d, J = 8.6 Hz, 2H, H7), 
3.79 (s, 3H, OMe), 2.71 (t, J = 7.7 Hz, 2H, H2), 2.61 (t, J = 7.8 Hz, 2H, H4), 1.88 (p, J = 
7.7 Hz, 2H, H3). 13C-NMR (101 MHz, CDCl3) δ 157.9 (C8), 144.9 (dd, J = 247, 12 Hz, 
C9), 139.4 (d, J = 249 Hz, C11), 137.4 (dt, J = 249, 15 Hz, C10), 133.2 (C5), 129.2 (C6), 
115.2 (t, J = 19 Hz, C1), 113.8 (C7), 55.2 (OMe), 34.5 (C4), 30.9 (C3), 22.0 (C2). HRMS 
for [C16H14F5O]+ calculated 317.0959 found 317.0962. Rf (1:4 EtOAc/PE) = 0.20. 
Spectroscopic data were consistent with literature values.[293] 
3-(4-methoxybenzyl) chroman-4-one (279) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.4 mmol of 4H-chromen-4-one. 
Purification by column chromatography on silica gel (10% EtOAc in hexane) afforded 
product 279 (17 mg, 0.064 mmol) as yellowish oil in 32% yield. 1H-NMR (400 MHz, 
CDCl3) δ 7.86 (dd, J = 7.8, 1.8 Hz, 1H, H9), 7.47 (ddd, J = 8.6, 7.2, 1.8 Hz, 1H, H11), 
7.17 (d, J = 8.6 Hz, 2H, H5), 7.03 – 6.96 (m, 2H, H10 and H12), 6.87 (d, J = 8.6 Hz, 2H, 
H6), 4.68 – 4.59 (m, 1H, H14), 3.80 (s, 3H, OMe), 3.15 (dd, J = 14.1, 6.2 Hz, 1H, H3a), 
2.99 (dd, J = 14.1, 6.5 Hz, 1H, H2a), 2.70 – 2.62 (m, 2H, H2b and H3b). 13C-NMR 
(101 MHz, CDCl3) δ 192.4 (C1), 161.5 (C13), 158.6 (C7), 136.0 (C11), 130.6 (C4), 128.1 
(C9), 126.9 (C8), 121.3 (C10), 118.0 (C12), 114.0 (C6), 78.5 (C14), 55.3 (OMe), 42.1 (C2), 
40.3 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2909, 1736, 1651, 1507, 1132, 1100, 981, 699. 
HRMS for [C17H17O3]+ calculated 269.1172 found 269.1175. Rf (1:4 EtOAc/PE) = 0.50.  
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3-(4-methoxybenzyl)-2-phenylchroman-4-one (280) 
 
Obtained following GP(VI) at 0.2 mmol scale using 0.8 mmol of 3-phenyl-4H-chromen-
4-one. Purification by column chromatography on silica gel (10% EtOAc in hexane) 
afforded product 280 (17 mg, 0.064 mmol) as yellowish oil in 22% yield. 1H-NMR (400 
MHz, CDCl3) δ 7.69 (d, J = 7.8 Hz, 1H, H9), 7.45 (t, J = 7.8 Hz, 1H, H11), 7.31-7.26 (m, 
2H, H16), 7.26 – 7.15 (m, 3H, H17 and H18), 7.09 (d, J = 8.3 Hz, 1H, H10), 6.90 (d, J = 8.2 
Hz, 3H, H5 and H12), 6.75 (d, J = 8.2 Hz, 2H, H6), 3.77 (s, 3H, OMe), 3.31 (d, J = 14.1 
Hz, 1H, H3a), 3.23 (d, J = 16.5 Hz, 1H, H2a), 3.11 (d, J = 14.1 Hz, 1H, H3b), 3.08 (d, J = 
16.5 Hz, 1H, H2b). 13C-NMR (101 MHz, CDCl3) δ 191.8 (C1), 159.9 (C13), 158.6 (C7), 
141.1 (C15), 136.1 (C4), 131.8 (C5), 128.4 (C11), 127.7 (C17), 127.2 (C16), 126.5 (C9), 
126.2 (C18), 121.4 (C8), 121.0 (C10), 118.3 (C12), 113.4 (C6), 85.0 (C14), 55.2 (OMe), 48.7 
(C2), 45.2 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2914, 1687, 1605, 1459, 1302, 1176, 1030, 
734, 696. HRMS for [C23H21O3]+ calculated 345.1485 found 345.1480. Rf (1:4 
EtOAc/PE) = 0.54. 
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5.3.2.2 Scope of  boronic esters 
 
GP(VII): A 5 mL glass vial equipped with a magnetic stir bar was charged with the 
desired boronic ester (0.20 mmol, 1.0 equiv.), the photoredox catalyst 
[Ir(dF(CF3)ppy)2(bpy)]PF6 (Ir-4, 4.0 mg, 2 mol%) and the Lewis base catalyst (LB, 0.04 
mmol, 20 mol%). The vial was then sealed with a rubber septum and evacuated/backfilled 
with argon three times. Methyl vinyl ketone (66 µL, 0.8 mmol, 4.0 equiv.) was then 
added followed by 2.0 mL of a degassed acetone/methanol (1:1) mixture to lead a clear 
yellow transparent 0.1 M solution. This solution was then stirred while irradiated with a 
commercial blue LED strip (Ledxon, 14.4 W, 470 nm) for 24 hours, the temperature was 
maintained at 30°C using a desktop fan. The content of the vial was then concentrated in 
vacuo and immobilised on ISOLUTE® HM-N for easy dry loading on flash column 
chromatography to yield the pure product. 
5-phenylpentan-2-one (285) 
 
Obtained following GP(VII) using 2-benzyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(44 mg, 0.20 mmol) and quinuclidin-3-ol (5.0 mg, 40 µmol, 20 mol%) as Lewis base 
catalyst. Purification by column chromatography on silica gel (0% to 5% EtOAc in 
hexane) afforded product 285 (21 mg, 0.13 mmol) as a colourless oil in 65% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.29 (t, J = 7.6 Hz, 2H, H7), 7.22 – 7.15 (m, 3H, H6, H8), 
2.62 (t, J = 7.5 Hz, 2H, H4), 2.44 (t, J = 7.5 Hz, 2H, H2), 2.12 (s, 3H, H9), 1.91 (p, 
J = 7.5 Hz, 2H, H3). 13C-NMR (151 MHz, CDCl3) δ 208.9 (C1), 141.7 (C5), 128.6 (C8), 
128.5 (C7), 126.1 (C6), 43.0 (C2), 35.2 (C4), 30.1 (C9), 25.3 (C3). HRMS for [C11H15O]+ 
calculated 163.1117 found 163.1121. Rf (1:4 EtOAc/PE) = 0.54. Spectroscopic data were 
consistent with literature values.[294] 
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5-(p-tolyl)pentan-2-one (286) 
 
Obtained following GP(VII) using 4,4,5,5-tetramethyl-2-(4-methylbenzyl)-1,3,2-
dioxaborolane (46 mg, 0.20 mmol) and quinuclidin-3-ol (5.0 mg, 40 µmol, 20 mol%) as 
Lewis base catalyst. Purification by column chromatography on silica gel (0% to 5% 
EtOAc in hexane) afforded product 286 (23 mg, 0.13 mmol) as a colourless oil in 66% 
yield. 1H-NMR (600 MHz, CDCl3) δ 7.10 (d, J = 7.9 Hz, 2H, H7), 7.06 (d, 
J = 7.9 Hz, 2H, H6), 2.59 (t, J = 7.5 Hz, 2H, H4), 2.43 (t, J = 7.5 Hz, 2H, H2), 2.32 (s, 3H, 
H9), 2.12 (s, 3H, H10), 1.89 (p, J = 7.5 Hz, 2H, H3).13C-NMR (151 MHz, CDCl3) δ 
209.0 (C1), 138.6 (C5), 135.5 (C8), 129.2 (C7), 128.5 (C6), 43.0 (C2), 34.7 (C4), 30.1 (C10), 
25.4 (C3), 21.1 (C9). HRMS for [C12H17O]+ calculated 177.1274 found 177.1278. Rf (1:4 
EtOAc/PE) = 0.56. Spectroscopic data were consistent with literature values.[295] 
5-(4-fluorophenyl)pentan-2-one (287) 
 
Obtained following GP(VII) using 2-(4-fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (47 mg, 0.20 mmol) and quinuclidin-3-ol (5.0 mg, 40 µmol, 20 mol%) as 
Lewis base catalyst. Purification by column chromatography on silica gel (0% to 5% 
EtOAc in hexane) afforded product 287 (28 mg, 0.15 mmol) as a colourless oil in 71% 
yield. 1H-NMR (600 MHz, CDCl3) δ 7.12 (m, 2H, H6), 6.96 (m, 2H, H7), 2.59 (t, 
J = 7.5 Hz, 2H, H4), 2.42 (t, J = 7.5 Hz, 2H, H2), 2.12 (s, 3H, H9), 1.88 
(p, J = 7.5 Hz, 2H, H3).13C-NMR (151 MHz, CDCl3) δ 208.7 (C1), 161.5 
(d, J = 244 Hz, C8), 137.3 (d, J = 3.3 Hz, C5), 129.9 (d, J = 7.8 Hz, C6), 115.3 
(d, J = 21 Hz, C7), 42.8 (C2), 34.3 (C4), 30.1 (C9), 25.4 (C3). 19F-NMR (376 MHz, 
CDCl3) δ -117.6. HRMS for [C11H14OF]+ calculated 181.1023 found 181.1022. Rf (1:4 
EtOAc/PE) = 0.41. Spectroscopic data were consistent with literature values.[296] 
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5-(3,5-dimethoxyphenyl)pentan-2-one (288) 
 
Obtained following GP(VII) using 2-(3,5-dimethoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (56 mg, 0.20 mmol) and quinuclidin-3-ol (5.0 mg, 40 µmol, 20 mol%) as 
Lewis base catalyst. Purification by column chromatography on silica gel (5% to 10% 
EtOAc in hexane) afforded product 288 (36 mg, 0.13 mmol) as a colourless oil in 63% 
yield. 1H-NMR (600 MHz, CDCl3) δ 6.32 (d, J = 2.3 Hz, 2H, H6), 6.30 (t, J = 2.3 Hz, 
1H, H8), 3.77 (s, 6H, H9), 2.56 (t, J = 7.4 Hz, 2H, H4), 2.43 (t, J = 7.4 Hz, 2H, H2), 2.11 
(s, 3H, H10), 1.89 (p, J = 7.4 Hz, 2H, H3). 13C-NMR (151 MHz, CDCl3) δ 208.9 (C1), 
160.9 (C7), 144.1 (C5), 106.6 (C6), 98.0 (C8), 55.4 (C9), 42.9 (C2), 35.4 (C4), 30.1 (C10), 
25.0 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3002, 2925, 1713, 1594, 1460, 1428, 1354, 1203, 
1147, 1056, 830, 695. HRMS for [C13H19O3]+ calculated 223.1329 found 223.1328. Rf 
(1:4 EtOAc/PE) = 0.28. 
5-(phenylthio)pentan-2-one (289) 
 
Obtained following GP(VII) using 4,4,5,5-tetramethyl-2-((phenylthio)methyl)-1,3,2-
dioxaborolane (50 mg, 0.20 mmol) and quinuclidin-3-ol (5.0 mg, 40 µmol, 20 mol%) as 
Lewis base catalyst. Purification by column chromatography on silica gel (5% to 7% 
EtOAc in hexane) afforded product 289 (35 mg, 0.18 mmol) as a colourless oil in 91% 
yield. Repeating the same procedure with Mes-Acr-4 instead of Ir-4 afforded the same 
product in 80% yield. 1H-NMR (600 MHz, CDCl3) δ 7.35 – 7.31 (m, 2H, H6), 7.30 – 
7.26 (m, 2H, H7), 7.20 – 7.14 (m, 1H, H8), 2.94 (t, J = 7.0 Hz, 2H, H4), 2.60 (t, J = 
7.0 Hz, 2H, H2), 2.12 (s, 3H, H9), 1.90 (p, J = 7.0 Hz, 2H, H3). 13C-NMR (151 MHz, 
CDCl3) δ 208.1 (C1), 136.2 (C5), 129.3 (C6), 129.0 (C7), 126.1 (C8), 42.0 (C2), 33.1 (C4), 
30.1 (C9), 23.1 (C3). HRMS for [C11H15OS]+ calculated 195.0844 found 195.0838. Rf 
(1:4 EtOAc/PE) = 0.43. Spectroscopic data were consistent with literature values.[297] 
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tert-butyl (4-oxopentyl)carbamate (290) 
 
Obtained following GP(VII) using tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)carbamate (51 mg, 0.20 mmol, 1.0 equiv.) and PPh3 (10 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(10% to 60% EtOAc and 1% Et3N in hexane) afforded product 290 (37 mg, 0.19 mmol) 
as a colourless oil in 91% yield. 1H-NMR (600 MHz, CDCl3) δ 4.60 (s, 1H, NH), 3.13 
(m, 2H, H4), 2.49 (t, J = 7.1 Hz, 2H, H2), 2.16 (s, 3H, H8), 1.76 (p, J = 7.1 Hz, 2H, H3), 
1.44 (s, 9H, H7). 13C-NMR (151 MHz, CDCl3) δ 208.6 (C1), 156.2 (C5), 79.4 (C6), 
40.9 (C2), 40.1 (C4), 30.1 (C8), 28.6 (C7), 24.2 (C3). HRMS for [C10H19O3NNa]+ 
calculated 224.1257 found 224.1258. Rf (1:1 EtOAc/PE) = 0.50. Spectroscopic data were 
consistent with literature values.[95] 
tert-butyl methyl(4-oxopentyl)carbamate (291) 
 
Obtained following GP(VII) using tert-butyl methyl((4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methyl)carbamate (54 mg, 0.20 mmol) and PPh3 (10 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(10% EtOAc and 1% Et3N in hexane) afforded product 291 (35 mg, 0.16 mmol) as a 
colourless oil in 86% yield. 1H-NMR (600 MHz, CDCl3) δ 3.19 (t, J = 7.1 Hz, 2H, H4), 
2.80 (s, 3H, H8), 2.41 (t, J = 7.1 Hz, 2H, H2), 2.12 (s, 3H, H9), 1.75 (p, J = 7.1 Hz, 2H, 
H3), 1.43 (s, 9H, H7). 13C-NMR (151 MHz, CDCl3) δ 208.2 (C1), 156.0 (C5), 79.4 (C6) 
47.9 (C4), 40.5 (C2), 34.1 (C8), 30.1 (C9), 28.6 (C7), 21.8 (C3). HRMS for [C11H21O3N]+ 
calculated 215.1521 found 215.1519. Rf (1:4 EtOAc/PE) = 0.32. Spectroscopic data were 
consistent with literature values.[298] 
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5-phenylhexan-2-one (292) 
 
Obtained following GP(VII) using 4,4,5,5-tetramethyl-2-(1-phenylethyl)-1,3,2-
dioxaborolane (46 mg, 0.20 mmol) and DMAP (4.8 mg, 40 µmol, 20 mol%) as Lewis 
base catalyst. Purification by column chromatography on silica gel (0% to 5% EtOAc in 
hexane) afforded product 292 (24 mg, 0.13 mmol) as a colourless oil in 67% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.30 (t, J = 7.6 Hz, 2H, H7), 7.23 – 7.18 (m, 1H, H8), 7.18 – 
7.14 (m, 2H, H6), 2.74 – 2.64 (m, 1H, H4), 2.40 – 2.23 (m, 2H, H2), 2.05 (s, 3H, H9), 1.91 
(ddd, J = 13.8, 9.3, 6.0 Hz, 1H, H3a), 1.86 – 1.78 (m, 1H, H3b), 1.26 (d, J = 6.9 Hz, 
3H, H10). 13C-NMR (151 MHz, CDCl3) δ 209.1 (C1), 146.6 (C5), 128.6 (C7), 127.1 (C6), 
126.3 (C8), 42.0 (C2), 39.5 (C4), 32.0 (C3), 30.1 (C9), 22.6 (C10). HRMS for [C12H17O]+ 
calculated 177.1274 found 177.1276. Rf (1:4 EtOAc/PE) = 0.64. Spectroscopic data were 
consistent with literature values.[299]  
5-(p-tolyl)hexan-2-one (293) 
 
Obtained following GP(VII) using 4,4,5,5-tetramethyl-2-(1-(p-tolyl)ethyl)-1,3,2-
dioxaborolane (50 mg, 0.20 mmol) and DMAP (4.8 mg, 40 µmol, 20 mol%) as Lewis 
base catalyst. Purification by column chromatography on silica gel (0% to 5% EtOAc in 
hexane) afforded product 293 (28 mg, 0.15 mmol) as a colourless oil in 74% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.11 (d, J = 8.0 Hz, 2H, H7), 7.06 (d, J = 8.0 Hz, 2H, H6), 
2.69 – 2.61 (m, 1H, H4), 2.36 – 2.23 (m, 5H, H2 and  H9), 2.06 (s, 3H, H11), 1.89 (m, 
1H, H3a), 1.84 – 1.76 (m, 1H, H3b), 1.25 (d, J = 6.9 Hz, 3H, H10). 13C-NMR (151 MHz, 
CDCl3) δ 209.1 (C1), 143.5 (C5), 135.7 (C8), 129.3 (C7), 127.0 (C6), 42.0 (C2), 39.1 (C4), 
32.0 (C3), 30.1 (C11), 22.7 (C10), 21.1 (C9). HRMS for [C13H19O]+ calculated 191.1430 
found 191.1429. Rf (1:4 EtOAc/PE) = 0.49. Spectroscopic data were consistent with 
literature values.[300] 
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5,6-diphenylhexan-2-one (294) 
 
Obtained following GP(VII) using 2-(1,2-diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (62 mg, 0.20 mmol) and DMAP (4.8 mg, 40 µmol, 20 mol%) as Lewis 
base catalyst. Purification by column chromatography on silica gel (0% to 5% EtOAc in 
hexane) afforded product 294 (27 mg, 0.11 mmol) as a colourless oil in 55% yield. 1H-
NMR (600 MHz, CDCl3) δ 7.30 – 7.24 (m, 2H, H12), 7.22 – 7.17 (m, 3H, H6, H8), 7.16 – 
7.12 (m, 1H, H13), 7.11 – 7.08 (m, 2H, H7), 7.05 – 7.02 (m, 2H, H11), 2.95 – 2.84 (m, 
2H, H9), 2.79 (m, 1H, H4), 2.30 – 2.16 (m, 2H, H2), 2.06 – 1.97 (m, 4H, H14 and H3a), 
1.85 (dddd, J = 14.2, 10.7, 8.9, 5.8 Hz, 1H, H3b). 13C-NMR (151 MHz, CDCl3) δ 
208.9 (C1), 144.2 (C10), 140.4 (C5), 129.2 (C11), 128.6 (C12), 128.2 (C6), 127.9 (C7), 126.5 
(C8), 126.0 (C13), 47.4 (C4), 44.1 (C9), 41.9 (C2), 30.0 (C14), 29.3 (C3). IR (ATR – neat) 
?̃? (𝑐𝑚−1) = 3002, 2923, 1713, 1495, 1452, 1358, 1158, 758, 698. HRMS for [C18H21O]+ 
calculated 253.1587 found 253.1586. Rf (1:4 EtOAc/PE) = 0.58. 
4-(1-(4-chlorophenyl)cyclobutyl)butan-2-one (297) 
 
Obtained following GP(VII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (2% EtOAc in hexane) afforded product 297 (32 mg, 
0.13 mmol) as a colourless oil in 66% yield. 1H-NMR (600 MHz, CDCl3) δ 7.26 (d, J = 
7.9 Hz, 2H, H9), 7.03 (d, J = 8.1 Hz, 2H, H8), 2.36 – 2.26 (m, 2H, H5a), 2.18 – 2.03 (m, 
7H, H5b, H6b, H3 and H2), 2.03 (s, 3H, H11), 1.89 – 1.79 (m, 1H, H6a). 13C-NMR 
(151 MHz, CDCl3) δ 208.8 (C1), 147.8 (C7), 131.2 (C10), 128.2 (C9), 127.1 (C8), 45.3 
(C4), 39.2 (C2), 35.7 (C3), 32.5 (C5), 29.9 (C11), 15.8 (C6). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 
2976, 2952, 2853, 1715, 1491, 1364, 1245, 1161, 1092, 1013, 828, 721. HRMS for 
[C14H18OCl]+ calculated 237.1046 found 237.1037. Rf (1:4 EtOAc/PE) = 0.47.  
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4-(4-(4-chlorophenyl)tetrahydro-2H-pyran-4-yl)butan-2-one (298) 
 
Obtained following GP(VII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (10% EtOAc in hexane) afforded product 298 (27 mg, 0.10 
mmol) as a colourless oil in 51% yield. 1H-NMR (600 MHz, CDCl3) δ 7.33 (d, J = 8.6 
Hz, 2H, H9), 7.19 (d, J = 8.6 Hz, 2H, H8), 3.80 – 3.76 (m, 2H, H6a), 3.55 – 3.51 (m, 2H, 
H6b), 2.10 – 2.03 (m, 4H, H2 and H5a), 2.00 (s, 3H, H11), 1.91 – 1.87 (m, 2H, H3), 1.83 – 
1.78 (m, 2H, H5b). 13C-NMR (151 MHz, CDCl3) δ 208.2 (C1), 143.2 (C7), 132.0 (C10), 
128.7 (C9), 128.2 (C8), 64.1 (C6), 38.4 (C2), 37.8 (C3), 36.2 (C4), 36.1 (C5), 29.9 (C11). IR 
(ATR – neat) ?̃? (𝑐𝑚−1) = 2948, 2857, 1714, 1494, 1360, 1241, 1114, 1094, 1012, 824. 
HRMS for [C15H20O2Cl]+ calculated 267.1152 found 267.1149. Rf (1:4 EtOAc/PE) = 
0.14. 
5,5-dimethylhexan-2-one (299) 
 
Obtained following GP(VII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (5% Et2O in pentane) afforded product 299 (11 mg, 
0.09 mmol) as a colourless oil in 45% yield. Repeating the same procedure with Mes-
Acr-4 instead of Ir-4 afforded the same product in 35% yield. 1H-NMR (600 MHz, 
CDCl3) δ 2.42 – 2.36 (m, 2H, H3), 2.15 (s, 3H, H6), 1.50 – 1.45 (m, 2H, H2), 0.88 (s, 9H, 
H5). NMR (151 MHz, CDCl3) δ 209.8 (C1), 39.7 (C2), 37.5 (C3), 30.1 (C4), 30.0 (C6), 
29.3 (C5). HRMS for [C8H17O]+ calculated 129.1274 found 129.1269. Rf (1:4 
EtOAc/PE) = 0.66. Spectroscopic data were consistent with literature values.[301] 
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5.3.2.3 Scope of  boronic acids 
 
GP(VIII): A 5 mL glass vial equipped with a magnetic stir bar was charged with the 
desired boronic acid (0.20 mmol, 1.0 equiv.), the photoredox catalyst 
[Ir(dF(CF3)ppy)2(bpy)]PF6 (Ir-4, 2.0 mg, 2.0 mol%) and the Lewis base catalyst 
(0.04 mmol, 20 mol%). The vial was then sealed with a rubber septum and 
evacuated/backfilled with argon three times. Methyl vinyl ketone (66 µL, 0.8 mmol, 
4.0 equiv.) was then added followed by 2.0 mL of a degassed acetone/methanol (1:1) 
mixture to lead a clear yellow transparent 0.1 M solution. This solution was then stirred 
while irradiated with a commercial blue LED strip (Ledxon, 14.4 W, 470 nm) for 24 
hours, the temperature was maintained at 30°C using a desktop fan. The content of the 
vial was then concentrated in vacuo and immobilised on ISOLUTE® HM-N for easy dry 
loading on flash column chromatography to yield the pure product. 
4-(4-methoxyphenyl)butan-2-one (308) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(3% EtOAc in hexane) afforded product 308 (21 mg, 0.12 mmol) as a colourless oil in 
60% yield. 1H-NMR (600 MHz, CDCl3) δ 7.10 (d, J = 8.6 Hz, 2H, H5), 6.82 (d, J = 
8.6 Hz, 2H, H6), 3.78 (s, 3H, H8), 2.83 (t, J = 7.6 Hz, 2H, H3), 2.72 (t, J = 7.6 Hz, 2H, 
H2), 2.13 (s, 3H, H9). 13C-NMR (151 MHz, CDCl3) δ 208.2 (C9), 158.1 (C7), 133.1 (C4), 
129.3 (C5), 114.0 (C6), 55.4 (C8), 45.6 (C2), 30.2 (C3), 29.0 (C9). IR (ATR – neat) 
?̃? (𝑐𝑚−1) = 3004, 2921, 2833, 1713, 1611, 1510, 1362, 1300, 1241, 1179, 1157, 1033, 
820. HRMS for [C11H14O2]+ calculated 178.0994 found 178.0987. Rf (1:4 EtOAc/PE) = 
0.25. 
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4-(4-(methylthio)phenyl)butan-2-one (309) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(3% EtOAc in hexane) afforded product 309 (28 mg, 0.144 mmol) as a pinkish oil in 72% 
yield. 1H-NMR (600 MHz, CDCl3) δ 7.16 (d, J = 8.3 Hz, 2H, H6), 7.08 (d, J = 8.2 Hz, 
2H, H5), 2.82 (d, J = 7.6 Hz, 2H, H3), 2.71 (t, J = 7.6 Hz, 2H, H2), 2.43 (s, 3H, H8), 2.11 
(s, 3H, H9). 13C-NMR (151 MHz, CDCl3) δ 207.7 (C1), 138.0 (C4), 135.7 (C7), 128.8 
(C5), 127.1 (C6), 45.0 (C2), 30.0 (C3), 29.1 (C9), 16.1 (C8). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 
2988, 2921, 1715, 1495, 1439, 1407, 1360, 1161, 1096, 1017, 967, 807. HRMS for 
[C11H14O2]+ calculated 194.0765 found 194.0761. Rf (1:4 EtOAc/PE) = 0.34. 
tert-butyl (4-(3-oxobutyl)phenyl)carbamate (310) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(15% EtOAc in hexane) afforded product 310 (35 mg, 0.13 mmol) as white needles in 
67% yield. 1H-NMR (600 MHz, CDCl3) δ 7.26 (d, J = 8.2 Hz, 2H, H6), 7.08 (d, J = 8.2 
Hz, 2H, H5), 6.55 (bs, 1H, NHBoc), 2.82 (t, J = 7.6 Hz, 2H, H3), 2.71 (t, J = 7.6 Hz, 2H, 
H2), 2.11 (s, 3H, H8), 1.50 (s, 9H, NHCOOtBu).13C-NMR (151 MHz, CDCl3) δ 208.2 
(C1), 153.0 (NHCOOtBu), 136.6 (C7), 135.7 (C4), 128.9 (C5), 118.9 (C6), 80.5 
(NHCOOC(CH3)3), 45.3 (C2), 30.2 (C3), 29.2 (C8), 28.4 (NHCOOC(CH3)3). IR (ATR – 
neat) ?̃? (𝑐𝑚−1) = 3675, 3333, 2972, 2925, 1709, 1598, 1526, 1413, 1366, 1314, 1235, 
1157, 1056, 819, 773. HRMS for [C15H21NO3]+ calculated 263.1521 found 263.1511. Rf 
(2:3 EtOAc/PE) = 0.48. M.p. = 96–98°C 
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N-(4-(3-oxobutyl)phenyl)acetamide (311) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(60% EtOAc in hexane) afforded product 311 (32 mg, 0.16 mmol) as white needles in 
78% yield. 1H-NMR (600 MHz, CDCl3) δ 7.63 (bs, 1H, NHAc), 7.39 (d, J = 8.5 Hz, 2H, 
H6), 7.10 (d, J = 8.4 Hz, 2H, H5), 2.84 (t, J = 7.5 Hz, 2H, H2), 2.72 (t, J = 7.5 Hz, 2H, 
H3), 2.13 (s, 3H, H8), 2.12 (s, 3H, NHCOMe). 13C-NMR (151 MHz, CDCl3) 208.3 (C1), 
168.6 (NHCOMe), 137.0 (C7), 136.2 (C4), 128.9 (C5), 120.3 (C6), 45.2 (C2), 30.2 (C3), 
29.2 (C8), 24.6 (NHCOMe). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3294, 3123, 3060, 2937, 1711, 
1665, 1606, 1534, 1514, 1411, 1370, 1316, 1263, 1161, 819. HRMS for [C12H15NO2]+ 
calculated 205.1103 found 205.1099. Rf (EtOAc) = 0.33. M.p. = 104–106°C. 
N-(3-(3-oxobutyl)phenyl)acetamide (312) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(40% EtOAc in hexane) afforded product 312 (34 mg, 0.17 mmol) as a colourless oil in 
83% yield. 1H-NMR (600 MHz, CDCl3) δ 7.38 (br s, 1H, NHAc), 7.36 – 7.27 (m, 2H, H5 
and H7), 7.21 (t, J = 7.8 Hz, 1H, H8), 6.92 (d, J = 7.6 Hz, 1H, H9), 2.87 (t, J = 7.5 Hz, 
2H, H3), 2.75 (t, J = 7.5 Hz, 2H, H2), 2.16 (s, 3H, H11), 2.13 (s, 3H, H10). 13C-NMR 
(151 MHz, CDCl3) δ 208.3 (C1), 168.6 (NHCOMe), 142.1 (C4), 138.1 (C6), 129.2 (C8), 
124.4 (C9), 119.8 (C5), 117.7 (C7), 45.1 (C2), 30.3 (C3), 29.7 (C10), 24.8 (NHCOMe). IR 
(ATR – neat) ?̃? (𝑐𝑚−1) = 3298, 2964, 2929, 1713, 1669, 1611, 1594, 1552, 1491, 1437, 
1421, 1372, 1314, 1262, 1161, 789, 698. HRMS for [C12H15NO2]+ calculated 205.1103 
found 205.1097. Rf (Et2O) = 0.40. 
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4-(2-methoxyphenyl)butan-2-one (313) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(5% EtOAc in hexane) afforded product 313 (18 mg, 0.10 mmol) as a colourless oil in 
51% yield. 1H-NMR (600 MHz, CDCl3) δ 7.19 (t, J = 7.8 Hz, 1H, H7), 7.13 (d, J = 7.4 
Hz, 1H, H9), 6.87 (t, J = 7.4 Hz, 1H, H8), 6.84 (d, J = 7.8 Hz, 1H, H6), 3.82 (s, 3H, OMe), 
2.88 (t, J = 7.7 Hz, 2H, H3), 2.72 (t, J = 7.7 Hz, 2H, H2), 2.14 (s, 3H, H10).13C-NMR 
(151 MHz, CDCl3) δ 208.8 (C1), 157.5 (C5), 130.0 (C9), 129.4 (C4), 127.6 (C7), 120.6 
(C8), 110.3 (C6), 55.3 (OMe), 43.8 (C2), 30.0 (C10), 25.1 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) 
= 3004, 2956, 2933, 2837, 1713, 1602, 1588, 1494, 1465, 1441, 1358, 1241, 1161, 1116, 
1035, 753. HRMS for [C11H14O2]+ calculated 178.0994 found 178.0988. Rf (1:4 
EtOAc/PE) = 0.36. 
4-(2-(methylthio)phenyl)butan-2-one (314) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(3% EtOAc in hexane) afforded product 314 (23 mg, 0.12 mmol) as a colourless oil in 
60% yield. 1H-NMR (600 MHz, CDCl3) δ 7.24 – 7.18 (m, 2H, H6 and H7), 7.15 (d, J = 
8.0 Hz, 1H, H9), 7.09 (ddd, J = 8.0, 6.0, 2.6 Hz, 1H; H8), 2.99 (dd, J = 8.6, 6.9 Hz, 2H, 
H3), 2.78 (dd, J = 8.5, 7.0 Hz, 2H, H2), 2.47 (s, 3H, SMe), 2.16 (s, 3H, H10). 13C-NMR 
(151 MHz, CDCl3) δ 208.0 (C1), 138.7 (C5), 137.1 (C4), 129.2 (C9), 127.0 (C6), 125.6 
(C7), 125.1 (C8), 43.5 (C2), 29.9 (C3), 27.9 (C10), 15.7 (SMe). IR (ATR – neat) ?̃? (𝑐𝑚−1) 
= 3060, 2921, 1715, 1590, 1471, 1439, 1358, 1286, 1159, 1068, 967, 957, 747. HRMS 
for [C11H15OS]+ calculated 195.0844 found 195.0838. Rf (1:4 EtOAc/PE) = 0.40. 
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4-(benzo[d][1,3]dioxol-5-yl)butan-2-one (315) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(5% EtOAc in hexane) afforded product 315 (18 mg, 0.092 mmol) as an amorphous solid 
in 46% yield. Repeating the same procedure with Mes-Acr-4 instead of Ir-4 afforded the 
same product in 70% yield. 1H-NMR (600 MHz, CDCl3) δ 6.71 (d, J = 7.9 Hz, 1H, H9), 
6.66 (d, J = 1.7 Hz, 1H, H5), 6.61 (dd, J = 8.0, 1.7 Hz, 1H, H10), 5.90 (s, 2H, H7), 2.80 (t, 
J = 7.6 Hz, 2H, H3), 2.70 (t, J = 7.6 Hz, 2H, H2), 2.12 (s, 3H, H11). 13C-NMR (151 MHz, 
CDCl3) δ 208.0 (C1), 147.7 (C6), 145.9 (C8), 134.9 (C4), 121.1 (C10), 108.9 (C5), 108.3 
(C9), 100.9 (C7), 45.5 (C2), 30.2 (C3), 29.6 (C11). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2921, 
2897, 2782, 1713, 1504, 1489, 1443, 1360, 1245, 1187, 1159, 1096, 1035, 922, 803, 773. 
HRMS for [C11H12O3]+ calculated 192.0786 found 192.0782. Rf (1:4 EtOAc/PE) = 0.27. 
4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)butan-2-one (316) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(5% EtOAc in hexane) afforded product 316 (27 mg, 0.13 mmol) as an amorphous solid 
in 65% yield. 1H-NMR (600 MHz, CDCl3) δ 6.76 (d, J = 8.0 Hz, 1H, H9), 6.68 (d, J = 
2.1 Hz, 1H, H5), 6.64 (dd, J = 8.2, 2.2 Hz, 1H, H10), 4.26 – 4.17 (m, 4H, H7 and H7’), 2.78 
(t, J = 7.5 Hz, 2H, H3), 2.70 (t, J = 7.5 Hz, 2H, H2), 2.13 (s, 3H, H11). 13C-NMR 
(151 MHz, CDCl3) δ 208.1 (C1), 143.4 (C6), 141.9 (C8), 134.3 (C4), 121.3 (C10), 117.3 
(C9), 117.0 (C5), 64.5 (C7 or C7’), 64.4 (C7 or C7’), 45.4 (C2), 30.2 (C3), 29.1 (C11). IR 
(ATR – neat) ?̃? (𝑐𝑚−1) = 2976, 2925, 2873, 1715, 1590, 1508, 1431, 1364, 1308, 1282, 
1259, 1205, 1161, 1126, 1066, 1050, 918, 888, 807. HRMS for [C12H14O3]+ calculated 
206.0942 found 206.0934. Rf (1:4 EtOAc/PE) = 0.24. 
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4-(1H-indol-5-yl)butan-2-one (317) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(15% EtOAc in hexane) afforded product 317 (18 mg, 0.096 mmol) as a colourless oil in 
48% yield. 1H-NMR (600 MHz, CDCl3) δ 8.18 (bs, 1H, NH), 7.45 (s, 1H, H5), 7.31 (d, J 
= 8.3 Hz, 1H, H10), 7.18 (t, J = 2.8 Hz, 1H, H8), 7.03 (dd, J = 8.3, 1.7 Hz, 1H; H11), 6.50 
(ddd, J = 3.1, 2.0, 0.9 Hz, 1H, H7), 3.01 (t, J = 7.7 Hz, 2H, H3), 2.81 (t, J = 7.7 Hz, 2H, 
H2), 2.15 (s, 3H, H12). 13C-NMR (151 MHz, CDCl3) δ 208.9 (C1), 134.6 (C9), 132.4 (C4), 
128.2 (C6), 124.6 (C8), 122.8 (C11), 119.9 (C5), 111.1 (C10), 102.3 (C7), 46.3 (C2), 30.3 
(C12), 30.1 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3675, 3400, 2996, 2972, 1707, 1479, 1413, 
1362, 1221, 1161, 1066, 729. HRMS for [C12H13NO]+ calculated 187.0997 found 
187.0992. Rf (2:3 EtOAc/PE) = 0.52. 
4-(1H-indol-6-yl)butan-2-one (318) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(15% EtOAc in hexane) afforded product 318 (20 mg, 0.11 mmol) as a colourless oil in 
55% yield. 1H-NMR (600 MHz, CDCl3) δ 8.23 (bs, 1H, NH), 7.57 (d, J = 8.1 Hz, 1H, 
H10), 7.20 (dt, J = 1.6, 0.8 Hz, 1H, H5), 7.14 (dd, J = 3.2, 2.4 Hz, 1H, H7), 6.97 (dd, J = 
8.1, 1.5 Hz, 1H, H11), 6.52 (ddd, J = 3.1, 2.0, 1.0 Hz, 1H, H8), 3.02 (t, J = 7.7 Hz, 2H, 
H3), 2.82 (t, J = 7.7 Hz, 2H, H2), 2.14 (s, 3H, H12). 13C-NMR (151 MHz, CDCl3) δ 208.8 
(C1), 136.2 (C6), 134.9 (C4), 126.3 (C9), 124.1 (C7), 120.7 (C11), 120.6 (C10), 110.7 (C5), 
102.4 (C8), 46.0 (C3), 30.3 (C12), 30.3 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3400, 2960, 
2921, 2853, 1703, 1625, 1510, 1455, 1403, 1346, 1274, 1249, 1161, 1092, 896, 866, 807, 
769, 725. HRMS for [C12H13NO]+ calculated 187.0997 found 187.0992. Rf (2:3 
EtOAc/PE) = 0.49. 
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4-(dibenzo[b,d]thiophen-4-yl)butan-2-one (319) 
 
Obtained following GP(VIII) at 0.2 mmol scale using quinuclidin-3-ol (5.0 mg, 40 µmol, 
20 mol%) as Lewis base catalyst. Purification by column chromatography on silica gel 
(10% EtOAc in hexane) afforded product 319 (35 mg, 0.14 mmol) as a yellowish solid in 
69% yield. 1H-NMR (600 MHz, CDCl3) δ 8.16 – 8.08 (m, 1H, H10), 8.01 (d, J = 7.7 Hz, 
1H, H7), 7.90 – 7.82 (m, 1H, H13), 7.48 – 7.43 (m, 2H, H11 and H12), 7.41 (t, J = 7.6 Hz, 
1H, H6), 7.28 (d, J = 7.2 Hz, 1H, H5), 3.18 (t, J = 7.7 Hz, 2H, H3), 2.93 (t, J = 7.7 Hz, 
2H, H2), 2.17 (s, 3H, H16). 13C-NMR (151 MHz, CDCl3) δ 207.6 (C1), 139.0 (C14 or C15), 
138.9 (C15 or C14), 136.2 (C8 or C9), 135.9 (C9 or C8), 135.2 (C4), 126.8 (C12), 126.3 (C5), 
125.0 (C6), 124.5 (C11), 122.9 (C10), 121.8 (C13), 119.7 (C7), 42.7 (C2), 30.1 (C3), 29.0 
(C16). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3063, 2905, 1713, 1582, 1443, 1403, 1356, 1161, 
1054, 1021, 791, 706. HRMS for [C16H15O32S]+ calculated 255.0838 found 255.0834. Rf 
(2:3 EtOAc/PE) = 0.60. M.p. = 85–87°C 
6-phenylhexan-2-one (324) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (3% EtOAc in hexane) afforded product 324 (25 mg, 0.14 
mmol) as colourless oil in 70% yield. Repeating the same procedure with Mes-Acr-4 
instead of Ir-4 afforded the same product in 89% yield. 1H-NMR (600 MHz, CDCl3) δ 
7.31 – 7.26 (m, 2H, H8), 7.21 – 7.16 (m, 3H, H7 and H9), 2.67 – 2.60 (m, 2H, H5), 2.48 – 
2.42 (m, 2H, H2), 2.13 (s, 3H, H10), 1.67 – 1.60 (m, 4H, H2 and H3). 13C-NMR 
(151 MHz, CDCl3) δ 208.9 (C1), 142.2 (C6), 128.4 (C7), 128.3 (C8), 125.7 (C9), 43.6 (C2), 
35.7 (C5), 30.9 (C10), 29.9 (C4), 23.5 (C3). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2989, 2922, 
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1712, 1454, 1356, 1159, 1031, 745, 699. HRMS for [C12H17NO]+ calculated 177.1279 
found 177.1279. Rf (1:4 EtOAc/PE) = 0.43. 
6-methylheptan-2-one (325) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (10% Et2O in pentane) afforded product 325 (15 mg, 0.12 
mmol) as colourless oil in 60% yield. 1H-NMR (600 MHz, CDCl3) δ 2.40 (t, J = 7.5 Hz, 
2H, H2), 2.13 (s, 3H, H7), 1.60 – 1.54 (m, 3H, H3 and H5), 1.19 – 1.08 (m, 2H, H4), 0.87 
(d, J = 6.6 Hz, 6H, H6). 13C-NMR (151 MHz, CDCl3) δ 209.4 (C1), 44.0 (C2), 38.4 (C4), 
29.8 (C5), 27.8 (C7), 22.5 (C6), 21.7 (C3). HRMS for [C8H17O]+ calculated 129.1274 
found 129.1268. Rf (1:4 EtOAc/PE) = 0.43. Spectroscopic data were consistent with 
literature values.[302] 
10-bromodecan-2-one (326) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Filtration on silica gel (5% EtOAc in 
hexane) afforded product 326 (33 mg, 0.14 mmol) as colourless oil in 71% yield. 
Repeating the same procedure with Mes-Acr-4 instead of Ir-4 afforded the same product 
in 55% yield. 1H-NMR (600 MHz, CDCl3) δ 3.39 (t, J = 6.8 Hz, 2H, H9), 2.41 (t, J = 7.4 
Hz, 2H, H2), 2.12 (s, 3H, H10), 1.84 (p, J = 7.0 Hz, 2H, H8), 1.60 – 1.49 (m, 2H, H3), 1.44 
– 1.38 (m, 2H, H7), 1.34 – 1.26 (m, 6H, H4, H5 and H6). 13C-NMR (151 MHz, CDCl3) δ 
209.2 (C1), 43.7 (C2), 34.0 (C9), 32.7 (C8), 29.9 (C10), 29.2 (C5), 29.0 (C6), 28.5 (C4), 28.1 
(C7), 23.7 (C3). HRMS for [C10H20OBr]+ calculated 235.0698 found 235.0693. Rf (1:4 
EtOAc/PE) = 0.44. Spectroscopic data were consistent with literature values.[303] 
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4-cyclobutylbutan-2-one (327) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (5% Et2O in pentane) afforded product 327 (17 mg, 
0.14 mmol) as colourless oil in 68% yield. 1H-NMR (600 MHz, CDCl3) δ 2.31 (t, J = 7.6 
Hz, 2H, H2), 2.25 – 2.16 (m, 1H, H4), 2.11 (s, 3H, H8), 2.05 – 1.97 (m, 2H, H5a), 1.86 – 
1.74 (m, 2H, H5b), 1.64 (q, J = 7.6 Hz, 2H, H3), 1.56 (pd, J = 8.8, 2.6 Hz, 2H, H6). 13C-
NMR (151 MHz, CDCl3) δ 209.3 (C1), 41.4 (C2), 35.4 (C3), 30.9 (C7), 29.8 (C4), 27.9 
(C5), 18.2 (C6). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 2956, 2925, 2857, 1719, 1441, 1411, 1358, 
1241, 1169. HRMS for [C8H15O]+ calculated 127.1117 found 127.1112. Rf (1:4 
EtOAc/PE) = 0.45. 
4-cyclohexylbutan-2-one (328) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Filtration on silica gel (10% Et2O in 
pentane) afforded product 328 (28 mg, 0.18 mmol) as colourless oil in 90% yield. 
Repeating the same procedure with Mes-Acr-4 instead of Ir-4 afforded the same product 
in 90% yield. 1H-NMR (600 MHz, CDCl3) δ 2.43 (t, J = 7.8 Hz, 2H, H2), 2.14 (s, 3H, 
H8), 1.72 – 1.63 (m, 5H, H5a, H6a and H7a), 1.50 – 1.43 (m, 2H, H3), 1.26 – 1.08 (m, 4H, 
H4, H6b and H7b), 0.93 – 0.84 (m, 2H, H5b). 13C-NMR (151 MHz, CDCl3) δ 209.6 (C1), 
41.4 (C8), 37.2 (C4), 33.1 (C5), 31.2 (C3), 29.8 (C8), 26.5 (C7), 26.2 (C6). HRMS for 
[C10H19O]+ calculated 155.1430 found 155.1428. Rf (1:4 EtOAc/PE) = 0.51. 
Spectroscopic data were consistent with literature values.[67] 
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tert-butyl 2-(3-oxobutyl)pyrrolidine-1-carboxylate (329) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (10% EtOAc in hexane) afforded product 329 (38 mg, 0.16 
mmol) as colourless oil in 80% yield. 1H-NMR (600 MHz, CDCl3) δ 3.93 – 3.59 (m, 1H, 
H4), 3.46 – 3.22 (m, 2H, H7), 2.51 – 2.32 (m, 2H, H2), 2.11 (s, 3H, H8), 1.92 – 1.71 (m, 
4H, H3a, H5a and H6), 1.64 – 1.52 (m, 2H, H3b and H5b), 1.42 (s, 9H, NBoc). 13C-NMR 
(151 MHz, CDCl3) δ 208.5 (C1), 154.8 (COOC(CH3)3), 79.1 (COOC(CH3)3), 56.5 (C4), 
46.2 (C7), 40.6 (C2), 30.5 (C5), 29.8 (C8), 28.6 (C3), 28.5 (COOC(CH3)3), 23.3 (C6).IR 
(ATR – neat) ?̃? (𝑐𝑚−1) = 2968, 2933, 2873, 1715, 1685, 1391, 1364, 1253, 1167, 1102, 
1124, 939, 864, 775. HRMS for [C13H24NO3]+ calculated 242.1756 found 242.1749. Rf 
(1:4 EtOAc/PE) = 0.20. 
2,5-dichloro-N-(2-((2-methyl-7-oxooctan-4-yl)amino)-2-oxoethyl)benzamide (330) 
 
Obtained following GP(VIII) at 0.2 mmol scale using DMAP 
(4.8 mg, 40 µmol, 20 mol%) as Lewis base catalyst. Purification by column 
chromatography on silica gel (50% EtOAc in hexane) afforded product 330 (61 mg, 0.158 
mmol) as yellowish oil in 79% yield. 1H-NMR (600 MHz, CDCl3) δ 7.61 (bt, J = 1.6 Hz, 
1H, H18), 7.36 – 7.34 (m, 3H, H11, H15 and H16), 6.43 (d, J = 9.2 Hz, 1H, H8), 4.17 – 4.07 
(m, 2H, H10), 3.98 (qt, J = 9.2, 4.6 Hz, 1H, H4), 2.57 – 2.44 (m, 2H, H2), 2.11 (s, 3H, H19), 
1.85 – 1.74 (m, 1H, H3a), 1.65 – 1.54 (m, 2H, H3b and H6), 1.35 (ddd, J = 14.5, 9.1, 5.6 
Hz, 1H, H5a), 1.29 – 1.23 (m, 1H, H5b), 0.89 (d, J = 6.6 Hz, 3H, H7a), 0.88 (d, J = 6.6 Hz, 
3H, H7b). 13C-NMR (151 MHz, CDCl3) δ 208.8 (C4), 167.8 (C9), 165.4 (C12), 135.5 
(C13), 133.2 (C14), 131.6 (C15 or C16), 131.5 (C16 or C15), 129.9 (C18), 129.2 (C17), 47.6 
(C4), 44.7 (C5), 43.8 (C10), 40.1 (C2), 30.1 (C19), 29.3 (C3), 24.9 (C6), 23.0 (C7a), 22.1 
(C7b).IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3298, 3075, 2952, 2929, 2869, 1711, 1643, 1530, 
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1463, 1368, 1292, 1257, 1167, 1098, 1046, 912, 819, 729. HRMS for [C18H25N2O3Cl2]+ 
calculated 387.1242 found 387.1237. Rf (1:1 EtOAc/PE) = 0.19. 
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5.4 Experimental data for Chapter 4 
5.4.1 Synthetic procedures and characterisation for organic dyes 
tris(3,5-dimethoxyphenyl)amine 
 
In a 250 mL two-necked round-bottom flask equipped with a magnetic stir bar were 
placed 3,5-dimethoxyaniline (1.75 g, 11.4 mmol, 1.0 equiv.), 1-bromo-3,5-
dimethoxybenzene (4.96 g, 22.8 mmol, 2.0 equiv.), and chloro[(tri-tert-butylphosphine)-
2-(2-aminobiphenyl)]palladium(II) (168.8 mg, 0.34 mmol, 3.0 mol%). The headspace 
was purged with argon and the solid content dissolved with THF (40 mL). A 2.0 M 
solution of sodium tert-butoxide in THF (23 mL, 46 mmol, 4.0 equiv.) was then added in 
one portion under argon, and the reaction mixture was heated to 70°C. After 24 h, the 
reaction mixture was cooled down to room temperature. The THF solution was filtered 
through a pad of celite® and concentrated in vacuo. Residue was dissolved with 100 mL 
of water and 50 mL of MTBE. Layers were separated and aqueous layer extracted with 
MTBE (3 x 50 mL). Combined organic layers were washed with brine and dried over 
MgSO4. Further removal of the solvent in vacuo resulted in tris(3,5-
dimethoxyphenyl)amine (4.80 g, 11.3 mmol) as a brown amorphous solid in 99% yield. 
1H-NMR (600 MHz, CDCl3) δ 6.26 (d, J = 2.3 Hz, 6H, H2), 6.17 (t, J = 2.3 Hz, 3H, H4), 
3.71 (s, 12H, H5). 13C-NMR (151 MHz, CDCl3) δ 161.1 (C3), 149.1 (C1), 103.1 (C2), 
95.5 (C4), 55.3 (C5). HRMS for [C24H28NO6]+ calculated 426.1911 found 426.1916. Rf 
(1:1 EtOAc/PE) = 0.38. Spectroscopic data were consistent with literature values.[35] 
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10-(3,5-dimethoxyphenyl)-9-mesityl-1,3,6,8-tetramethoxyacridin-10-ium 
tetrafluoroborate (Mes-Acr-4)  
 
In a 250 mL round-bottom flask equipped with a magnetic stir bar were placed tris(3,5-
dimethoxyphenyl)amine (4.80 g, 11.3 mmol, 1.0 equiv.) and 2,4,6-trimethlbenzoyl 
chloride (4.0 mL, 24 mmol, 2.1 equiv.) followed by chlorobenzene (60 mL). Triflic acid 
(950 µL, 11.3 mmol, 1.0 equiv.) was then added slowly and the mixture heated to 90°C. 
After 24 h the reaction mixture was cooled to room temperature and washed with aqueous 
0.2 M NaBF4 solution (3 × 30 mL) and water (2 × 60 mL). To the organic layer was then 
dried over MgSO4 and concentrated in vacuo and cold MTBE (200 mL) was added 
slowly until a precipitate started to form. An additional 400 mL of MTBE was added 
slowly and the mixture was stirred at 0°C for 2 h. The orange precipitate was then 
filtered-off and the solid was washed with cold MTBE (200 mL). This brown-orange 
solid was then purified by column chromatography (CH2Cl2) to afford Mes-Acr-4 (3.75 g, 
6.77 mmol) as a bright orange solid in 60% yield. 
1H-NMR (600 MHz, CDCl3) δ 6.91 (s, 2H), 6.83 (t, J = 2.2 Hz, 1H), 6.63 (d, J = 2.1 Hz, 
2H), 6.49 (d, J = 2.3 Hz, 2H), 6.19 (d, J = 2.3 Hz, 2H), 3.93 (s, 6H), 3.86 (s, 6H), 3.49 (s, 
6H), 2.38 (s, 3H), 1.84 (s, 6H). 13C-NMR (151 MHz, CDCl3) δ 168.22, 163.14, 162.22, 
160.68, 144.76, 139.81, 136.43, 131.99, 127.03, 113.32, 105.56, 102.81, 97.62, 92.67, 
57.04, 56.49, 56.21, 21.10, 20.16. HRMS for [C34H37NO611BF4]+ calculated 554.2537 
found 554.2542. Rf (CH2Cl2) = 0.08. Spectroscopic data were consistent with literature 
values.[35] 
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2,4,5,6-tetra(9H-carbazol-9-yl)isophthalonitrile (4CzlPN)  
 
In a 250 mL round-bottom flask equipped with a magnetic stir bar was added carbazole 
(3.67 g, 21.9 mmol, 4.4 equiv.). The flask was sealed with a rubber septum and flushed 
with argon. THF (44 mL) was then added, and the solution was cooled to 0°C. The flask 
was then charged with a 1.0 M NaHMDS solution in THF (20.9 mL, 20.9 mmol, 4.2 
equiv.). The resulting orange-brown solution was then allowed to warm to room 
temperature and stirred for 1 h. The flask was then charged with 
tetrafluoroisophthalonitrile (1.00 g, 5.0 mmol, 1.0 equiv.) and equipped with a reflux 
condenser. The solution was heated at 70°C under argon for 72 h. The brown mixture 
with yellow precipitate was then allowed to cool to room temperature and filtered. The 
resulting yellow solid was successively washed with Et2O (200 mL) and cold CHCl3 (300 
mL). The yellow filtrate was then purified by column chromatography (50% CH2Cl2 in 
PE) to deliver 4CzlPN (2.2 g, 2.76 mmol) as a bright yellow solid in 55% yield. 
1H-NMR (600 MHz, CDCl3) δ 8.23 (d, J = 7.7 Hz, 2H), 7.75 – 7.68 (m, 8H), 7.53 (t, J = 
7.2 Hz, 2H), 7.34 (d, J = 7.5 Hz, 2H), 7.25 – 7.21 (m, 4H), 7.13 – 7.06 (m, 8H), 6.83 (t, J 
= 8.0 Hz, 4H), 6.65 (t, J = 7.7 Hz, 2H). 13C-NMR (151 MHz, CDCl3) δ 145.2, 144.6, 
140.0, 138.2, 136.9, 134.7, 126.9, 125.8, 124.9, 124.7, 124.5, 123.8, 122.4, 121.9, 121.4, 
121.0, 120.4, 119.6, 116.3, 111.6, 109.9, 109.5, 109.4. HRMS for [C56H33N6]+ calculated 
789.2761 found 789.2770. Rf (1:1 CH2Cl2/PE) = 0.19. Spectroscopic data were consistent 
with literature values.[112] 
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5.4.2 Synthetic procedures and characterisation for starting 
materials 
diethyl 2-(4-chlorobenzylidene)malonate (357) 
 
4-Chlorobenzaldehyde (7.00 g, 50.0 mmol, 1.0 equiv.) was added to a solution of diethyl 
malonate (6.3 mL, 42.0 mmol, 0.8 equiv.) and piperidine (0.5 mL, 5.0 mmol, 0.1 equiv.) 
in toluene (25 mL). Glacial acetic acid (0.3 mL, 5.0 mmol, 0.1 equiv.) was added and the 
reaction mixture was heated to 160°C for 24 h with a Dean-Stark apparatus. The solvent 
was evaporated under reduced pressure and the orange residue was diluted with EtOAc 
(30 mL). The organic phase was washed with water (30 mL), aqueous 1 M HCl (30 mL), 
saturated aqueous NaHCO3 (30 mL) and brine (30 mL). The organic phase was then dried 
over MgSO4 and the solvents removed in vacuo. Column chromatography on silica gel 
(15% EtOAc in PE) afforded product 357 (4.10 g, 14.5 mmol) as a yellowish oil in 29% 
yield. 
1H-NMR (600 MHz, CDCl3) δ 7.69 (s, 1H, H3), 7.41 (d, J = 8.6 Hz, 2H, H5), 7.37 (d, J = 
8.6 Hz, 2H, H6), 4.35 (q, J = 7.1 Hz, 2H, H8), 4.32 (q, J = 7.1 Hz, 2H, H8ʹ), 1.35 (t, J = 7.1 
Hz, 3H, H9), 1.31 (t, J = 7.1 Hz, 3H, H9ʹ). 13C-NMR (151 MHz, CDCl3) δ 166.4 (C1), 
163.9 (C1ʹ), 140.6 (C3), 136.6 (C7), 131.4 (C4), 130.7 (C5), 129.1 (C6), 126.9 (C2), 61.8 
(C8), 61.8 (C8ʹ), 14.1 (C9), 13.9 (C9ʹ). HRMS for [C14H15O4ClNa]+ calculated 305.0551 
found 305.0540. Rf (2:1 EtOAc/PE) = 0.50. Spectroscopic data were consistent with 
literature values.[95] 
  
Experimental 187 
 
diethyl 2-benzylidenemalonate (358) 
 
A solution of diethylmalonate (3.8 mL, 25 mmol, 1.0 equiv.), benzaldehyde (2.4 mL, 
24 mmol, 1.0 equiv.), piperidine (0.40 mL, 4.0 mmol, 0.2 equiv.) and benzoic acid 
(0.32 g, 2.6 mmol  0.1 equiv.) in toluene (25 mL) was heated to 130°C for 21 h with a 
Dean-Stark apparatus. The reaction mixture was then washed with water (25 mL), 
aqueous 1 M HCl (25 mL), saturated aqueous NaHCO3 (25 mL) and brine (25 mL). The 
organic phase was then dried with MgSO4 and the solvents were removed in vacuo. 
Column chromatography (0% to 5% EtOAc in hexane) afforded the product 358 
(5.4 g, 22 mmol) as a yellowish oil in 91% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.74 (s, 1H, H3), 7.45 (dd, J = 7.7, 2.0 Hz, 2H, H5), 7.41 
– 7.36 (m, 3H, H6 and H7), 4.34 (q, J = 7.1 Hz, 2H, H8), 4.31 (q, J = 7.1 Hz, 2H, H8ʹ), 
1.33 (t, J = 7.1 Hz, 3H, H9), 1.28 (t, J = 7.1 Hz, 3H, H9ʹ). 13C-NMR (151 MHz, CDCl3) 
δ 166.8 (C1), 164.3 (C1ʹ), 142.3 (C3), 133.1 (C4), 130.7 (C6), 129.6 (C5), 128.9 (C7), 126.5 
(C2), 61.8 (C8 and C8ʹ), 14.3 (C9), 14.0 (C9ʹ). HRMS for [C14H15O4]+ calculated 247.0965 
found 247.0978. Rf (1:4 EtOAc/PE) = 0.53. Spectroscopic data were consistent with 
literature values.[304] 
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1,3‐diethyl 2‐(3‐methylbutylidene)propanedioate (359) 
 
A solution of diethyl malonate (7.6 mL, 50 mmol, 1.0 equiv.) and piperidine (0.5 mL, 
5.0 mmol, 0.1 equiv.) in heptane (25 mL) was mixed with glacial acetic acid (0.3 mL, 
5.0 mmol, 0.1 equiv.) and iso-valeraldehyde (5.3 mL, 50 mmol, 1.0 equiv.). The solution 
was heated to 160°C for 24 h using a Dean-Stark apparatus. Water (15 mL) and diethyl 
ether (15 mL) were then added and the phases separated. The organic phase was washed 
with saturated aqueous NaHCO3 (15 mL), brine (15 mL), water (15 mL), and dried over 
MgSO4.. Solvents were then removed in vacuo. Column chromatography on silica gel 
(5% EtOAc in PE) afforded product 359 (5.00 g, 21.9 mmol) as a colourless oil in 44% 
yield. 
1H-NMR (600 MHz, CDCl3) δ 7.01 (t, J = 8.0 Hz, 1H, H3), 4.30 (q, J = 7.1 Hz, 2H, H7), 
4.23 (q, J = 7.1 Hz, 2H, H7ʹ), 2.20 – 2.16 (m, 2H, H4), 1.86 – 1.76 (m, 1H, H5), 1.32 (t, J = 
7.1 Hz, 3H, H8), 1.29 (t, J = 7.1 Hz, 3H, H8ʹ), 0.93 (d, J = 6.7 Hz, 6H, H6). 13C-NMR 
(151 MHz, CDCl3) δ 165.7 (C1), 164.0 (C1ʹ), 148.3 (C3), 129.3 (C2), 61.2 (C7), 61.1 (C7ʹ), 
38.5 (C4), 28.2 (C5), 22.4 (C6), 14.2 (C8), 14.1 (C8ʹ). HRMS for [C12H21O4]+ calculated 
229.1434 found 229.1437. Rf (1:4 EtOAc/PE) = 0.58. Spectroscopic data were consistent 
with literature values.[305] 
diethyl 2-cyclohexylidenemalonate (360) 
 
A mixture of THF (18 mL) and CH2Cl2 (56 mL) was cooled to 0°C and TiCl4 
(5.3 mL, 48 mmol, 1.9 equiv.) was added dropwise. Diethylmalonate (3.8 mL, 25 mmol, 
1.0 equiv.) and cyclohexanone (2.7 mL, 29 mmol, 1.2 equiv.) were then added 
portionwise. The slurry was diluted by the addition of CH2Cl2 (30 mL), allowed to warm 
to room temperature and stirred for 18 h. The reaction mixture was washed with water (2 
x 40 mL), the organic layer was dried over MgSO4 and concentrated in vacuo. Column 
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chromatography on silica gel (0% to 5% EtOAc in hexane) afforded the product 360 
(3.2 g, 14 mmol) as a yellowish oil in 54% yield. 
1H-NMR (600 MHz, CDCl3) δ 4.22 (q, J = 7.1 Hz, 4H, H7), 2.59 – 2.43 (m, 4H, H4), 
1.75 – 1.65 (m, 4H, H5), 1.65 – 1.53 (m, 2H, H6), 1.28 (t, J = 7.1 Hz, 6H, H8). 13C-NMR 
(151 MHz, CDCl3) δ 165.9 (C1), 161.7 (C3), 121.9 (C2), 61.0 (C7), 32.7 (C4), 28.3 (C5), 
26.2 (C6), 14.2 (C8). HRMS for [C13H20O4Na]+ calculated 263.1259 found 263.1245. Rf 
(1:4 EtOAc/PE) = 0.63. Spectroscopic data were consistent with literature values.[306]  
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5.4.3  Synthetic procedures and characterisation for γ-amino 
butyric acid analogues 
 
GP(IX): A 10 mL microwave vial was charged with the desired alkene (0.4 mmol, 
1.0 equiv.), tert-butyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
(0.48–0.60 mmol, 1.2–1.5 equiv.), the photoredox catalyst [Ir(dF(CF3)ppy)2(bpy)]PF6 (Ir-
4, 8.0 mg, 2.0 mol%) and DMAP (9.6 mg, 80 µmol, 20 mol%) as Lewis base catalyst. 
The vial was then capped, evacuated and backfilled with argon three times before 4.0 mL 
of a degassed acetone/methanol (1:1) mixture was added to obtain a clear yellow 
transparent 0.1 M solution. This solution was then stirred while irradiated with a 
commercial blue LED strip (Ledxon, 14.4 W, 470 nm) for 24 hours, the temperature was 
maintained at 30°C using a desktop fan. The content of the vial was then concentrated in 
vacuo and purified by flash column chromatography to yield the pure product. 
 
GP(X): A 10 mL microwave vial was charged with the desired alkene (0.5 mmol, 
1.0 equiv.), tert-butyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
(0.15 g, 0.60 mmol, 1.2 equiv.), the photoredox catalyst Mes-Acr-4 (5.5 mg, 2.0 mol%) 
and DMAP (12 mg, 100 µmol, 20 mol%) as Lewis base catalyst. The vial was then 
capped, evacuated and backfilled with argon three times before 4.0 mL of a degassed 
acetone/methanol (1:1) mixture was added to obtain a clear yellow transparent 0.1 M 
solution. The clear solution was then pumped at 125 to 250 µL/min through a Vapourtec 
UV-150 photochemical reactor (10 mL reactor coil, FEP tubing, τ = 40 to 80 min) held at 
35°C. Once the reaction mixture has fully be taken up by the pump, the input was 
swapped to acetone:methanol (1:1) solvent to push the rest of the reaction mixture 
through the reactor. When the reaction plug was exiting the output stream (yellow 
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colour), the totality of the plug was collected in a vial wrapped in aluminium foil and 
concentrated in vacuo before being purified by flash column chromatography to yield the 
pure product. 
diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-(4-chlorophenyl)ethyl)malonate (361) 
 
Obtained following GP(IX) using diethyl 2-(4-chlorobenzylidene) malonate 
(0.11 g, 0.40 mmol) as olefin and tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)carbamate (0.12 g, 0.48 mmol, 1.2 equiv.). Purification by column 
chromatography on silica gel (7% to 10% EtOAc and 1% Et3N in hexane) afforded 
product 361 (0.11 g, 0.28 mmol) as a white solid in 71% yield. 
Also obtained following GP(X) using diethyl 2-(4-chlorobenzylidene) malonate 
(0.14 g, 0.50 mmol) and 60 min residence time. Purification by column chromatography 
on silica gel (7% to 10% EtOAc and 1% Et3N in hexane) afforded product 361 
(0.13 g, 0.35 mmol) as a white solid in 69% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.26 (d, J = 8.3 Hz, 2H, H5), 7.16 (d, J = 8.3 Hz, 2H, H6), 
4.52 –4.37 (m, 1H, NH), 4.23 (q, J = 7.1 Hz, 2H, H12), 3.97 – 3.88 (m, 2H, H12ʹ), 3.66 
(d, J = 10.3 Hz, 1H, H2), 3.62 – 3.54 (m, 1H, H3), 3.49 (m, 1H, H8a), 3.37 (m, 1H, H8b), 
1.36 (s, 9H, H11), 1.27 (t, J = 7.1 Hz, 3H, H13), 0.99 (t, J = 7.1 Hz, 3H, H13ʹ). 13C-NMR 
(151 MHz, CDCl3) δ 168.3 (C1), 167.7 (C1ʹ), 155.8 (C9), 137.8 (C4), 133.6 (C7), 130.1 
(C6), 129.0 (C5), 79.8 (C10), 62.2 (C12), 61.8 (C12ʹ), 55.8 (C2), 45.2 (C3), 44.1 (C8), 28.6 
(C11), 14.4 (C13), 14.1 (C13ʹ). HRMS for [C20H28NO6ClNa]+ calculated 436.1497 found 
436.1483. Rf (1:1 Et2O:PE) = 0.45. M.p. = 105–106°C. Spectroscopic data were 
consistent with literature values.[95] 
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baclofen·HCl (365) 
 
diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-(4-chlorophenyl)ethyl)malonate (361, 
0.11 g, 0.28 mmol.) was dissolved in aqueous 6 M HCl (3.0 mL) and heated to 120°C for 
24 h in a sealed vial. The solvent was removed under reduced pressure, the residue was 
dissolved in water (6.0 mL) and washed with Et2O (2 x 8 mL). Removal of the solvent in 
vacuo afforded the amino acid hydrochloride 365 (67 mg, 0.27 mmol) as white crystals in 
97% yield. 
1H-NMR (600 MHz, D2O) δ 7.47 (d, J = 8.5 Hz, 2H, H5), 7.36 (d, J = 8.5 Hz, 2H, H6), 
3.48 (m, 1H, H3), 3.40 (dd, J = 12.9, 5.0 Hz, 1H, H8a), 3.27 (dd, J = 12.9, 10.6 Hz, 
1H, H8b), 2.90 (dd, J = 16.0, 5.8 Hz, 1H, H2a), 2.80 (dd, J = 16.0, 9.4 Hz, 1H, H2b). 13C-
NMR (151 MHz, D2O) δ 173.9 (C1), 136.8 (C4), 133.4 (C7), 129.4 (C6), 129.2 (C5), 43.5 
(C8), 39.4 (C3), 38.1 (C2). HRMS for [C10H13NO2Cl]+ calculated 214.0629 found 
214.0629. M.p. 195–198°C. Spectroscopic data were consistent with literature values.[246] 
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diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-phenylethyl)malonate (362) 
 
Obtained following GP(IX) using diethyl 2-benzylidenemalonate (0.10 g, 0.41 mmol) as 
olefin and tert-butyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
(0.12 g, 0.48 mmol, 1.2 equiv.). Purification by column chromatography on silica gel (5% 
to 10% EtOAc and 1% Et3N in hexane) afforded product 362 (0.12 g, 0.32 mmol) as an 
amorphous white solid in 79% yield. 
Also obtained following GP(X) using diethyl 2-benzylidenemalonate (0.12 g, 0.50 mmol) 
as olefin and 80 min residence time. Purification by column chromatography on silica gel 
(5% to 10% EtOAc and 1% Et3N in hexane) afforded product 362 (0.14 g, 0.37 mmol) as 
an amorphous white solid in 74% yield. 
1H-NMR (600 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H, H6), 7.25 – 7.18 (m, 3H, H6, H7), 
4.42 (s, 1H, NH), 4.24 (q, J = 7.2 Hz, 2H, H12), 3.96 – 3.85 (m, 2H, H12ʹ), 3.70 
(d, J = 10.4 Hz, 1H, H2), 3.64 – 3.58 (m, 1H, H3), 3.53 (dt, J = 13.0, 6.2 Hz, 1H, H8a), 
3.45 – 3.34 (m, 1H, H8b), 1.37 (s, 9H, H11), 1.28 (t, J = 7.2 Hz, 3H, H13), 0.95 
(t, J = 7.1 Hz, 3H, H13ʹ). 13C-NMR (151 MHz, CDCl3) δ 168.3 (C1), 167.6 (C1ʹ), 155.7 
(C9), 139.0 (C4), 128.7 (C6), 128.5 (C5), 127.6 (C7), 79.4 (C10), 61.9 (C12), 61.5 (C12ʹ), 
55.9 (C2), 45.5 (C3), 44.1 (C8), 28.4 (C11), 14.2 (C13), 13.8 (C13ʹ). HRMS for 
[C20H29NO6Na]+ calculated 402.1887 found 402.1875. Rf (1:1 Et2O:PE) = 0.45. 
Spectroscopic data were consistent with literature values.[95] 
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phenibut·HCl (366) 
 
diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-phenylethyl)malonate (362, 0.12 g, 
0.32 mmol) was dissolved in aqueous 6 M HCl (3.0 mL) and heated to 120°C for 1 h. A 
small amount of active charcoal was added and the mixture was heated to 120°C for 
20 min. The mixture was allowed to cool to room temperature and filtered. Removal of 
the solvent in vacuo afforded the amino acid hydrochloride (61 mg, 0.28 mmol) as 
colourless crystals in 88% yield. 
1H-NMR (600 MHz, D2O) δ 7.47 (t, J = 7.6 Hz, 2H, H6), 7.40 (d, J = 7.6 Hz, 3H, H5 
and H7), 3.50 – 3.37 (m, 2H, H7, H8a), 3.33 – 3.23 (m, 1H, H8b), 2.92 – 2.86 (m, 1H, H2a), 
2.80 (dd, J = 16.1, 8.8 Hz, 1H, H2b).
 13C-NMR (151 MHz, D2O) δ 175.5 (C1), 138.3 (C4), 
129.3 (C6), 128.3 (C7), 127.8 (C5), 43.8 (C8), 39.9 (C3), 38.2 (C2). HRMS for 
[C10H14NO2]+ calculated 180.1019 found 180.1021. M.p. 185–188°C. Spectroscopic data 
were consistent with literature values.[246] 
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diethyl 2-(1-((tert-butoxycarbonyl)amino)-4-methylpentan-2-yl)malonate (363) 
 
Obtained following GP(IX) using diethyl 2-(3-methylbutylidene)malonate (91 mg, 
0.40 mmol) as olefin and tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)carbamate (0.12 g, 0.48 mmol, 1.2 equiv.). Purification by column 
chromatography on silica gel (0% to 7% EtOAc and 1% Et3N in hexane) afforded product 
363 (0.13 g, 0.35 mmol) as a colourless oil in 89% yield. 
Also obtained following GP(IX) using diethyl 2-(3-methylbutylidene)malonate (0.11 g, 
0.40 mmol) as olefin and 40 min residence time. Purification by column chromatography 
on silica gel (0% to 7% EtOAc and 1% Et3N in hexane) afforded product 363 
(0.15 g, 0.42 mmol) as a colourless oil in 85% yield. 
1H-NMR (600 MHz, CDCl3) δ 4.82 (t, J = 6.5 Hz, 1H, NH), 4.27 – 4.14 (m, 4H, H4, H11 
and H11ʹ), 3.38 (d, J = 6.6 Hz, 1H, H2), 3.26 (dt, J = 14.3, 5.4 Hz, 1H, H7a), 3.18 (dt, 
J = 14.3, 6.8 Hz, 1H, H7b), 2.40 (m, 1H, H3), 1.68 (m, 1H, H5) 1.41 (s, 9H, H10), 1.29 –
1.21 (m, 7H, H4a, H12 and H12ʹ), 1.11 (ddd, J = 13.8, 8.6, 5.2 Hz, 1H, H4b), 0.95 – 0.81 
(m, 6H, H6 and H6ʹ). 13C-NMR (151 MHz, CDCl3) δ 169.1 (C1 and C1ʹ), 156.0 (C8), 79.2 
(C9), 61.5 (C11 and C11ʹ), 54.3 (C2), 41.7 (C7), 39.3 (C4), 37.0 (C3), 28.5 (C10), 25.4 (C5), 
23.4 (C6), 22.1 (C6ʹ), 14.2 (C12 and C12ʹ). HRMS for [C18H33NO6Na]+ calculated 
382.2200 found 382.2188. Rf (1:1 Et2O:PE) = 0.58. Spectroscopic data were consistent 
with literature values.[96] 
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pregabalin (342) 
 
diethyl 2-(1-((tert-butoxycarbonyl)amino)-4-methylpentan-2-yl)malonate (363, 89 mg, 
0.24 mmol) was dissolved in aqueous 6 M HCl (3.0 mL) and heated to 125°C for 24 h. 
Removal of the solvent in vacuo at 60°C for 2 h afforded the amino acid hydrochloride 
367 (65 mg, 0.33 mmol) as a sticky residue in 94% yield. For the preparation of 
crystalline material, which was used for characterization, a sample of the hydrochloride 
was dissolved in water, neutralised with aqueous 1 M NaOH to pH 7 and recrystallised 
from a mixture of iso-PrOH (30%) in H2O to afford colourless crystals of pregabalin 342 
as the free amino acid. 
1H-NMR (600 MHz, D2O) δ 2.99 (m, 2H, H7a and H7b), 2.38 – 2.29 (m, 1H, H4a), 2.24 
(m, 1H, H4b), 2.21 – 2.13 (m, 1H, H3), 1.72 – 1.56 (m, 1H, H5), 1.23 (t, J = 7.2 Hz, 
2H, H2), 1.02 – 0.82 (m, 6H, H6 and H6ʹ). 13C-NMR (151 MHz, D2O) δ 181.1 (C1), 
43.7 (C7), 40.7 (C4), 40.6 (C2), 31.7 (C3), 24.4 (C5), 22.0 (C6), 21.5 (C6ʹ). HRMS for 
[C8H18NO2]+ calculated 160.1332 found 160.1334. M.p. 167–168°C. Spectroscopic data 
were consistent with literature values.[96]  
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diethyl 2-(1-((tert-butoxycarbonyl)amino)cyclohexyl)malonate (364) 
 
Obtained following GP(IX) using diethyl 2-cyclohexylidenemalonate 
(96 mg, 0.40 mmol) as olefin and tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)carbamate (0.15 g, 0.60 mmol, 1.5 equiv.). Purification by column 
chromatography on silica gel (5% to 10% EtOAc in hexane) afforded product 364 
(89 mg, 0.24 mmol) as a colourless oil in 56% yield. 
1H-NMR (600 MHz, CDCl3) δ 5.36 (t, J = 6.6 Hz, 1H, NH), 4.22 – 4.15 (m, 4H, H11), 
3.52 (s, 1H, H2), 3.37 (d, J = 6.6 Hz, 2H,  H7), 1.63 – 1.44 (m, 9H, H4, H5 and H6a), 1.42 
(s, 9H, H10), 1.37 – 1.29 (m, 1H, H6b), 1.27 (t, J = 7.1 Hz, 6H, H12). 13C-NMR (151 MHz, 
CDCl3) δ 168.7 (C1), 156.5 (C8), 79.0 (C9), 61.4 (C11), 57.5 (C2), 44.4 (C7), 40.9 (C3), 
32.2 (C4), 28.5 (C10), 25.7 (C6), 21.4 (C5), 14.2 (C12). IR (ATR – neat) ?̃? (𝑐𝑚−1) = 3420, 
1752, 1716, 1511, 1454, 1366, 1240, 1095, 1031, 758. HRMS for [C19H33NO6Na]+ 
calculated 394.2200 found 394.2188. Rf  (1:1 Et2O:PE) = 0.56. 
gabapentin·HCl (368) 
 
diethyl 2-(1-((tert-butoxycarbonyl)amino)cyclohexyl)malonate (364, 89 mg, 0.24 mmol) 
was dissolved in aqueous 6 M HCl (3.0 mL) and heated to 120°C for 24 h. The solvent 
was removed under reduced pressure, the residue was dissolved in water (6.0 mL) and 
washed with Et2O (2 x 8 mL). Removal of the solvent in vacuo afforded the amino acid 
hydrochloride 368 (45 mg, 0.22 mmol) as white crystals in 91% yield. 
1H-NMR (600 MHz, D2O) δ 3.12 (s, 2H, H7), 2.55 (s, 2H, H2), 1.56 – 1.34 
(m, 10H, H4, H5 and H6).
 13C-NMR (151 MHz, D2O) δ 176.1 (C1), 46.6 (C7), 38.8 (C2), 
34.6 (C3), 32.8 (C4), 25.0 (C6), 20.5 (C5). HRMS for [C9H18NO2]+ calculated 172.1332 
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found 172.1334. M.p. 116–118°C. Spectroscopic data were consistent with literature 
values.[307]  
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7 Appendices (NMR spectra) 
7.1 Spectra for Chapter 2 
7.1.1 Starting materials spectra 
2-(3,5-dimethoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
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13C-NMR (151 MHz, CDCl3)  
 
11B-NMR (193 MHz, CDCl3) 
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methyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzoate 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
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2-(3,5-bis(trifluoromethyl)benzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
 
19F-NMR (376 MHz, CDCl3) 
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2-(4-fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
19F-NMR (376 MHz, CDCl3) 
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2-(1-(4-methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4,4,5,5-tetramethyl-2-(1-phenylethyl)-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2-benzhydryl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3)  
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2-(2,6-difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
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2-(1-(3-Methoxyphenyl)-2-methylpropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane  
1H-NMR (400 MHz, CDCl3) 
13C-
NMR (151 MHz CDCl3) 
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11B-NMR (128 MHz, CDCl3) 
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Potassium trifluoro(4-methoxybenzyl)borate (155) 
1H-NMR (600 MHz, methanol-d4) 
13C-NMR (151 MHz, methanol-d4) 
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11B-NMR (128 MHz, methanol-d4) 
 
19F-NMR (376 MHz, methanol-d4) 
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Potassium trifluoro(1-(3-methoxyphenyl)-2-methylpropyl)borate (156) 
1H-NMR (600 MHz, methanol-d4) 
13C-NMR (151 MHz, methanol-d4) 
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11B-NMR (128 MHz, methanol-d4) 
19F-NMR (376 MHz, methanol-d4) 
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8-(1-(3-methoxyphenyl)-2-methylpropyl)hexahydro-1,3,2-oxazaborolo[2,3-b]-1,3,2-
oxazaborol-4-ium-8-uide (168) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (128 MHz, CDCl3) 
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7.1.2 Coupling products spectra 
4-(benzyl)pyridine (161) 
1H-NMR (600 MHz, CDCl3) 
13C-
NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)pyridine (162) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(1-(3-methoxyphenyl)-2-methylpropyl)pyridine (163) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)benzonitrile (173) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3)  
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2-(4-methoxybenzyl)pyrimidine (171)  
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)pyridine (162) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methylbenzyl)pyridine (191) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
  
Appendices (NMR spectra) 241 
 
4-(benzyl)pyridine (161) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(1-(4-methoxyphenyl)ethyl)pyridine (192) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(4-methoxybenzyl)isoquinoline (184) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(1-phenylethyl)isoquinoline (194) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(4-methylbenzyl)isoquinoline (193) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-benzhydrylisoquinoline (195) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(4-fluorobenzyl)isoquinoline (196) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(3,5-bis(trifluoromethyl)benzyl)isoquinoline (197) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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1-(2,6-difluorobenzyl)isoquinoline (198) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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19F-NMR (376 MHz, CDCl3) 
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1-(3,5-dimethoxybenzyl)isoquinoline (199) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine (183) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)quinoline (184) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)picolinonitrile (181) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)nicotinonitrile (182) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2-(4-methoxybenzyl)pyridine (170) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2-benzhydrylquinoline (185) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-allylpyridine (165) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-allylisoquinoline (201) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-allyl-1H-pyrrolo[2,3-b]pyridine (202) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)benzonitrile (173) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(3,5-dimethoxybenzyl)benzonitrile (247) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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methyl 4-(4-cyanobenzyl)benzoate (248) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(3,5-bis(trifluoromethyl)benzyl)benzonitrile (249) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methylbenzyl)benzonitrile (250) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-fluorobenzyl)benzonitrile (251) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-methoxy-4-(4-(trifluoromethyl)benzyl)benzene (172) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)benzaldehyde (252) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-(4-methoxybenzyl)-2-methylbenzene (253) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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1-methoxy-4-(4-vinylbenzyl)benzene (254) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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((4-(4-methoxybenzyl)phenyl)ethynyl)trimethylsilane (255) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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4-(4-methoxybenzyl)phenol (257) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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7.2 Spectra for Chapter 3 
7.2.1 Starting materials spectra 
2-(1-phenylvinyl) pyridine 
1H-NMR (400 MHz, CDCl3)  
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13C-NMR (151 MHz, CDCl3) 
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tert-butyl dimethylcarbamate 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3) 
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tert-butyl methyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
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tert-butyl ((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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11B-NMR (193 MHz, CDCl3) 
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7.2.2 Coupling products spectra 
methyl 4-(4-methoxyphenyl)butanoate (263) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3) 
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tert-butyl 4-(4-methoxyphenyl)butanoate (264) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3) 
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benzyl 4-(4-methoxyphenyl)butanoate (265) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3) 
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5-(4-methoxyphenyl)pentan-2-one (266) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(4-methoxyphenyl)butanal (267) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
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4-(4-methoxyphenyl)butanenitrile (268) 
1H-NMR (400 MHz, CDCl3) 
 
 
13C-NMR (101 MHz, CDCl3) 
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1-methoxy-4-(3-(phenylsulfonyl)propyl)benzene (269) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3) 
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methyl 4-(4-methoxyphenyl)-2-methylbutanoate (270) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
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3-(4-methoxyphenethyl) dihydrofuran-2(3H)-one (271) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2-(4-methoxybenzyl)cyclopentanone (272) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3) 
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3-(4-methoxybenzyl)cyclohexanone (273) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3) 
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Diethyl 2-(4-methoxybenzyl)succinate (274) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
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4-(3-(4-methoxyphenyl)propyl)pyridine (275) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2-(3-(4-methoxyphenyl)propyl)pyridine (276) 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (101 MHz, CDCl3)  
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2-(3-(4-methoxyphenyl)-1-phenylpropyl)pyridine (277) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3)  
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1,2,3,4,5-pentafluoro-6-(3-(4-methoxyphenyl)propyl)benzene (278) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3)  
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3-(4-methoxybenzyl) chroman-4-one (279) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3) 
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3-(4-methoxybenzyl)-2-phenylchroman-4-one (280) 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (101 MHz, CDCl3)  
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5-phenylpentan-2-one (285) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-(p-tolyl)pentan-2-one (286) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-(4-fluorophenyl)pentan-2-one (287) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-(3,5-dimethoxyphenyl)pentan-2-one (288) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-(phenylthio)pentan-2-one (289) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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tert-butyl (4-oxopentyl)carbamate (290) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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tert-butyl methyl(4-oxopentyl)carbamate (291) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-phenylhexan-2-one (292) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5-(p-tolyl)hexan-2-one (293) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5,6-diphenylhexan-2-one (294) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(1-(4-chlorophenyl)cyclobutyl)butan-2-one (297) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(4-(4-chlorophenyl)tetrahydro-2H-pyran-4-yl)butan-2-one (298) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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5,5-dimethylhexan-2-one (299) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3)  
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4-(4-methoxyphenyl)butan-2-one (308) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(4-(methylthio)phenyl)butan-2-one (309) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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tert-butyl (4-(3-oxobutyl)phenyl)carbamate (310) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3)  
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N-(4-(3-oxobutyl)phenyl)acetamide (311) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3)  
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N-(3-(3-oxobutyl)phenyl)acetamide (312) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(2-methoxyphenyl)butan-2-one (313) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(2-(methylthio)phenyl)butan-2-one (314) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(benzo[d][1,3]dioxol-5-yl)butan-2-one (315) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)butan-2-one (316) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(1H-indol-5-yl)butan-2-one (317) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(1H-indol-6-yl)butan-2-one (318) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-(dibenzo[b,d]thiophen-4-yl)butan-2-one (319) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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6-phenylhexan-2-one (324) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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6-methylheptan-2-one (325) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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10-bromodecan-2-one (326) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-cyclobutylbutan-2-one (327) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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4-cyclohexylbutan-2-one (328) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
 
  
Appendices (NMR spectra) 328 
 
tert-butyl 2-(3-oxobutyl)pyrrolidine-1-carboxylate (329) 
1H-NMR (600 MHz, CDCl3) 
 
 13C-NMR (151 MHz, CDCl3)  
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2,5-dichloro-N-(2-((2-methyl-7-oxooctan-4-yl)amino)-2-oxoethyl)benzamide (330) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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7.3 Spectra for Chapter 4 
7.3.1 Organic dyes spectra 
tris(3,5-dimethoxyphenyl)amine 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3) 
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10-(3,5-dimethoxyphenyl)-9-mesityl-1,3,6,8-tetramethoxyacridin-10-ium 
tetrafluoroborate (Mes-Acr-4) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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2,4,5,6-tetra(9H-carbazol-9-yl)isophthalonitrile (4CzlPN) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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7.3.2 Starting materials spectra 
diethyl 2-(4-chlorobenzylidene)malonate (357) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3) 
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diethyl 2-benzylidenemalonate (358) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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1,3‐diethyl 2‐(3‐methylbutylidene)propanedioate (359) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3) 
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diethyl 2-cyclohexylidenemalonate (360) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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7.3.3 Coupling products and final APIs spectra 
Diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-(4-chlorophenyl)ethyl)malonate (361) 
1H-NMR (600 MHz, CDCl3) 
 
13C-NMR (151 MHz, CDCl3)  
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baclofen·HCl (365) 
1H-NMR (600 MHz, D2O) 
13C-NMR (151 MHz, D2O)  
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diethyl 2-(2-((tert-butoxycarbonyl)amino)-1-phenylethyl)malonate (362) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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phenibut·HCl (366) 
1H-NMR (600 MHz, D2O) 
13C-NMR (151 MHz, D2O)  
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diethyl 2-(1-((tert-butoxycarbonyl)amino)-4-methylpentan-2-yl)malonate (363) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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pregabalin (342) 
1H-NMR (600 MHz, D2O) 
13C-NMR (151 MHz, D2O)  
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diethyl 2-(1-((tert-butoxycarbonyl)amino)cyclohexyl)malonate (364) 
1H-NMR (600 MHz, CDCl3) 
13C-NMR (151 MHz, CDCl3)  
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gabapentin·HCl (368) 
1H-NMR (600 MHz, D2O) 
13C-NMR (151 MHz, D2O)  
 
